Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
17 "Jin Soo Lee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Lung cancer
Phase II Study of Pemetrexed as a Salvage Chemotherapy for Thymidylate Synthase–Low Squamous Cell Lung Cancer
Mihong Choi, Heung Tae Kim, Ji-Youn Han, Geon Kook Lee, Soo-Hyun Lee, Kun Young Lim, Jungnam Joo, Hye Jin Won, Jin Soo Lee, Youngjoo Lee
Cancer Res Treat. 2021;53(1):87-92.   Published online August 13, 2020
DOI: https://doi.org/10.4143/crt.2020.741
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Squamous cell carcinomas (SqCC) of the lung often express high levels of thymidylate synthase (TS), which is associated with primary resistance to pemetrexed. We explored the efficacy of pemetrexed in a selected population of patients with lung SqCC with low TS expression.
Materials and Methods
In this single-arm phase II trial, we enrolled 32 previously-treated patients with advanced lung SqCC exhibiting low immunohistochemical staining for TS (i.e., in 10% or less of tumor cells). The primary endpoint was 12-week progression-free survival (PFS) rate.
Results
Of 32 patients, eight patients (25%) had an Eastern Cooperative Oncology Group performance status of 2, and seven patients (22%) had previously received three or more lines of chemotherapy. The disease control rate from pemetrexed treatment was 30%, and no objective response was observed. The 12-week PFS rate was 24.5% (95% confidence interval [CI], 13.0 to 46.1). Median PFS was 1.3 months (95% CI, 1.3 to 2.7), and median overall survival was 11.8 months (95% CI, 8.1 to not applicable). Most of adverse events were grade 1 or 2.
Conclusion
Pemetrexed demonstrated modest activity as a salvage chemotherapy in patients with advanced lung SqCC with low TS expression, although its toxicity was generally manageable.

Citations

Citations to this article as recorded by  
  • Bioengineered miR-7-5p modulates non–small cell lung cancer cell metabolism to improve therapy
    Gavin M. Traber, Mei-Juan Tu, Su Guan, Neelu Batra, Ai-Ming Yu
    Molecular Pharmacology.2025; 107(1): 100006.     CrossRef
  • 6,989 View
  • 129 Download
  • 1 Crossref
Close layer
Sequential Treatment with an Immune Checkpoint Inhibitor Followed by a Small-Molecule Targeted Agent Increases Drug-Induced Pneumonitis
Jongheon Jung, Hyae Young Kim, Dong-Gil Kim, Seog Yun Park, A Ra Ko, Ji-Youn Han, Heung Tae Kim, Jin Soo Lee, Youngjoo Lee
Cancer Res Treat. 2021;53(1):77-86.   Published online August 6, 2020
DOI: https://doi.org/10.4143/crt.2020.543
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Immune checkpoint inhibitors (ICI) and targeted small-molecule drugs are mainstay elements of lung cancer chemotherapy. However, they are associated with development of pneumonitis, a rare, but potentially life-threatening event. We analyzed lung cancer patients treated with ICI to evaluate the effect of sequential therapeutic administration on the incidence of pneumonitis.
Materials and Methods
In this retrospective study, 242 patients were included. Serial radiologic findings taken during and immediately after ICI treatment were reviewed. Factors that increased pneumonitis and the relationship between peri-ICI chemotherapy and the development of pneumonitis were evaluated.
Results
Pneumonitis developed in 23 patients (9.5%); severe pneumonitis (grade ≥ 3) occurred in 13 of 23 patients (56%); pneumonitis-related death occurred in six. High-dose thoracic radiation (≥ 6,000 cGy) revealed a tendency toward high risk of pneumonitis (odds ratio, 2.642; 95% confidence interval, 0.932 to 7.490; p=0.068). Among 149 patients followed for ≥ 8 weeks after the final ICI dose, more patients who received targeted agents within 8-weeks post-ICI experienced pneumonitis (3/16, 18.8%) compared with patients who received cytotoxic agents (4/54, 7.4%) or no chemotherapy (4/79, 5.1%) (p=0.162). Targeted therapy was associated with earlier-onset pneumonitis than treatment with cytotoxic agents (35 vs. 62 days post-ICI, p=0.007); the resulting pneumonitis was more severe (grade ≥ 3, 100% vs. 0%, p=0.031).
Conclusion
Sequential administration of small-molecule targeted agents immediately after ICI may increase the risk of severe pneumonitis. The sequence of chemotherapy regimens that include ICI and targeted agents should be carefully planned to reduce the risk of pneumonitis in lung cancer patients.

Citations

Citations to this article as recorded by  
  • Toxicities associated with sequential or combined use of immune checkpoint inhibitors and small targeted therapies in non-small cell lung cancer: A critical review of the literature
    Anne-Laure Désage, Michael Duruisseaux, Claire Lafitte, Sophie Bayle-Bleuez, Christos Chouaid, Pierre Fournel, Thomas Pierret
    Cancer Treatment Reviews.2024; 129: 102805.     CrossRef
  • Deep learning for predicting the risk of immune checkpoint inhibitor-related pneumonitis in lung cancer
    M. Cheng, R. Lin, N. Bai, Y. Zhang, H. Wang, M. Guo, X. Duan, J. Zheng, Z. Qiu, Y. Zhao
    Clinical Radiology.2023; 78(5): e377.     CrossRef
  • Evaluating Pneumonitis Incidence in Patients with Non–small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data
    Qi Liu, Chenan Zhang, Yue Huang, Ruihao Huang, Shiew-Mei Huang, Erin Larkins, Liza Stapleford, Donna R. Rivera, Paul G. Kluetz, Shenggang Wang, Hao Zhu, James Weese, Elizabeth Cromartie, Mahder Teka, Sheetal Walters, Frank Wolf, Thomas D. Brown
    Cancer Research Communications.2023; 3(2): 258.     CrossRef
  • Pulmonary toxicity in driver gene positive non-small cell lung cancer therapy
    Yi-Pu Zhao, Yong Long
    Current Medical Research and Opinion.2022; 38(8): 1369.     CrossRef
  • Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review
    Yuxuan Hao, Xiaoye Zhang, Li Yu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform
    Norbert Banyi, Deepu Alex, Curtis Hughesman, Kelly McNeil, Diana N. Ionescu, Carmen Ma, Stephen Yip, Barbara Melosky
    Current Oncology.2022; 29(10): 7900.     CrossRef
  • Sequential or combined immune checkpoint inhibitors and targeted therapy: Navigating uncharted waters
    K. El Husseini, M. Wislez
    Respiratory Medicine and Research.2021; 79: 100820.     CrossRef
  • Multiple drugs

    Reactions Weekly.2021; 1863(1): 255.     CrossRef
  • Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway
    Jeong Hun Kim, Won Suk Lee, Hye Jin Lee, Hannah Yang, Seung Joon Lee, So Jung Kong, Soyeon Je, Hyun-Jin Yang, Jongsun Jung, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon, Chan Kim
    OncoImmunology.2021;[Epub]     CrossRef
  • 7,926 View
  • 202 Download
  • 9 Web of Science
  • 9 Crossref
Close layer
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
Sun Min Lim, Sang-We Kim, Byoung Chul Cho, Jin Hyung Kang, Myung-Ju Ahn, Dong-Wan Kim, Young-Chul Kim, Jin Soo Lee, Jong-Seok Lee, Sung Yong Lee, Keon Uk Park, Ho Jung An, Eun Kyung Cho, Tae Won Jang, Bong-Seog Kim, Joo-Hang Kim, Sung Sook Lee, Im-II Na, Seung Soo Yoo, Ki Hyeong Lee
Cancer Res Treat. 2020;52(4):1112-1119.   Published online May 15, 2020
DOI: https://doi.org/10.4143/crt.2020.245
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The introduction of immune checkpoint inhibitors represents a major advance in the treatment of lung cancer, allowing sustained recovery in a significant proportion of patients. Nivolumab is a monoclonal anti–programmed death cell protein 1 antibody licensed for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy. In this study, we describe the demographic and clinical outcomes of patients with advanced NSCLC treated with nivolumab in the Korean expanded access program.
Materials and Methods
Previously treated patients with advanced non-squamous and squamous NSCLC patients received nivolumab at 3 mg/kg every 2 weeks up to 36 months. Efficacy data including investigator-assessed tumor response, progression data, survival, and safety data were collected.
Results
Two hundred ninety-nine patients were treated across 36 Korean centers. The objective response rate and disease control rate were 18% and 49%, respectively; the median progression-free survival was 2.1 months (95% confidence interval [CI], 1.87 to 3.45), and the overall survival (OS) was 13.2 months (95% CI, 10.6 to 18.9). Patients with smoking history and patients who experienced immune-related adverse events showed a prolonged OS. Cox regression analysis identified smoking history, presence of immune-related adverse events as positive factors associated with OS, while liver metastasis was a negative factor associated with OS. The safety profile was generally comparable to previously reported data.
Conclusion
This real-world analysis supports the use of nivolumab for pretreated NSCLC patients, including those with an older age.

Citations

Citations to this article as recorded by  
  • Advances in reprogramming of energy metabolism in tumor T cells
    Liu Xuekai, Song Yan, Chu Jian, Song Yifei, Wu Xinyue, Zhang Wenyuan, Han Shuwen, Yang Xi
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Effectiveness and Safety of PD-1 Inhibitors’ Treatment for Patients with Non-Small-Cell Lung Cancer in China: A Real-World Study
    Ning Wan, Yongbang Chen, Liqing Lu, Bing Wang, Liuliu He, Hongyi Liang, Fei Xie, Xiaoshun Jian, Bo Ji, Jianping Zhang, Hammoda Abu-Odah
    European Journal of Cancer Care.2024; 2024: 1.     CrossRef
  • Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer
    Qiang Chen, Shuo Ying, Jianwen Qin, Li Zhang
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index
    Ana Ortega-Franco, Clare Hodgson, Haseem Raja, Mathew Carter, Colin Lindsay, Sarah Hughes, Laura Cove-Smith, Paul Taylor, Yvonne Summers, Fiona Blackhall, Raffaele Califano
    Targeted Oncology.2022; 17(4): 453.     CrossRef
  • Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis
    Handai Xia, Wengang Zhang, Yuqing Zhang, Xiaoling Shang, Yanguo Liu, Xiuwen Wang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Immune-Related Adverse Events Predict the Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Patients: A Meta-Analysis
    Donghui Wang, Cen Chen, Yanli Gu, Wanjun Lu, Ping Zhan, Hongbing Liu, Tangfeng Lv, Yong Song, Fang Zhang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Broad-Spectrum Antibiotic Regimen Affects Survival in Patients Receiving Nivolumab for Non-Small Cell Lung Cancer
    Min Jung Geum, Chungsoo Kim, Ji Eun Kang, Jae Hee Choi, Jae Song Kim, Eun Sun Son, Sun Min Lim, Sandy Jeong Rhie
    Pharmaceuticals.2021; 14(5): 445.     CrossRef
  • Nivolumab

    Reactions Weekly.2021; 1855(1): 269.     CrossRef
  • Immune-Related Adverse Events Associated With Outcomes in Patients With NSCLC Treated With Anti-PD-1 Inhibitors: A Systematic Review and Meta-Analysis
    Zhe Zhao, Xinfeng Wang, Jinghan Qu, Wei Zuo, Yan Tang, Huijuan Zhu, Xiaoguang Chen
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • 10,560 View
  • 308 Download
  • 15 Web of Science
  • 9 Crossref
Close layer
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer
Joohae Kim, Hyo Jae Kang, Sung Ho Moon, Jong Mog Lee, Hyae Young Kim, Geon-Kook Lee, Jin Soo Lee, Bin Hwangbo
Cancer Res Treat. 2019;51(4):1488-1499.   Published online March 15, 2019
DOI: https://doi.org/10.4143/crt.2019.031
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used for the diagnosis and staging of lung cancer. However, evidence of its usefulness for re-biopsy in treated lung cancer, especially according to the previous treatment, is limited. We evaluated the role of EBUS-TBNA for re-biopsy and its diagnostic values in patients with different treatment histories.
Materials and Methods
We reviewed the medical records of patients who underwent EBUS-TBNA for re-biopsy of suspicious recurrent or progressive lesions between January 2006 and December 2016 at the National Cancer Center in South Korea. Patients were categorized into three groups based on the previous treatment modalities: surgery, radiation, and palliation.
Results
Among the 367 patients (surgery, n=192; radiation, n=40; palliation, n=135) who underwent EBUS-TBNA for re-biopsy, the overall sensitivity, negative predictive value (NPV), and diagnostic accuracy of EBUS-TBNA in detecting malignancy were 95.6%, 82.7%, and 96.3%, respectively. The sensitivity was lower in the radiation group (83.3%) when compared with the surgery (95.7%, p=0.042) and palliation (97.7%, p=0.012) groups. The NPV was lower in the palliation group (50.0%) than in the surgery group (88.5%, p=0.042). The sample adequacy of EBUS-TBNA specimens was lower in the radiation group (80.3%) than in the surgery (95.4%, p < 0.001) or palliation (97.8%, p < 0.001) groups. EGFR mutation analysis was feasible in 94.6% of the 92 cases, in which mutation analysis was requested. There were no major complications. Minor complications were reported in 12 patients (3.3%).
Conclusion
EBUS-TBNA showed high diagnostic values and high suitability for EGFR mutation analysis with regard to re-biopsy in patients with previously treated lung cancer. The sensitivity was lower in the radiation group and NPV was lower in the palliation group. The complication rate was low.

Citations

Citations to this article as recorded by  
  • Repeat biopsy versus initial biopsy in terms of complication risk factors and clinical outcomes for patients with non-small cell lung cancer: a comparative study of 113 CT-guided needle biopsy of lung lesions
    Yangyang Wang, Yongyuan Zhang, Nana Ren, Fangting Li, Lin Lu, Xin Zhao, Zhigang Zhou, Mengyu Gao, Meng Wang
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Artificial Intelligence Algorithm Can Predict Lymph Node Malignancy from Endobronchial Ultrasound Transbronchial Needle Aspiration Images for Non-Small Cell Lung Cancer
    Yogita S. Patel, Anthony A. Gatti, Forough Farrokhyar, Feng Xie, Waël C. Hanna
    Respiration.2024; : 1.     CrossRef
  • Place de l’endoscopie dans l’exploration du médiastin, indications et résultats
    F. Wallyn, C. Fournier, V. Jounieaux, D. Basille
    Revue des Maladies Respiratoires.2023; 40(1): 78.     CrossRef
  • Prognostic Impact of EBUS TBNA for Lung Adenocarcinoma Patients with Postoperative Recurrences
    Ying-Yi Chen, Ying-Shian Chen, Tsai-Wang Huang
    Diagnostics.2022; 12(10): 2547.     CrossRef
  • Endobronchial ultrasound-guided transbronchial needle aspiration in patients with previously treated malignancies: diagnostic performance and predictive value
    Yan Yan, Zhilong Wang, Wanpu Yan, Shijie Li, Qi Wu
    BMC Pulmonary Medicine.2022;[Epub]     CrossRef
  • The Feasibility of Interventional Pulmonology Methods for Detecting the T790M Mutation after the First or Second-Generation EGFR-TKI Resistance of Non-Small Cell Lung Cancer
    Wen-Chien Cheng, Yi-Cheng Shen, Chieh-Lung Chen, Wei-Chih Liao, Hung-Jen Chen, Te-Chun Hsia, Chia-Hung Chen, Chih-Yen Tu
    Diagnostics.2022; 13(1): 129.     CrossRef
  • Impact of EBUS-TBNA in addition to [18F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
    Maja Guberina, Kaid Darwiche, Hubertus Hautzel, Till Ploenes, Christoph Pöttgen, Nika Guberina, Ken Herrmann, Lale Umutlu, Axel Wetter, Dirk Theegarten, Clemens Aigner, Wilfried Ernst Erich Eberhardt, Martin Schuler, Rüdiger Karpf-Wissel, Martin Stuschke
    European Journal of Nuclear Medicine and Molecular Imaging.2021; 48(9): 2894.     CrossRef
  • Tissue Adequacy and Safety of Percutaneous Transthoracic Needle Biopsy for Molecular Analysis in Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis
    Bo Da Nam, Soon Ho Yoon, Hyunsook Hong, Jung Hwa Hwang, Jin Mo Goo, Suyeon Park
    Korean Journal of Radiology.2021; 22(12): 2082.     CrossRef
  • 10,538 View
  • 182 Download
  • 8 Web of Science
  • 8 Crossref
Close layer
WITHDRAWN:The Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer
Joohae Kim, Hyo Jae Kang, Sung Ho Moon, Jong Mog Lee, Hyae Young Kim, Geon-Kook Lee, Jin Soo Lee, Bin Hwangbo
Received April 16, 2018  Accepted August 21, 2018  Published online September 3, 2018  
DOI: https://doi.org/10.4143/crt.2018.222    [Accepted]
  • 417,094 View
  • 94 Download
Close layer
Lung Cancer Screening with Low-Dose CT in Female Never Smokers: Retrospective Cohort Study with Long-term National Data Follow-up
Hyae Young Kim, Kyu-Won Jung, Kun Young Lim, Soo-Hyun Lee, Jae Kwan Jun, Jeongseon Kim, Bin Hwangbo, Jin Soo Lee
Cancer Res Treat. 2018;50(3):748-756.   Published online July 17, 2017
DOI: https://doi.org/10.4143/crt.2017.312
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Because of growing concerns about lung cancer in female never smokers, chest low-dose computed tomography (LDCT) screening is often performed although it has never shown clinical benefits. We examinewhether or not female never smokers really need annual LDCT screening when the initial LDCT showed negative findings.
Materials and Methods
This retrospective cohort study included 4,365 female never smokers aged 40 to 79 years who performed initial LDCT from Aug 2002 to Dec 2007. Lung cancer diagnosis was identified from the Korea Central Cancer Registry Database registered until December 31, 2013. We calculated the incidence, cumulative probability, and standardized incidence ratio (SIR) of lung cancer by Lung Imaging Reporting and Data System (Lung-RADS) categories showed on initial LDCT.
Results
After median follow-up of 9.69 years, 22 (0.5%) had lung cancer. Lung cancer incidence for Lung-RADS category 4 was 1,848.4 (95% confidence interval [CI], 1,132.4 to 3,017.2) per 100,000 person-years and 16.4 (95% CI, 7.4 to 36.4) for categories 1, 2, and 3 combined. The cumulative probability of lung cancer for category 4 was 10.6% at 5 years and 14.8% at 10 years while they were 0.07% and 0.17% when categories 1, 2, and 3 were combined. The SIR for subjects with category 4 was 43.80 (95% CI, 25.03 to 71.14), which was much higher than 0.47 (95% CI, 0.17 to 1.02) for categories 1, 2, and 3 combined.
Conclusion
Considering the low risk of lung cancer development in female never smokers, it seems unnecessary to repeat annual LDCT screening for at least 5 years or even longer unless the initial LDCT showed Lung-RADS category 4 findings.

Citations

Citations to this article as recorded by  
  • Lung cancer screening for never smokers: current evidence and future directions
    Kay Choong See
    Singapore Medical Journal.2024;[Epub]     CrossRef
  • Cooking oil fume exposure and Lung-RADS distribution among school cafeteria workers of South Korea
    Minjun Kim, Yangho Kim, A Ram Kim, Woon Jung Kwon, Soyeoun Lim, Woojin Kim, Cheolin Yoo
    Annals of Occupational and Environmental Medicine.2024;[Epub]     CrossRef
  • Distribution of Solid Lung Nodules Presence and Size by Age and Sex in a Northern European Nonsmoking Population
    Jiali Cai, Marleen Vonder, Gert Jan Pelgrim, Mieneke Rook, Gerdien Kramer, Harry J.M. Groen, Geertruida H. de Bock, Rozemarijn Vliegenthart, Albert de Roos
    Radiology.2024;[Epub]     CrossRef
  • Low Dose Computed Tomography for Lung Cancer Screening in Tuberculosis Endemic Countries: A Systematic Review and Meta-Analysis
    Vikram Damaraju, Juhu Kiran Krushna Karri, Gayathri Gandrakota, Yamini Marimuthu, Adimulam Ganga Ravindra, Rajeev Aravindakshan, Navneet Singh
    Journal of Thoracic Oncology.2024;[Epub]     CrossRef
  • Toward More Effective Lung Cancer Risk Stratification to Empower Screening Programs for the Asian Nonsmoking Population
    Fu-Zong Wu, Yeun-Chung Chang
    Journal of the American College of Radiology.2023; 20(2): 156.     CrossRef
  • ACR Appropriateness Criteria® Lung Cancer Screening: 2022 Update
    Kim L. Sandler, Travis S. Henry, Arya Amini, Saeed Elojeimy, Aine Marie Kelly, Christopher T. Kuzniewski, Elizabeth Lee, Maria D. Martin, Michael F. Morris, Neeraja B. Peterson, Constantine A. Raptis, Gerard A. Silvestri, Arlene Sirajuddin, Betty C. Tong,
    Journal of the American College of Radiology.2023; 20(5): S94.     CrossRef
  • Performance of Lung-RADS in different target populations: a systematic review and meta-analysis
    Yifei Mao, Jiali Cai, Marjolein A. Heuvelmans, Rozemarijn Vliegenthart, Harry J. M. Groen, Matthijs Oudkerk, Marleen Vonder, Monique D. Dorrius, Geertruida H. de Bock
    European Radiology.2023; 34(3): 1877.     CrossRef
  • Preoperative computed tomography-guided patent blue localization for pulmonary nodules
    Po-Chih Chang, Shah-Hwa Chou, Che-Yu Chuang, I-Hsiao Yang, Yu-Wei Liu, Ming-Cheng Shi, Reu-Sheng Sheu, Ting-Wei Chang
    Formosan Journal of Surgery.2022; 55(3): 102.     CrossRef
  • Lung cancer screening in never-smokers: facts and remaining issues
    Maurizio V. Infante, Giuseppe Cardillo
    European Respiratory Journal.2020; 56(5): 2002949.     CrossRef
  • Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers
    Yeon Wook Kim, Hye-Rin Kang, Byoung Soo Kwon, Sung Yoon Lim, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Kyung Won Lee, Jae Ho Lee, Choon-Taek Lee
    European Respiratory Journal.2020; 56(5): 2000177.     CrossRef
  • Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model
    Li-Hsin Chien, Chung-Hsing Chen, Tzu-Yu Chen, Gee-Chen Chang, Ying-Huang Tsai, Chin-Fu Hsiao, Kuan-Yu Chen, Wu-Chou Su, Wen-Chang Wang, Ming-Shyan Huang, Yuh-Min Chen, Chih-Yi Chen, Sheng-Kai Liang, Chung-Yu Chen, Chih-Liang Wang, Mei-Hsuan Lee, Ren-Hua C
    Cancer Epidemiology, Biomarkers & Prevention.2020; 29(2): 452.     CrossRef
  • Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers
    Hye-Rin Kang, Jun Yeun Cho, Sang Hoon Lee, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Kyung Won Lee, Jae Ho Lee, Choon-Taek Lee
    Journal of Thoracic Oncology.2019; 14(3): 436.     CrossRef
  • Prevention and Early Detection for NSCLC: Advances in Thoracic Oncology 2018
    Haval Balata, Kwun M. Fong, Lizza E. Hendriks, Stephen Lam, Jamie S. Ostroff, Nir Peled, Ning Wu, Charu Aggarwal
    Journal of Thoracic Oncology.2019; 14(9): 1513.     CrossRef
  • 14,576 View
  • 357 Download
  • 16 Web of Science
  • 13 Crossref
Close layer
Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
Youngjoo Lee, Ki Hyeong Lee, Geon Kook Lee, Soo-Hyun Lee, Kun Young Lim, Jungnam Joo, Yun Jung Go, Jin Soo Lee, Ji-Youn Han
Cancer Res Treat. 2017;49(4):1001-1011.   Published online January 13, 2017
DOI: https://doi.org/10.4143/crt.2016.546
AbstractAbstract PDFPubReaderePub
Purpose
This phase II study examined whether the addition of simvastatin to afatinib provides a clinical benefit compared with afatinib monotherapy in previously treated patients with nonadenocarcinomatous non-small cell lung cancer (NA-NSCLC).
Materials and Methods
Patientswith advancedNA-NSCLCwho progressed after one ortwo chemotherapy regimens were randomly assigned to a simvastatin (40 mg/day) plus afatinib (40 mg/day) (AS) arm or to an afatinib (A) arm. The primary endpoint was response rate (RR).
Results
Sixty-eight patients were enrolled (36 in the AS arm and 32 in the A arm). The RR was 5.7% (95% confidence interval [CI], 0.7 to 19.2) for AS and 9.4% (95% CI, 2.0 to 25.0) for A (p=0.440). In arms AS and A, the median progression-free survival (PFS) was 1.0 versus 3.6 months (p=0.240) and the overall survival was 10.0 months versus 7.0 months (p=0.930), respectively. Skin rash, stomatitis, and diarrhea were the most common adverse events in both arms. More grade 3 or 4 diarrhea was observed in arm A (18.8% vs. 5.6% in arm AS). In all patients, the median PFS for treatment including afatinib was not correlated with the status of epidermal growth factor receptor (EGFR) mutation (p=0.122), EGFR fluorescence in situ hybridization (p=0.944), or EGFR immunohistochemistry (p=0.976). However, skin rash severity was significantly related to the risk of progression for afatinib (hazard ratio for skin rash grade ≥ 2 vs. grade < 2, 0.44; 95% CI, 0.25 to 0.78; p=0.005).
Conclusion
There were no significant differences in the efficacy between AS and A arms in patients with NA-NSCLC.

Citations

Citations to this article as recorded by  
  • Statins in the Cause and Prevention of Cancer: Confounding by Indication and Mediation by Rhabdomyolysis and Phosphate Toxicity
    Ronald B. Brown
    Journal of Cardiovascular Development and Disease.2024; 11(9): 296.     CrossRef
  • Unraveling lipid metabolism reprogramming for overcoming drug resistance in melanoma
    Ruilong Wang, Qin Yan, Xiao Liu, Jinfeng Wu
    Biochemical Pharmacology.2024; 223: 116122.     CrossRef
  • Cardiovascular/anti‐inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta‐analysis of randomized trials
    David J. Benjamin, Alyson Haslam, Vinay Prasad
    Cancer Medicine.2024;[Epub]     CrossRef
  • The preventative effects of statin on lung cancer development in patients with idiopathic pulmonary fibrosis using the National Health Insurance Service Database in Korea
    Yoo Jung Lee, Nayoon Kang, Junghyun Nam, Eung Gu Lee, Jiwon Ryoo, Soon Seog Kwon, Yong Hyun Kim, Hye Seon Kang, Tsai-Ching Hsu
    PLOS ONE.2024; 19(3): e0299484.     CrossRef
  • DHCR24 in Tumor Diagnosis and Treatment: A Comprehensive Review
    Xin Fu, Zhaosong Wang
    Technology in Cancer Research & Treatment.2024;[Epub]     CrossRef
  • β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers
    Pedro Gabriel Senger Braga, Janaína da Silva Vieira, Aline Rachel Bezerra Gurgel, Patricia Chakur Brum
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • The effects of statins in patients with advanced-stage cancers - a systematic review and meta-analysis
    Qiang Zhou, Zhihua Jiao, Yuxi Liu, Peter N. Devreotes, Zhenyu Zhang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients
    Claes R. Andersson, Jiawei Ye, Kristin Blom, Mårten Fryknäs, Rolf Larsson, Peter Nygren
    Anti-Cancer Drugs.2023; 34(1): 92.     CrossRef
  • New insights into the therapeutic potentials of statins in cancer
    Chengyu Liu, Hong Chen, Bicheng Hu, Jiajian Shi, Yuchen Chen, Kun Huang
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Functional significance of cholesterol metabolism in cancer: from threat to treatment
    Mingming Xiao, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Jialin Li, Hang Xu, Yingjun Zhao, Xianjun Yu, Si Shi
    Experimental & Molecular Medicine.2023; 55(9): 1982.     CrossRef
  • Simvastatin Enhanced Anti-tumor Effects of Bevacizumab against Lung Adenocarcinoma A549 Cells via Abating HIF-1α-Wnt/β-Catenin Signaling Pathway
    Xin Tu, Jian Zhang, Wei Yuan, Xia Wu, Zhi Xu, Cuo Qing
    Anti-Cancer Agents in Medicinal Chemistry.2023; 23(19): 2083.     CrossRef
  • Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs
    Kush K. Patel, Khosrow Kashfi
    Biochemical Pharmacology.2022; 196: 114654.     CrossRef
  • Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
    Yoichi Morofuji, Shinsuke Nakagawa, Kenta Ujifuku, Takashi Fujimoto, Kaishi Otsuka, Masami Niwa, Keisuke Tsutsumi
    Pharmaceuticals.2022; 15(2): 151.     CrossRef
  • Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer
    Kamal Eltayeb, Silvia La Monica, Marcello Tiseo, Roberta Alfieri, Claudia Fumarola
    Cells.2022; 11(3): 413.     CrossRef
  • Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role
    Gianmarco Marcianò, Caterina Palleria, Alessandro Casarella, Vincenzo Rania, Emanuele Basile, Luca Catarisano, Cristina Vocca, Luigi Bianco, Corrado Pelaia, Erika Cione, Bruno D’Agostino, Rita Citraro, Giovambattista De Sarro, Luca Gallelli
    Pharmaceuticals.2022; 15(5): 589.     CrossRef
  • The effects of epithelial–mesenchymal transitions in COPD induced by cigarette smoke: an update
    Xiaoshan Su, Weijing Wu, Zhixing Zhu, Xiaoping Lin, Yiming Zeng
    Respiratory Research.2022;[Epub]     CrossRef
  • Scientific Research Directions on the Histopathology and Immunohistochemistry of the Cutaneous Squamous Cell Carcinoma: A Scientometric Study
    Iuliu Gabriel Cocuz, Maria Elena Cocuz, Angela Repanovici, Adrian-Horațiu Sabău, Raluca Niculescu, Andreea-Cătălina Tinca, Vlad Vunvulea, Corina Eugenia Budin, Andreea Raluca Szoke, Maria Cătălina Popelea, Raluca Moraru, Titiana Cornelia Cotoi, Ovidiu Sim
    Medicina.2022; 58(10): 1449.     CrossRef
  • Lipid metabolism and cancer
    Xueli Bian, Rui Liu, Ying Meng, Dongming Xing, Daqian Xu, Zhimin Lu
    Journal of Experimental Medicine.2021;[Epub]     CrossRef
  • Simvastatin-romidepsin combination kills bladder cancer cells synergistically
    Kazuki Okubo, Kosuke Miyai, Kimi Kato, Takako Asano, Akinori Sato
    Translational Oncology.2021; 14(9): 101154.     CrossRef
  • Statins Decrease Programmed Death-Ligand 1 (PD-L1) by Inhibiting AKT and β-Catenin Signaling
    Woo-Jin Lim, Mingyu Lee, Yerin Oh, Xue-Quan Fang, Sujin Lee, Chang-Hoon Lim, Jooho Park, Ji-Hong Lim
    Cells.2021; 10(9): 2488.     CrossRef
  • ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells
    Jillian Hattaway Luttman, Jacob P. Hoj, Kevin H. Lin, Jiaxing Lin, Jing Jin Gu, Clay Rouse, Amanda G. Nichols, Nancie J. MacIver, Kris C. Wood, Ann Marie Pendergast
    Cell Reports.2021; 37(4): 109880.     CrossRef
  • Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT-ROC feasibility study
    L. Alexandre, A. B. Clark, S. Walton, M. P. Lewis, B. Kumar, E. C. Cheong, H. Warren, S. S. Kadirkamanathan, S. L. Parsons, S. M. Dresner, E. Sims, M. Jones, M. Hammond, M. Flather, Y. K. Loke, A. M. Swart, A. R. Hart
    BJS Open.2020; 4(1): 59.     CrossRef
  • Whether statin use improves the survival of patients with glioblastoma?
    Yonglin Xie, Qin Lu, Cameron Lenahan, Shuxu Yang, Daoyang Zhou, Xuchen Qi
    Medicine.2020; 99(9): e18997.     CrossRef
  • Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells
    Kazuki Okubo, Makoto Isono, Kosuke Miyai, Takako Asano, Akinori Sato
    Cancer Science.2020; 111(1): 112.     CrossRef
  • Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
    Paolo Gelosa, Laura Castiglioni, Marina Camera, Luigi Sironi
    Biochemical Pharmacology.2020; 177: 113895.     CrossRef
  • Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins
    Sabine Galland, Patricia Martin, Giulia Fregni, Igor Letovanec, Ivan Stamenkovic
    Cancer Letters.2020; 484: 50.     CrossRef
  • Efficacy and safety profile of statins in patients with cancer: a systematic review of randomised controlled trials
    John P. Thomas, Yoon K. Loke, Leo Alexandre
    European Journal of Clinical Pharmacology.2020; 76(12): 1639.     CrossRef
  • Statins as Anticancer Agents in the Era of Precision Medicine
    Joseph Longo, Jenna E. van Leeuwen, Mohamad Elbaz, Emily Branchard, Linda Z. Penn
    Clinical Cancer Research.2020; 26(22): 5791.     CrossRef
  • Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway
    Sheng Zhou, Huanji Xu, Qiulin Tang, Hongwei Xia, Feng Bi
    Molecular Cancer Therapeutics.2020; 19(1): 135.     CrossRef
  • Repurposed Drugs Trials by Cancer Type
    Joseph C. Murray, Benjamin Levy
    The Cancer Journal.2019; 25(2): 127.     CrossRef
  • Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate
    Saveg Yadav, Shrish Kumar Pandey, Yugal Goel, Mithlesh Kumar Temre, Sukh Mahendra Singh
    Frontiers in Pharmacology.2019;[Epub]     CrossRef
  • Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis
    Cheng-Wei Chou, Ching-Heng Lin, Tzu-Hung Hsiao, Chia-Chien Lo, Chih-Ying Hsieh, Cheng-Chung Huang, Yuh-Pyng Sher
    Scientific Reports.2019;[Epub]     CrossRef
  • Drug Repurposing of Metabolic Agents in Malignant Glioma
    Corinna Seliger, Peter Hau
    International Journal of Molecular Sciences.2018; 19(9): 2768.     CrossRef
  • The Effect of Statin Added to Systemic Anticancer Therapy: A Meta-Analysis of Randomized, Controlled Trials
    Hyun Joo Jang, Hyeong Su Kim, Jung Han Kim, Jin Lee
    Journal of Clinical Medicine.2018; 7(10): 325.     CrossRef
  • Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials
    Mohammed A. M. Farooqi, Nikita Malhotra, Som D. Mukherjee, Stephanie Sanger, Sukhbinder K. Dhesy-Thind, Peter Ellis, Darryl P. Leong, Robert M. Lafrenie
    PLOS ONE.2018; 13(12): e0209486.     CrossRef
  • Synergistic effect of receptor-interacting protein 140 and simvastatin on the inhibition of proliferation and survival of hepatocellular carcinoma cells
    Kun Xia, Panpan Zhang, Jian Hu, Huan Hou, Mingdi Xiong, Junping Xiong, Nianlong Yan
    Oncology Letters.2018;[Epub]     CrossRef
  • 12,139 View
  • 346 Download
  • 43 Web of Science
  • 36 Crossref
Close layer
Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status
Youngjoo Lee, Ji-Youn Han, Sung Ho Moon, Byung-Ho Nam, Kun Young Lim, Geon Kook Lee, Heung Tae Kim, Tak Yun, Hye Jin An, Jin Soo Lee
Cancer Res Treat. 2017;49(4):981-989.   Published online January 6, 2017
DOI: https://doi.org/10.4143/crt.2016.522
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Concurrent chemoradiotherapy (CCRT) is the standard care for stage III non-small cell lung cancer (NSCLC) patients; however, a more effective regimen is needed to improve the outcome by better controlling occult metastases. We conducted two parallel randomized phase II studies to incorporate erlotinib or irinotecan-cisplatin (IP) into CCRT for stage III NSCLC depending on epidermal growth factor receptor (EGFR) mutation status.
Materials and Methods
Patients with EGFR-mutant tumors were randomized to receive three cycles of erlotinib first and then either CCRT with erlotinib followed by erlotinib (arm A) or CCRT with IP only (arm B). Patients with EGFR unknown or wild-type tumors were randomized to receive either three cycles of IP before (arm C) or after CCRT with IP (arm D).
Results
Seventy-three patients were screened and the study was closed early because of slow accrual after 59 patients were randomized. Overall, there were seven patients in arm A, five in arm B, 22 in arm C, and 25 in arm D. The response rate was 71.4% and 80.0% for arm A and B, and 70.0% and 73.9% for arm C and D. The median overall survival (OS) was 39.3 months versus 31.2 months for arm A and B (p=0.442), and 16.3 months versus 25.3 months for arm C and D (p=0.050). Patients with sensitive EGFR mutations had significantly longer OS than EGFR-wild patients (74.8 months vs. 25.3 months, p=0.034). There were no unexpected toxicities.
Conclusion
Combined-modality treatment by molecular diagnostics is feasible in stage III NSCLC. EGFR-mutant patients appear to be a distinct subset with longer survival.

Citations

Citations to this article as recorded by  
  • Targeted treatment for unresectable EGFR mutation-positive stage III non-small cell lung cancer: Emerging evidence and future perspectives
    Terufumi Kato, Ignacio Casarini, Manuel Cobo, Corinne Faivre-Finn, Fiona Hegi-Johnson, Shun Lu, Mustafa Özgüroğlu, Suresh S. Ramalingam
    Lung Cancer.2024; 187: 107414.     CrossRef
  • The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC
    Allison E B Chang, Andrew J Piper-Vallillo, Raymond H Mak, Michael Lanuti, Alona Muzikansky, Julia Rotow, Pasi A Jänne, Mari Mino-Kenudson, Scott Swanson, Cameron D Wright, David Kozono, Paul Marcoux, Zofia Piotrowska, Lecia V Sequist, Henning Willers
    The Oncologist.2024; 29(7): 609.     CrossRef
  • Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving Scenario
    Valeria Fuorivia, Ilaria Attili, Carla Corvaja, Riccardo Asnaghi, Ambra Carnevale Schianca, Pamela Trillo Aliaga, Ester Del Signore, Gianluca Spitaleri, Antonio Passaro, Filippo de Marinis
    Current Oncology.2024; 31(9): 5121.     CrossRef
  • Comparison of treatment regimens for unresectable stage III epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer
    Xin Dai, Qian Xu, Lei Sheng, Xue Zhang, Miao Huang, Song Li, Kai Huang, Jiahui Chu, Jian Wang, Jisheng Li, Yanguo Liu, Jianyuan Zhou, Shulun Nie, Lian Liu
    Chinese Medical Journal.2024;[Epub]     CrossRef
  • Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung Cancer
    Jerold Loh, Jia Li Low, Manavi Sachdeva, Peter QJ Low, Rachel Su Jen Wong, Yiqing Huang, Puey Ling Chia, Ross A Soo
    Expert Review of Anticancer Therapy.2023; 23(9): 913.     CrossRef
  • Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery
    Farid Hajareh Haghighi, Roya Binaymotlagh, Ilaria Fratoddi, Laura Chronopoulou, Cleofe Palocci
    Gels.2023; 9(12): 953.     CrossRef
  • Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1‐STAT1 loop in lung adenocarcinoma
    Wei‐Chao Liao, Tsung‐Jen Lin, Yu‐Chin Liu, Yu‐Shan Wei, Guan‐Ying Chen, Hsiang‐Pu Feng, Yi‐Feng Chang, Hsin‐Tzu Chang, Chih‐Liang Wang, Hsinag‐Cheng Chi, Chun‐I Wang, Kwang‐Huei Lin, Wei‐Ting Ou Yang, Chia‐Jung Yu
    Cancer Science.2022; 113(1): 205.     CrossRef
  • Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
    Ligang Xing, Gang Wu, Luhua Wang, Jiancheng Li, Jianhua Wang, Zhiyong Yuan, Ming Chen, Yaping Xu, Xiaolong Fu, Zhengfei Zhu, You Lu, Chun Han, Tingyi Xia, Conghua Xie, Guang Li, Shenglin Ma, Bing Lu, Qin Lin, Guangying Zhu, Baolin Qu, Wanqi Zhu, Jinming Y
    International Journal of Radiation Oncology*Biology*Physics.2021; 109(5): 1349.     CrossRef
  • A systematic review and meta-analysis of treatment-related toxicities of curative and palliative radiation therapy in non-small cell lung cancer
    M. Or, B. Liu, J. Lam, S. Vinod, W. Xuan, R. Yeghiaian-Alvandi, E. Hau
    Scientific Reports.2021;[Epub]     CrossRef
  • Tyrosine Kinase Inhibitor Therapy in Unresectable Locally Advanced NSCLC: Keep Holding Our Breaths or Time to Take a Breather?
    Aruz Mesci, Theodoros Tsakiridis, Anand Swaminath
    Journal of Thoracic Oncology.2021; 16(10): 1607.     CrossRef
  • Experiences of patients with lung cancer receiving concurrent chemo-radiotherapy
    Choi Eunsook, Park Sunhee
    Clinical Journal of Nursing Care and Practice.2021; 5(1): 015.     CrossRef
  • Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer
    Miguel J Sotelo, José Luis García, Cesar Torres-Mattos, Héctor Milián, Carlos Carracedo, María Ángeles González-Ruiz, Xabier Mielgo-Rubio, Juan Carlos Trujillo-Reyes, Felipe Couñago
    World Journal of Clinical Oncology.2021; 12(10): 912.     CrossRef
  • PLGA nanoparticle-reinforced supramolecular peptide hydrogels for local delivery of multiple drugs with enhanced synergism
    Can Wu, Chunlu Wang, Lu Sun, Keming Xu, Wenying Zhong
    Soft Matter.2020; 16(46): 10528.     CrossRef
  • Epidermal growth factor receptor tyrosine kinase inhibitors combined with thoracic radiotherapy or chemoradiotherapy for advanced or metastatic non-small cell lung cancer: A systematic review and meta-analysis of single-arm trials
    Ruifeng Liu, Shihong Wei, Qiuning Zhang, Xueliang Zhang, Hongtao Luo, Jinhui Tian, Yi Li, Long Ge, Xiaohu Wang
    Medicine.2019; 98(29): e16427.     CrossRef
  • Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?
    Sanjal Desai, Chul Kim, Irina Veytsman
    Current Oncology Reports.2019;[Epub]     CrossRef
  • 10,410 View
  • 311 Download
  • 14 Web of Science
  • 15 Crossref
Close layer
ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer
Ji-Youn Han, Geon Kook Lee, Kun Young Lim, Young Ju Lee, Byung Ho Nam, Jin Soo Lee
Cancer Res Treat. 2017;49(3):678-687.   Published online October 11, 2016
DOI: https://doi.org/10.4143/crt.2016.365
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
We evaluated the clinical utility of excision repair cross-complementation group 1 (ERCC1) expression as a predictive biomarker for platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC).
Materials and Methods
Eligible patients were randomly assigned to the GP (gemcitabine 1,250 mg/m2 on days 1 and 8, and cisplatin 75 mg/m2 on day 1 every 3 weeks) or IP (irinotecan 65 mg/m2 and cisplatin 30 mg/m2 on days 1 and 8 every 3 weeks) arm. The primary goal of this study was to compare the response rate (RR) of the GP and IP arms according to the ERCC1 expression level.
Results
A total of 279 patients were randomly assigned to the GP (n=139) and IP (n=140) arms, among which 63% were ERCC1-positive and 268 patients were assessable for the RR. The GP and IP arms did not differ significantly with respect to the RR (29.8% vs. 27.0%, respectively; p=0.082), median progression-free survival (PFS; 4.5 months vs. 3.9 months, respectively; p=0.117), and overall survival (OS; 16.5 months vs. 16.7 months, respectively; p=0.313). When comparing the efficacy between the ERCC1-positive and ERCC1-negative groups, there was no significant difference in the RR (GP, 28.2% vs. 32.6%, respectively, p=0.509; IP, 30.2% vs. 21.6%, respectively, p=0.536), median PFS (GP, 4.6 months vs. 5.0 months, respectively, p=0.506; IP, 3.9 months vs. 3.7 months, respectively, p=0.748), or median OS (GP, 18.6 months vs. 11.9 months, respectively, p=0.070; IP, 17.5 months vs. 14.0 months, respectively, p=0.821).
Conclusion
Immunohistochemical analysis of the ERCC1 expression level did not differentiate the efficacy of platinum-based chemotherapy in advanced NSCLC.

Citations

Citations to this article as recorded by  
  • Meta‐Analysis of ERCC1 Protein Expression and Platinum Chemosensitivity in Non‐Small‐Cell Lung Cancer
    Guoping Li, Dan Cheng, Jamal A. Mahajna
    Evidence-Based Complementary and Alternative Medicine.2020;[Epub]     CrossRef
  • The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma
    Yu-Liang Huang, Jun-Rong Wu, Min Fang, Hui-Liu Zhao, Zhi-Min Liu, Jian Ye, Ling-Sha Huang, Bo Zhu
    Medicine.2019; 98(14): e15090.     CrossRef
  • 10,049 View
  • 195 Download
  • 5 Web of Science
  • 2 Crossref
Close layer
A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR–Tyrosine Kinase Inhibitors
Ji-Youn Han, Ki Hyeong Lee, Sang-We Kim, Young Joo Min, Eunkyung Cho, Youngjoo Lee, Soo-Hyun Lee, Hyae Young Kim, Geon Kook Lee, Byung Ho Nam, Hyesun Han, Jina Jung, Jin Soo Lee
Cancer Res Treat. 2017;49(1):10-19.   Published online May 3, 2016
DOI: https://doi.org/10.4143/crt.2016.058
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
We examined the efficacy of poziotinib, a second-generation epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitor (TKI) in patients with lung adenocarcinoma with activating EGFR mutations, who developed acquired resistance (AR) to EGFR-TKIs.
Materials and Methods
This single-arm phase II study included EGFR-mutant lung adenocarcinoma with AR to erlotinib or gefitinib based on the Jackman criteria. Patients received poziotinib 16 mg orally once daily in a 28-day cycle. The primary endpoint was progression-free survival (PFS). Prestudy tumor biopsies and blood samples were obtained to determine resistance mechanisms.
Results
Thirty-nine patients were treated. Tumor genotyping was determined in 37 patients; 19 EGFR T790M mutations and two PIK3CAmutations were detected in the prestudy tumors, and seven T790M mutations were detected in the plasma assay. Three (8%; 95% confidence interval [CI], 2 to 21) and 17 (44%; 95% CI, 28 to 60) patients had partial response and stable disease, respectively. The median PFS and overall survival were 2.7 months (95% CI, 1.8 to 3.7) and 15.0 months (95% CI, 9.5 to not estimable), respectively. A longer PFS was observed for patients without T790M or PIK3CA mutations in tumor or plasma compared to those with these mutations (5.5 months vs. 1.8 months, p=0.003). The most frequent grade 3 adverse events were rash (59%), mucosal inflammation (26%), and stomatitis (18%). Most patients required one (n=15) or two (n=15) dose reductions.
Conclusion
Low activity of poziotinib was detected in patients with EGFR-mutant non-small cell lung cancer who developed AR to gefitinib or erlotinib, potentially because of severe-toxicityimposed dose limitation.

Citations

Citations to this article as recorded by  
  • Repeat biopsy versus initial biopsy in terms of complication risk factors and clinical outcomes for patients with non-small cell lung cancer: a comparative study of 113 CT-guided needle biopsy of lung lesions
    Yangyang Wang, Yongyuan Zhang, Nana Ren, Fangting Li, Lin Lu, Xin Zhao, Zhigang Zhou, Mengyu Gao, Meng Wang
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-Analysis
    Isabella Michelon, Maysa Vilbert, Caio Ernesto do Rego Castro, Carlos Stecca, Maria Inez Dacoregio, Manglio Rizzo, Vladmir Cláudio Cordeiro de Lima, Ludimila Cavalcante
    Journal of Personalized Medicine.2024; 14(7): 752.     CrossRef
  • 3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation
    Yoo-mi Choi, Haram Lee, Minjun Ann, Minyeong Song, Jinguen Rheey, Jinah Jang
    Biofabrication.2023; 15(3): 034104.     CrossRef
  • Association of Hypokalemia Incidence and Better Treatment Response in NSCLC Patients: A Meta-Analysis and Systematic Review on Anti-EGFR Targeted Therapy Clinical Trials
    Jiawei Zhou, Jianling Bai, Yuanping Yue, Xin Chen, Theis Lange, Dongfang You, Yang Zhao
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Anlotinib plus chemotherapy for T790M‐negative EGFR‐mutant non‐sqNSCLC resistant to TKIs: A multicenter phase 1b/2 trial
    Juan Li, Yuke Tian, Min Zheng, Jun Ge, Jiliang Zhang, Dejun Kong, Mei Chen, Ping Yu
    Thoracic Cancer.2022; 13(24): 3496.     CrossRef
  • Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers
    Vidhi Malik, Vipul Kumar, Sunil C. Kaul, Renu Wadhwa, Durai Sundar
    Biomolecules.2021; 11(2): 160.     CrossRef
  • Validation of a multicellular tumor microenvironment system for modeling patient tumor biology and drug response
    Devin G. Roller, Stephen A. Hoang, Kristopher D. Rawls, Katherine A. Owen, Michael B. Simmers, Robert A. Figler, Julia D. Wulfkuhle, Emanuel F. Petricoin, Brian R. Wamhoff, Daniel Gioeli
    Scientific Reports.2021;[Epub]     CrossRef
  • Epidermal growth factor receptor inhibitor-induced diarrhea: clinical incidence, toxicological mechanism, and management
    Gabriel Tao, Pavan Kumar Chityala
    Toxicology Research.2021; 10(3): 476.     CrossRef
  • Geriatric Nutritional Risk Index as a Prognostic Factor for Mortality in Elderly Patients with Moderate to Severe Traumatic Brain Injuries
    Wei-Ti Su, Ching-Hua Tsai, Chun-Ying Huang, Sheng-En Chou, Chi Li, Shiun-Yuan Hsu, Ching-Hua Hsieh
    Risk Management and Healthcare Policy.2021; Volume 14: 2465.     CrossRef
  • Geriatric nutritional risk index in screening malnutrition among young adult and elderly trauma patients
    Yueh-Wei Liu, Ching-Hua Tsai, Sheng-En Chou, Wei-Ti Su, Chi Li, Shiun-Yuan Hsu, Ching-Hua Hsieh
    Formosan Journal of Surgery.2021; 54(5): 183.     CrossRef
  • In silico studies on p21-activated kinase 4 inhibitors: comprehensive application of 3D-QSAR analysis, molecular docking, molecular dynamics simulations, and MM-GBSA calculation
    Yinli Gao, Hanxun Wang, Jian Wang, Maosheng Cheng
    Journal of Biomolecular Structure and Dynamics.2020; 38(14): 4119.     CrossRef
  • Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC
    Iosune Baraibar, Laura Mezquita, Ignacio Gil-Bazo, David Planchard
    Critical Reviews in Oncology/Hematology.2020; 148: 102906.     CrossRef
  • Overcoming trastuzumab resistance in HER2‐positive breast cancer using combination therapy
    Afshin Derakhshani, Zohreh Rezaei, Hossein Safarpour, Morteza Sabri, Atefeh Mir, Mohammad Amin Sanati, Fatemeh Vahidian, Ali Gholamiyan Moghadam, Ali Aghadoukht, Khalil Hajiasgharzadeh, Behzad Baradaran
    Journal of Cellular Physiology.2020; 235(4): 3142.     CrossRef
  • Toward a More Precise Future for Oncology
    Yonina R. Murciano-Goroff, Barry S. Taylor, David M. Hyman, Alison M. Schram
    Cancer Cell.2020; 37(4): 431.     CrossRef
  • Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer
    Jigar D. Vanza, Rashmin B. Patel, Mrunali R. Patel
    Journal of Drug Delivery Science and Technology.2020; 60: 102070.     CrossRef
  • Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells
    Yongchao Zhang, Zhuo-Xun Wu, Yuqi Yang, Jing-Quan Wang, Jun Li, Zoey Sun, Qiu-Xu Teng, Charles R. Ashby, Dong-Hua Yang
    Cancers.2020; 12(11): 3249.     CrossRef
  • Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib
    Nishan Tchekmedyian, Bill Paxton, Francois Lebel, Lena Keossayan, John V. Heymach
    JTO Clinical and Research Reports.2020; 1(4): 100081.     CrossRef
  • Geriatric Nutritional Risk Index as a Screening Tool to Identify Patients with Malnutrition at a High Risk of In-Hospital Mortality among Elderly Patients with Femoral Fractures—A Retrospective Study in a Level I Trauma Center
    Wei-Ti Su, Shao-Chun Wu, Chun-Ying Huang, Sheng-En Chou, Ching-Hua Tsai, Chi Li, Shiun-Yuan Hsu, Ching-Hua Hsieh
    International Journal of Environmental Research and Public Health.2020; 17(23): 8920.     CrossRef
  • Geriatric Nutritional Risk Index as a Tool to Evaluate Impact of Malnutrition Risk on Mortality in Adult Patients with Polytrauma
    Cheng-Hsi Yeh, Shao-Chun Wu, Sheng-En Chou, Wei-Ti Su, Ching-Hua Tsai, Chi Li, Shiun-Yuan Hsu, Ching-Hua Hsieh
    International Journal of Environmental Research and Public Health.2020; 17(24): 9233.     CrossRef
  • Association between Geriatric Nutritional Risk Index and Mortality in Older Trauma Patients in the Intensive Care Unit
    Hang-Tsung Liu, Shao-Chun Wu, Ching-Hua Tsai, Chi Li, Sheng-En Chou, Wei-Ti Su, Shiun-Yuan Hsu, Ching-Hua Hsieh
    Nutrients.2020; 12(12): 3861.     CrossRef
  • Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology
    Rashmi R. Shah, Devron R. Shah
    Drug Safety.2019; 42(2): 181.     CrossRef
  • Receptor tyrosine kinases in PI3K signaling: The therapeutic targets in cancer
    Wei Jiang, Meiju Ji
    Seminars in Cancer Biology.2019; 59: 3.     CrossRef
  • Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non–Small-Cell Lung Cancer
    Juliane Martin, Annika Lehmann, Frederick Klauschen, Michael Hummel, Dido Lenze, Christian Grohé, Antje Tessmer, Joachim Gottschalk, Berndt Schmidt, Hans-Wilhelm Pau, Christian Witt, Stefan Moegling, Robert Kromminga, Korinna Jöhrens
    Clinical Lung Cancer.2019; 20(5): 350.     CrossRef
  • Metastasiertes Lungenkarzinom – therapierbare molekulare Alterationen
    W. M. Brückl, J. H. Ficker
    Der Pneumologe.2019; 16(6): 343.     CrossRef
  • Successful Treatment of a Miliary Metastatic NSCLC Patient With Activating EGFR Exon 20 Insertion Mutation with Response to Poziotinib
    Juyin Yang, Jian Yang, Shao Ban, Xinmin Li, Xingde Chen, Jihua Yang, Jun Qian
    Journal of Thoracic Oncology.2019; 14(9): e198.     CrossRef
  • Targeting Epidermal Growth Factor Receptor in Non-Small-Cell-Lung Cancer: Current State and Future Perspective
    Shui-Ming Bao, Qing-Hui Hu, Wen-Ting Yang, Yao Wang, Yin-Ping Tong, Wen-Dai Bao
    Anti-Cancer Agents in Medicinal Chemistry.2019; 19(8): 984.     CrossRef
  • Maximum allele frequency observed in plasma: A potential indicator of liquid biopsy sensitivity
    Yong Tang, Xianling Liu, Zhu'an Ou, Zhe He, Qihang Zhu, Ye Wang, Mei Yang, Junyi Ye, Han Han‑Zhang, Guibin Qiao
    Oncology Letters.2019;[Epub]     CrossRef
  • TAS6417/CLN-081 Is a Pan-Mutation–Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant EGFR Mutations
    Hibiki Udagawa, Shinichi Hasako, Akihiro Ohashi, Rumi Fujioka, Yumi Hakozaki, Mikiko Shibuya, Naomi Abe, Toshiharu Komori, Tomonori Haruma, Miki Terasaka, Ryoto Fujita, Akihiro Hashimoto, Kaoru Funabashi, Hiroyuki Yasuda, Kazutaka Miyadera, Koichi Goto, D
    Molecular Cancer Research.2019; 17(11): 2233.     CrossRef
  • Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor
    Chengying Xie, Xiaozhe Wan, Haitian Quan, Mingyue Zheng, Li Fu, Yun Li, Liguang Lou
    Cancer Science.2018; 109(4): 1207.     CrossRef
  • Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
    Jacqulyne P. Robichaux, Yasir Y. Elamin, Zhi Tan, Brett W. Carter, Shuxing Zhang, Shengwu Liu, Shuai Li, Ting Chen, Alissa Poteete, Adriana Estrada-Bernal, Anh T. Le, Anna Truini, Monique B. Nilsson, Huiying Sun, Emily Roarty, Sarah B. Goldberg, Julie R.
    Nature Medicine.2018; 24(5): 638.     CrossRef
  • Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma
    In-Jae Oh, Jae Young Hur, Cheol-Kyu Park, Young-Chul Kim, Seung Joon Kim, Min Ki Lee, Hee Joung Kim, Kye Young Lee, Jae Cheol Lee, Chang-Min Choi
    Clinical Lung Cancer.2018; 19(5): e775.     CrossRef
  • Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors
    Yanmei Peng, Qiang Li, Jingyi Zhang, Wen Shen, Xu Zhang, Chenyao Sun, Huijuan Cui
    BioScience Trends.2018; 12(6): 537.     CrossRef
  • EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas
    Susan E. Jorge, Antonio R. Lucena-Araujo, Hiroyuki Yasuda, Zofia Piotrowska, Geoffrey R. Oxnard, Deepa Rangachari, Mark S. Huberman, Lecia V. Sequist, Susumu S. Kobayashi, Daniel B. Costa
    Clinical Cancer Research.2018; 24(24): 6548.     CrossRef
  • EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs
    Zhiyong Liang, Ying Cheng, Yuan Chen, Yanping Hu, Wei-Ping Liu, You Lu, Jie Wang, Ye Wang, Gang Wu, Jian-Ming Ying, He-Long Zhang, Xu-Chao Zhang, Yi-Long Wu
    Cancer Letters.2017; 403: 186.     CrossRef
  • Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer
    Xuefei Li, Caicun Zhou
    Oncotarget.2017; 8(59): 100801.     CrossRef
  • 14,558 View
  • 563 Download
  • 37 Web of Science
  • 35 Crossref
Close layer
A Phase II Study of Weekly Paclitaxel Plus Gemcitabine as a Second-Line Therapy in Patients with Metastatic or Recurrent Small Cell Lung Cancer
Tak Yun, Heung Tae Kim, Ji-Youn Han, Sung Jin Yoon, Hyae Young Kim, Byung-Ho Nam, Jin Soo Lee
Cancer Res Treat. 2016;48(2):465-472.   Published online May 26, 2015
DOI: https://doi.org/10.4143/crt.2015.061
AbstractAbstract PDFPubReaderePub
Purpose
Paclitaxel (P) and gemcitabine (G) are clinically synergistic in small cell lung cancer (SCLC). We evaluated the efficacy of PG as a salvage treatment for SCLC patients whose disease progressed after a platinum-containing regimen.
Materials and Methods
Eligibility included histologically confirmed SCLC, one dimensionally measurable disease, Eastern Cooperative Oncology Group performance status 0-2, and progressive disease after platinum-based chemotherapy. Treatment consisted of P (80 mg/m2) and G (1,000 mg/m2) on days 1 and 8 of each cycle of 21 days until disease progression.
Results
Thirty-three patients seen between December 2005 and February 2009 were selected into this study. Thirty patients (91%) had received irinotecan-platinum, and three had received etoposide-platinum. Sixteen patients (49%) had a treatment-free interval of less than 3 months. The overall response rate was 30.3% (29.4% in sensitive relapse and 31.3% in refractory relapse). The median time to progression was 12.0 weeks and median overall survival (OS) 31.0 weeks, with a 1-year OS rate of 30.3%. Toxicities were moderate and manageable with 18.2% grade (G) 4 neutropenia, 24.2% G3 thrombocytopenia, 6.1% G3 sensory neuropathy, and 3% G3 asthenia. One patient developed febrile neutropenia.
Conclusion
Second-line paclitaxel and gemcitabine were well-tolerated and moderately active in SCLC patients previously treated with platinum-based chemotherapy.

Citations

Citations to this article as recorded by  
  • Overcoming multi-drug resistance in SCLC: a synergistic approach with venetoclax and hydroxychloroquine targeting the lncRNA LYPLAL1-DT/BCL2/BECN1 pathway
    Shuxin Li, Jianyi Lv, Zhihui Li, Qiuyu Zhang, Jing Lu, Xueyun Huo, Meng Guo, Xin Liu, Changlong Li, Jinghui Wang, Hanping Shi, Li Deng, Zhenwen Chen, Xiaoyan Du
    Molecular Cancer.2024;[Epub]     CrossRef
  • Impact of Nab-Paclitaxel Plus PD-1/PD-L1 Inhibitor on Chemorefractory Relapsed Small-Cell Lung Cancer
    Fengchun Mu, Bingjie Fan, Haoqian Li, Wenru Qin, Chunni Wang, Bing Zou, Linlin Wang
    Future Oncology.2023; 19(19): 1367.     CrossRef
  • Iron oxide nanoparticles induce ferroptosis via the autophagic pathway by synergistic bundling with paclitaxel
    Qi Nie, Wenqing Chen, Tianmei Zhang, Shangrong Ye, Zhongyu Ren, Peng Zhang, Jian Wen
    Molecular Medicine Reports.2023;[Epub]     CrossRef
  • Current Strategies for Extensive Stage Small Cell Lung Cancer Beyond First-line Therapy
    Zhonglin Hao, Janeesh Sekkath Veedu
    Clinical Lung Cancer.2022; 23(1): 14.     CrossRef
  • Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
    Jan A. Stratmann, Radha Timalsina, Akin Atmaca, Vivian Rosery, Nikolaj Frost, Jürgen Alt, Cornelius F. Waller, Niels Reinmuth, Gernot Rohde, Felix C. Saalfeld, Aaron Becker von Rose, Fabian Acker, Lukas Aspacher, Miriam Möller, Martin Sebastian
    Therapeutic Advances in Medical Oncology.2022;[Epub]     CrossRef
  • Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment
    Fatima Hameedat, Nuria A. Pizarroso, Natália Teixeira, Soraia Pinto, Bruno Sarmento
    European Journal of Pharmaceutical Sciences.2022; 176: 106259.     CrossRef
  • Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data
    Chengcheng Gong, Yizhao Xie, Yannan Zhao, Yi Li, Jian Zhang, Leiping Wang, Jun Cao, Zhonghua Tao, Xichun Hu, Biyun Wang
    Therapeutic Advances in Drug Safety.2022;[Epub]     CrossRef
  • Impact of Nab-Paclitaxel Plus PD-1/PD-L1 Inhibitor Versus Traditional Chemotherapy for Retreatment Small Cell Lung Cancer Patients
    Fengchun Mu, Bingjie Fan, Wenru Qin, Shijiang Wang, Bing Zou, Linlin Wang
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • FcRn expression in cancer: Mechanistic basis and therapeutic opportunities
    Imke Rudnik-Jansen, Kenneth A. Howard
    Journal of Controlled Release.2021; 337: 248.     CrossRef
  • Nanoparticle Albumin Bound Paclitaxel in the Third-Line Treatment of Recurrent Small Cell Lung Cancer in Real-World Practice: A Single Center Experience
    Yuchao Wang, Li Li, Chunhua Xu
    Technology in Cancer Research & Treatment.2021;[Epub]     CrossRef
  • Combination therapy with carboplatin and paclitaxel for small cell lung cancer
    Atsuto Mouri, Ou Yamaguchi, Sachiko Miyauchi, Ayako Shiono, Harue Utsugi, Fuyumi Nishihara, Yoshitake Murayama, Hiroshi Kagamu, Kunihiko Kobayashi
    Respiratory Investigation.2019; 57(1): 34.     CrossRef
  • Response to and toxicity of gemcitabine for recurrent ovarian cancer according to number of previous chemotherapy regimens
    Yuji Takei, Yoshifumi Takahashi, Shizuo Machida, Akiyo Taneichi, Suzuyo Takahashi, Tomomi Nagashima, Hiroyuki Morisawa, Yasushi Saga, Shigeki Matsubara, Hiroyuki Fujiwara
    Journal of Obstetrics and Gynaecology Research.2017; 43(2): 358.     CrossRef
  • Second-line treatments of small-cell lung cancers
    Nathalie Baize, Isabelle Monnet, Laurent Greillier, Gilles Quere, Mallorie Kerjouan, Henri Janicot, Alain Vergnenegre, Jean Bernard Auliac, Christos Chouaid
    Expert Review of Anticancer Therapy.2017; 17(11): 1033.     CrossRef
  • 12,596 View
  • 126 Download
  • 12 Web of Science
  • 13 Crossref
Close layer
Special Articles
Prediction of Cancer Incidence and Mortality in Korea, 2014
Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Duk Hyoung Lee, Jin Soo Lee
Cancer Res Treat. 2014;46(2):124-130.   Published online April 15, 2014
DOI: https://doi.org/10.4143/crt.2014.46.2.124
AbstractAbstract PDFPubReaderePub
Purpose

We studied and reported on cancer incidence and mortality rates as projected for the year 2014 in order to estimate Korea's current cancer burden.

Materials and Methods

Cancer incidence data from 1999 to 2011 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2012 were acquired from Statistics Korea. Cancer incidence in 2014 was projected by fitting a linear regression model to observed age-specific cancer incidence rates against observed years, then multiplying the projected age-specific rates by the age-specific population. For cancer mortality, a similar procedure was employed, except that a Joinpoint regression model was used to determine at which year the linear trend changed significantly.

Results

A total of 265,813 new cancer cases and 74,981 cancer deaths are expected to occur in Korea in 2014. Further, the crude incidence rate per 100,000 of all sites combined will likely reach 524.7 and the age-standardized incidence rate, 338.5. Meanwhile, the crude mortality rate of all sites combined and age-standardized rate are projected to be 148.0 and 84.6, respectively. Given the rapid rise in prostate cancer cases, it is anticipated to be the fourth most frequently occurring cancer site in men for the first time.

Conclusion

Cancer has become the most prominent public health concern in Korea, and as the population ages, the nation's cancer burden will continue to increase.

Citations

Citations to this article as recorded by  
  • Updates on global epidemiology, risk and prognostic factors of gastric cancer
    Wen-Juan Yang, He-Ping Zhao, Yan Yu, Ji-Han Wang, Lei Guo, Jun-Ye Liu, Jie Pu, Jing Lv
    World Journal of Gastroenterology.2023; 29(16): 2452.     CrossRef
  • Excellent Outcomes in Children, Adolescents, and Young Adults with Ovarian Germ Cell Tumors Treated by Either Reduced- or Standard-Dose Bleomycin
    Meerim Park, Jin Kyung Suh, Jun Ah Lee, Hyeon Jin Park, Eun Young Park, Chong Woo Yoo, Myong Cheol Lim, Sang-Yoon Park, Byung Kiu Park
    Cancers.2023; 15(21): 5290.     CrossRef
  • Analysis of postoperative pulmonary complications after gastrectomy for gastric cancer: development and validation of a nomogram
    Ling Zhou, Yuanna Li, Yuanbo Ni, Cunming Liu
    Frontiers in Surgery.2023;[Epub]     CrossRef
  • Glycosidic flavonoids and their potential applications in cancer research: a review
    Abuyaseer Abusaliya, Sang Eun Ha, Pritam Bhagwan Bhosale, Hun Hwan Kim, Min Yeong Park, Preethi Vetrivel, Gon Sup Kim
    Molecular & Cellular Toxicology.2022; 18(1): 9.     CrossRef
  • Nueva clasificación molecular del carcinoma de endometrio: impacto en el diagnóstico histopatológico, tratamiento y pronóstico
    Camilo Andrés Pérez-Montiel
    MedUNAB.2022; 24(3): 365.     CrossRef
  • Clinical outcomes of targeted therapies in elderly patients aged ≥ 80 years with metastatic colorectal cancer
    Hee Ryeong Jang, Hui-Young Lee, Seo-Young Song, Kyu-Hyoung Lim
    World Journal of Clinical Cases.2022; 10(28): 10066.     CrossRef
  • The utility of high-mobility group A2 overexpression for predicting the prognosis of gastric cancer patients and its contribution to poor prognosis via chemoresistance and the propensity for the occurrence of carcinomatosis peritonei
    Hayemin Lee, Han Hong Lee, Chae Youn Lim, Junhyun Lee
    Surgery.2021; 169(5): 1213.     CrossRef
  • Immunotherapeutic advances in gastric cancer
    Akira Yoneda, Tamotsu Kuroki, Susumu Eguchi
    Surgery Today.2021; 51(11): 1727.     CrossRef
  • Apoptotic Effects of Anthocyanins from Vitis coignetiae Pulliat Are Enhanced by Augmented Enhancer of the Rudimentary Homolog (ERH) in Human Gastric Carcinoma MKN28 Cells
    Cheol Park, Won Sup Lee, Se-Il Go, Sang-Ho Jeong, Jiyun Yoo, Hee-Jae Cha, Young-Joon Lee, Heui-Soo Kim, Sun-Hee Leem, Hye Jung Kim, Gon Sup Kim, Soon-Chan Hong, Yung Hyun Choi
    International Journal of Molecular Sciences.2021; 22(6): 3030.     CrossRef
  • The effect of marital and insurance status on the survival of elderly patients with stage M1b colon cancer: a SEER-based study
    Chenghui Zhou, Yiwei Zhang, Xi Hu, Min Fang, Shuai Xiao
    BMC Cancer.2021;[Epub]     CrossRef
  • Ameliorating and anti-inflammatory role of Balanites aegyptiaca aqueous extract on Doxorubicin-induced hepatotoxicity in male Wistar rats
    Hanaa F.A. Elkareem, Abd El-Naby I. Essawy, Mahmoud Ashry, Manal A. Badawi, Khaled G. Abdel-Wahhab
    Egyptian Pharmaceutical Journal.2021; 20(2): 157.     CrossRef
  • Long non-coding RNA HOXA-AS3 facilitates the malignancy in colorectal cancer by miR-4319/SPNS2 axis
    Yang Jiang, Xiao-yu Yu, Hui-xin Sun, Xin-yue Gu, Jing-shu Geng
    Journal of Physiology and Biochemistry.2021; 77(4): 653.     CrossRef
  • A Simple Predictive Index of the Abdominal Shape for Postoperative Complications After Laparoscopy-Assisted Distal Gastrectomy for Gastric Cancer
    Wei Tao, Yu-Xi Cheng, Xiao-Yu Liu, Bin Zhang, Chao Yuan, Dong Peng, Wei Zhang
    Frontiers in Surgery.2021;[Epub]     CrossRef
  • Negative Impact of Endoscopic Submucosal Dissection on Short-Term Surgical Outcomes of Subsequent Laparoscopic Distal Gastrectomy for Gastric Cancer
    Hayemin Lee, Han Hong Lee, Kyo Young Song, Cho Hyun Park, Junhyun Lee
    Annals of Surgical Oncology.2020; 27(1): 313.     CrossRef
  • Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
    Silvia Schmidtova, Lambert C. J. Dorssers, Katarina Kalavska, Ad J. M. Gillis, J. Wolter Oosterhuis, Hans Stoop, Svetlana Miklikova, Zuzana Kozovska, Monika Burikova, Katarina Gercakova, Erika Durinikova, Michal Chovanec, Michal Mego, Lucia Kucerova, Leen
    Cancer Cell International.2020;[Epub]     CrossRef
  • Role of Human Epididymis Protein 4 (HE4) in Determining Survival of Patients With Endometrial Cancer: A Meta-Analysis
    Ying He, Jing Wang, Chun-Xing Ma, Yan-Hua Kang
    Technology in Cancer Research & Treatment.2020;[Epub]     CrossRef
  • Effect of intraoperative lung-protective mechanical ventilation on pulmonary oxygenation function and postoperative pulmonary complications after laparoscopic radical gastrectomy
    Jing Liu, Zhipeng Meng, Ran lv, Yaping Zhang, Gaojian Wang, Junran Xie
    Brazilian Journal of Medical and Biological Research.2019;[Epub]     CrossRef
  • EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non–Small Cell Lung Cancer Patients
    Yong Won Choi, So Yeon Jeon, Geum Sook Jeong, Hyun Woo Lee, Seong Hyun Jeong, Seok Yun Kang, Joon Seong Park, Jin-Hyuk Choi, Young Wha Koh, Jae Ho Han, Seung Soo Sheen
    American Journal of Clinical Oncology.2018; 41(4): 385.     CrossRef
  • Early Detection is Important to Reduce the Economic Burden of Gastric Cancer
    Jie-Hyun Kim, Sung Soo Kim, Jeong Hoon Lee, Da Hyun Jung, Dae Young Cheung, Woo-Chul Chung, Soo-Heon Park
    Journal of Gastric Cancer.2018; 18(1): 82.     CrossRef
  • Safety of Laparoscopic Radical Gastrectomy in Gastric Cancer Patients with End-Stage Renal Disease
    Hayemin Lee, Cho Hyun Park, Seung Man Park, Wook Kim, Hyung Min Chin, Jin Jo Kim, Kyo Young Song, Sung Geun Kim, Kyong Hwa Jun, Jeong Goo Kim, Han Hong Lee, Junhyun Lee, Dong Jin Kim
    Journal of Gastric Cancer.2018; 18(3): 287.     CrossRef
  • Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer
    Seo Young Kang, Gi Jeong Cheon, Maria Lee, Hee Seung Kim, Jae-Weon Kim, Noh-Hyun Park, Yong Sang Song, Hyun Hoon Chung
    Translational Oncology.2017; 10(2): 178.     CrossRef
  • Evaluation of Robust Classifier Algorithm for Tissue Classification under Various Noise Levels
    Su Hyun Youn, Ki Young Shin, Ahnryul Choi, Joung Hwan Mun
    ETRI Journal.2017; 39(1): 87.     CrossRef
  • Safety of laparoscopic radical gastrectomy in gastric cancer patients with liver cirrhosis
    Dong Jin Kim, Cho Hyun Park, Wook Kim, Hyung Min Jin, Jin Jo Kim, Han Hong Lee, Jun Hyun Lee
    Surgical Endoscopy.2017; 31(10): 3898.     CrossRef
  • Burden of Disease Attributable to Smoking in Korea
    Aqeela Zahra, Hae-Kwan Cheong, Jae-Hyun Park
    Asia Pacific Journal of Public Health.2017; 29(1): 47.     CrossRef
  • Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
    Yong Won Choi, Jin-Hyuk Choi
    The Korean Journal of Internal Medicine.2017; 32(3): 422.     CrossRef
  • Single-incision endoscopic thyroidectomy for papillary thyroid cancer: A pilot study
    Jinbeom Cho, Yohan Park, Jongmin Baek, Kiyoung Sung
    International Journal of Surgery.2017; 43: 1.     CrossRef
  • Immunotherapy in Gastrointestinal Cancers
    Letizia Procaccio, Marta Schirripa, Matteo Fassan, Loredana Vecchione, Francesca Bergamo, Alessandra Anna Prete, Rossana Intini, Chiara Manai, Vincenzo Dadduzio, Alice Boscolo, Vittorina Zagonel, Sara Lonardi
    BioMed Research International.2017; 2017: 1.     CrossRef
  • Optimization of RNA Extraction from Formalin-Fixed Paraffin-Embedded Blocks for Targeted Next-Generation Sequencing
    Yoojin Choi, Aeree Kim, Jinkyoung Kim, Jinhwan Lee, Soo Yeon Lee, Chungyeul Kim
    Journal of Breast Cancer.2017; 20(4): 393.     CrossRef
  • Morusin induces apoptosis by regulating expression of Bax and Survivin in human breast cancer cells
    Sukmin Kang, Eun-Ok Kim, Sung-Hoon Kim, Jun-Hee Lee, Kwang Seok Ahn, Miyong Yun, Seok-Geun Lee
    Oncology Letters.2017; 13(6): 4558.     CrossRef
  • Is the Location of the Tumor Another Prognostic Factor for Patients With Colon Cancer?
    Myung-Kyu Jung, Ui Sup Shin, Young-Jun Ki, Yong-Bae Kim, Sun-Mi Moon, Se-Jin Sung
    Annals of Coloproctology.2017; 33(6): 210.     CrossRef
  • Stromal p16 expression is significantly increased in endometrial carcinoma
    Gun Yoon, Chang Won Koh, Nara Yoon, Ji-Ye Kim, Hyun-Soo Kim
    Oncotarget.2017; 8(3): 4826.     CrossRef
  • Postoperative Lower Extremity Edema in Patients with Primary Endometrial Cancer
    Hyo Sook Bae, Myong Cheol Lim, Jeong Seon Lee, Yumi Lee, Byung Ho Nam, Sang-Soo Seo, Sokbom Kang, Seung Hyun Chung, Joo-Young Kim, Sang-Yoon Park
    Annals of Surgical Oncology.2016; 23(1): 186.     CrossRef
  • Comparison of Lower Extremity Edema in Locally Advanced Cervical Cancer: Pretreatment Laparoscopic Surgical Staging with Tailored Radiotherapy Versus Primary Radiotherapy
    Se Ik Kim, Myong Cheol Lim, Jeong Seon Lee, Yeon-Joo Kim, Sang-Soo Seo, Sokbom Kang, Chong Woo Yoo, Byung-Ho Nam, Joo-Young Kim, Seung Hyun Chung, Sang-Yoon Park
    Annals of Surgical Oncology.2016; 23(1): 203.     CrossRef
  • Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of
    Jin Hyoung Kang, Myung-Ju Ahn, Dong-Wan Kim, Eun Kyung Cho, Joo-Hang Kim, Sang Won Shin, Xin Wang, Jong Seok Kim, Mauro Orlando, Keunchil Park
    Cancer Research and Treatment.2016; 48(2): 458.     CrossRef
  • Anti-cancer effects of traditional Korean wild vegetables in complementary and alternative medicine
    Hyun-Mok Ju, Kwang-Won Yu, Sung-Dae Cho, Sun Hee Cheong, Ki Han Kwon
    Complementary Therapies in Medicine.2016; 24: 47.     CrossRef
  • Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography
    Tae-Hyung Kim, Myong Cheol Lim, Se Ik Kim, Sang-Soo Seo, Sun Ho Kim, Sang-Yoon Park
    Annals of Surgical Oncology.2016; 23(4): 1302.     CrossRef
  • Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy
    Sehhoon Park, Hwi Young Kim, Haeryoung Kim, Jin Hyun Park, Jung Ho Kim, Ki Hwan Kim, Won Kim, In Sil Choi, Yong Jin Jung, Jin-Soo Kim
    Medicine.2016; 95(2): e2454.     CrossRef
  • CompoundEGFRmutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
    Eun Young Kim, Eun Na Cho, Heae Surng Park, Ji Young Hong, Seri Lim, Jong Pil Youn, Seung Yong Hwang, Yoon Soo Chang
    Cancer Biology & Therapy.2016; 17(3): 237.     CrossRef
  • Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary
    Jeong-Yeol Park, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
    International Journal of Gynecology & Obstetrics.2016; 134(1): 49.     CrossRef
  • Risk Factors for Gallstone Formation in Resected Gastric Cancer Patients
    Kyu-hyun Paik, Jong-Chan Lee, Hyoung Woo Kim, Jingu Kang, Yoon Suk Lee, Jin-Hyeok Hwang, Sang Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Jaihwan Kim
    Medicine.2016; 95(15): e3157.     CrossRef
  • Polyphenols fromArtemisia annuaL Inhibit Adhesion and EMT of Highly Metastatic Breast Cancer Cells MDA-MB-231
    Young Shin Ko, Won Sup Lee, Radha Panchanathan, Young Nak Joo, Yung Hyun Choi, Gon Sup Kim, Jin-Myung Jung, Chung Ho Ryu, Sung Chul Shin, Hye Jung Kim
    Phytotherapy Research.2016; 30(7): 1180.     CrossRef
  • Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional Study
    Hyung Suk Kim, Ja Hyeon Ku, Se Joong Kim, Sung Joon Hong, Sung Hoo Hong, Hong Sup Kim, Tae Gyun Kwon, Jin Seon Cho, Seong Soo Jeon, Kwan Joong Joo, Han Jong Ahn, Hong Seok Park, Do Hwan Seong, Dong Deuk Kwon, Hyung Jin Kim, Jae Sung Lim, Hyung-Lae Lee
    Yonsei Medical Journal.2016; 57(4): 855.     CrossRef
  • Tumore del colon retto: percorsi diagnostici sulla base di linee guida internazionali
    Maria Golato, Marco Moretti, Stefano Martinotti, Elena Maria Toniato, Massimiliano Bonafè, Beatrice Caruso, Marika Caruso, Marzia Cozzi, Vincenzo De Iuliis, Romolo Marco Dorizzi, Mario Laneve, Franca Maria Lattanzio, Myriam Luongo, Maria Grazia Marin, Sab
    La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine.2016; 12(2): 70.     CrossRef
  • Endometrial cancer: Not your grandmother's cancer
    Jessica N. McAlpine, Sarah M. Temkin, Helen J. Mackay
    Cancer.2016; 122(18): 2787.     CrossRef
  • Knowledge of HPV and Surgery among Women Who Underwent Cervical Conization: A Korean Multi-Center Study
    So Yeun Jun, Se Ik Kim, Myong Cheol Lim, Jung-Yun Lee, San Hui Lee, Yong Jung Song, Kyoung-Chul Chun, Jae Weon Kim, Sang-Yoon Park
    Yonsei Medical Journal.2016; 57(5): 1222.     CrossRef
  • Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
    Aline Talhouk, Lien N. Hoang, Melissa K. McConechy, Quentin Nakonechny, Joyce Leo, Angela Cheng, Samuel Leung, Winnie Yang, Amy Lum, Martin Köbel, Cheng-Han Lee, Robert A. Soslow, David G. Huntsman, C. Blake Gilks, Jessica N. McAlpine
    Gynecologic Oncology.2016; 143(1): 46.     CrossRef
  • Cause of Death in Korean Men with Prostate Cancer: an Analysis of Time Trends in a Nationwide Cohort
    Jinsung Park, Beomseok Suh, Dong Wook Shin, Jun Hyuk Hong, Hanjong Ahn
    Journal of Korean Medical Science.2016; 31(11): 1802.     CrossRef
  • Use of a Comprehensive Geriatric Assessment to Predict Short-Term Postoperative Outcome in Elderly Patients With Colorectal Cancer
    Yoon Hyun Lee, Heung-Kwon Oh, Duck-Woo Kim, Myong Hoon Ihn, Jee Hyun Kim, Il Tae Son, Sung Il Kang, Gwang Il Kim, Soyeon Ahn, Sung-Bum Kang
    Annals of Coloproctology.2016; 32(5): 161.     CrossRef
  • New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care
    A. Talhouk, J. N. McAlpine
    Gynecologic Oncology Research and Practice.2016;[Epub]     CrossRef
  • Polyphenols from Korean prostrate spurge Euphorbia supina induce apoptosis through the Fas-associated extrinsic pathway and activation of ERK in human leukemic U937 cells
    MIN-HO HAN, WON SUP LEE, ARULKUMAR NAGAPPAN, HYE JUNG KIM, CHEOL PARK, GI-YOUNG KIM, SANG HOON HONG, NAM DEUK KIM, GONSUP KIM, CHUNG HO RYU, SUNG CHUL SHIN, YUNG HYUN CHOI
    Oncology Reports.2016; 36(1): 99.     CrossRef
  • Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?
    Yong Won Choi, Mi Sun Ahn, Geum Sook Jeong, Hyun Woo Lee, Seong Hyun Jeong, Seok Yun Kang, Joon Seong Park, Jin-Hyuk Choi, Soon Young Lee
    Lung Cancer.2015; 87(2): 155.     CrossRef
  • Prevalence of Precancerous Conditions and Gastric Cancer Based upon the National Cancer Screening Program in Korea for 7 Years, Single Center Experience
    Ji Hyuk Kang, Yun Jeong Lim, Jung Hyun Kang, Jae Nam Yang, Seung Min Shin, Jae Hyeuk Choi, Jin Ho Lee
    Gastroenterology Research and Practice.2015; 2015: 1.     CrossRef
  • A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancer
    Dae Ro Choi, Sang Nam Yoon, Hyeong Su Kim, Jung Han Kim, Kwang Yong Kim, Byung Chun Kim, Young Kyun Choi, Jin Bae Kim, Boram Han, Hun Ho Song, Dae Young Zang
    Cancer Chemotherapy and Pharmacology.2015; 75(3): 639.     CrossRef
  • Survival outcome in endometrial cancer patients according to hereditary predisposition
    Heon Jong Yoo, Myong Cheol Lim, Yedong Son, Sang-Soo Seo, Sokbom Kang, Sun Ho Kim, Chong Woo Yoo, Sang-Yoon Park
    Taiwanese Journal of Obstetrics and Gynecology.2015; 54(1): 24.     CrossRef
  • Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors
    Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
    Gynecologic Oncology.2015; 137(3): 418.     CrossRef
  • Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes
    Mi-Ae Jang, Sang-Heon Lee, Namshin Kim, Chang-Seok Ki
    Genetics in Medicine.2015; 17(12): 1007.     CrossRef
  • Quality of life and sexuality comparison between sexually active ovarian cancer survivors and healthy women
    Se Ik Kim, Yumi Lee, Myong Cheol Lim, Jungnam Joo, KiByung Park, Dong Ock Lee, Sang-Yoon Park
    Journal of Gynecologic Oncology.2015; 26(2): 148.     CrossRef
  • Need to Pay More Attention to Attendance at Follow-Up Consultation after Cancer Screening in Smokers and Drinkers
    Jaeyong Shin, Eun-Cheol Park, Hong-Chul Bae, Seri Hong, Suk-Yong Jang, Jae-Hyun Kim, Jee Suk Chang, Sang Gyu Lee
    Asian Pacific Journal of Cancer Prevention.2015; 16(1): 109.     CrossRef
  • Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder
    Hyung Suk Kim, Kyung Chul Moon, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku
    Scientific Reports.2015;[Epub]     CrossRef
  • Association between Promoter Polymorphisms of TFF1, TFF2, and TFF3 and the Risk of Gastric and Diffuse Gastric Cancers in a Korean Population
    Eun-Heui Jin, Sang-Il Lee, JaeWoo Kim, Eun Young Seo, Su Yel Lee, Gang Min Hur, Sanghee Shin, Jang Hee Hong
    Journal of Korean Medical Science.2015; 30(8): 1035.     CrossRef
  • Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea
    Sung Han Kim, Ho Kyung Seo, Hee Chul Shin, Sung Ja Chang, Sooin Yun, Jungnam Joo, Ja Hyeon Ku, Hyung Suk Kim, Hwang Gyun Jeon, Byong Chang Jeong, In Gab Jeong, Seok Ho Kang, Bumsik Hong
    Journal of Korean Medical Science.2015; 30(8): 1150.     CrossRef
  • Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use
    Se Ik Kim, Yumi Lee, Yedong Son, So Yeun Jun, Sooin Yun, Hyo Sook Bae, Myong Cheol Lim, So-Youn Jung, Jungnam Joo, Eun Sook Lee
    Journal of Korean Medical Science.2015; 30(11): 1604.     CrossRef
  • Survival analysis for colon subsite and rectal cancers: Experience from a single surgeon
    Inhwa Lee, Seung-Hyun Baek, Hyunsung Kim, Hong-Jae Jo, Nahm-Gun Oh, Sanghwa Ko
    Korean Journal of Clinical Oncology.2015; 11(2): 114.     CrossRef
  • Definitive radiotherapy with concurrent oncothermia for stage IIIB non-small-cell lung cancer: A case report
    SEUNG-GU YEO
    Experimental and Therapeutic Medicine.2015; 10(2): 769.     CrossRef
  • Chemotherapy for colorectal cancer in the elderly
    Jung Han Kim
    World Journal of Gastroenterology.2015; 21(17): 5158.     CrossRef
  • Comparison of adenocarcinoma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery
    Min-Hyun Baek, Jeong-Yeol Park, Daeyeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
    Gynecologic Oncology.2014; 135(3): 462.     CrossRef
  • Chemotherapy in Elderly Patients with Colorectal Cancer
    Hye Sook Han
    Korean Journal of Medicine.2014; 87(5): 530.     CrossRef
  • Diet and Cancer Risk in the Korean Population: A Meta-analysis
    Hae Dong Woo, Sohee Park, Kyungwon Oh, Hyun Ja Kim, Hae Rim Shin, Hyun Kyung Moon, Jeongseon Kim
    Asian Pacific Journal of Cancer Prevention.2014; 15(19): 8509.     CrossRef
  • Dietary Flavonoids and Gastric Cancer Risk in a Korean Population
    Hae Woo, Jeonghee Lee, Il Choi, Chan Kim, Jong Lee, Oran Kwon, Jeongseon Kim
    Nutrients.2014; 6(11): 4961.     CrossRef
  • 16,476 View
  • 103 Download
  • 75 Web of Science
  • 69 Crossref
Close layer
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011
Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Duk Hyoung Lee, Jin Soo Lee
Cancer Res Treat. 2014;46(2):109-123.   Published online April 15, 2014
DOI: https://doi.org/10.4143/crt.2014.46.2.109
AbstractAbstract PDFPubReaderePub
Purpose

This study aimed to report nationwide cancer statistics in Korea, including incidence, mortality, survival, and prevalence, and their trends.

Materials and Methods

Incidence data from 1993 to 2011 were obtained from the Korea National Cancer Incidence Database, and vital status was followed through December 31, 2012. Mortality data from 1983 to 2011 were obtained from Statistics Korea. Crude and age-standardized rates for incidence, mortality, and prevalence, and relative survival were calculated.

Results

A total of 218,017 cancer cases and 71,579 cancer deaths were reported to have occurred in 2011, and there were 1,097,253 prevalent cases identified in Korea as of January 1, 2012. Over the past 13 years (1999-2011), overall incidence rates have increased by 3.4% per year. The incidence rates of liver and cervical cancers have decreased, while those of thyroid, breast, prostate, and colorectal cancers have increased. Notably, thyroid cancer increased by 23.3% per year in both sexes, and became the most common cancer since 2009. The mortality for all cancers combined decreased by 2.7% per year from 2002 to 2011. Five-year relative survival rates of patients diagnosed in the last 5 years (2007-2011) have improved by 25.1% compared with those from 1993 to 1995.

Conclusion

Overall cancer mortality rates have declined since 2002 in Korea, while incidence has increased rapidly and survival has improved.

Citations

Citations to this article as recorded by  
  • Racial disparities of gastric cancer in the USA: an overview of epidemiology, global screening guidelines, and targeted screening in a heterogeneous population
    Jean Woo Mok, Yeong Ha Oh, Deepa Magge, Sekhar Padmanabhan
    Gastric Cancer.2024; 27(3): 426.     CrossRef
  • The Use of Lipid-based Nanocarriers to Improve Ovarian Cancer Treatment: An Overview of Recent Developments
    Junaid Tantray, Akhilesh Patel, Bhupendra G. Prajapati, Sourabh Kosey, Sankha Bhattacharya
    Current Pharmaceutical Biotechnology.2024; 25(17): 2200.     CrossRef
  • The diagnostic capability of i-scan for early gastric cancer detection: a systematic review and meta-analysis
    Andrew CANAKIS, Kourosh KALACHI, Jay BAPAYE, Nevin VARGHESE, Benjamin TWERY, Jerrold S. CANAKIS
    Minerva Gastroenterology.2024;[Epub]     CrossRef
  • Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study
    Soheil Hassanipour, Reza Zare, Alireza Shahedi, Hamed Delam
    Endocrine.2023; 82(2): 237.     CrossRef
  • Survival rate of ovarian cancer in Asian countries: a systematic review and meta-analysis
    Zahra Maleki, Mohebat Vali, Hossein-Ali Nikbakht, Soheil Hassanipour, Aida Kouhi, Saman Sedighi, Roya Farokhi, Haleh Ghaem
    BMC Cancer.2023;[Epub]     CrossRef
  • Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk
    Bin Li, Xing Shu, Haoqi Jiang, Change Shi, Le Qi, Lili Zhu, Juanyan Zhou, Min Tang, Anla Hu
    Metabolomics.2023;[Epub]     CrossRef
  • Family Communication About Cancer in Korea: A Dyadic Analysis of Parent-Adolescent Conversation
    Heeyeon Son, Laura E. Miller
    Global Qualitative Nursing Research.2023;[Epub]     CrossRef
  • Prevalence of Extensive and Limited Gastric Intestinal Metaplasia and Progression to Dysplasia and Gastric Cancer
    Monika Laszkowska, Han Truong, Adam S. Faye, Judith Kim, Sarah Xinhui Tan, Francesca Lim, Julian A. Abrams, Chin Hur
    Digestive Diseases and Sciences.2022; 67(8): 3693.     CrossRef
  • Genomic differentiation within East Asian Helicobacter pylori
    Yuanhai You, Kaisa Thorell, Lihua He, Koji Yahara, Yoshio Yamaoka, Jeong-Heon Cha, Kazunari Murakami, Yukako Katsura, Ichizo Kobayashi, Daniel Falush, Jianzhong Zhang
    Microbial Genomics .2022;[Epub]     CrossRef
  • Discovery of BRCA1/BRCA2 founder variants by haplotype analysis
    Won Kyung Kwon, Hyeok-Jae Jang, Jeong Eon Lee, Yeon Hee Park, Jai Min Ryu, Jonghan Yu, Ja-Hyun Jang, Jong-Won Kim
    Cancer Genetics.2022; 266-267: 19.     CrossRef
  • Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019
    Juhee Park, Kyeongjun Moon, Dong-Sook Kim
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Comparison of Detection of Epidermal Growth Factor Receptor (EFGR) Gene Mutation in Peripheral Blood Plasma (Liquid Biopsy) with Cytological Specimens in Lung Adenocarcinoma Patients
    Laksmi Wulandari, Gatot Soegiarto, Anna Febriani, Farah Fatmawati, Sahrun
    Indian Journal of Surgical Oncology.2021; 12(S1): 65.     CrossRef
  • Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models
    Hyeok Jun Yun, Hee Jun Kim, Jungmin Kim, Sang Yong Kim, Hang-Seok Chang, Cheong Soo Park, Ho-Jin Chang, Ki Cheong Park
    International Journal of Molecular Sciences.2021; 22(2): 536.     CrossRef
  • The utility of high-mobility group A2 overexpression for predicting the prognosis of gastric cancer patients and its contribution to poor prognosis via chemoresistance and the propensity for the occurrence of carcinomatosis peritonei
    Hayemin Lee, Han Hong Lee, Chae Youn Lim, Junhyun Lee
    Surgery.2021; 169(5): 1213.     CrossRef
  • Cost-effectiveness of prevention and early detection of gastric cancer in Western countries
    Iris Lansdorp-Vogelaar, Reinier G.S. Meester, Monika Laszkowska, Fernando Alarid Escudero, Zachary J. Ward, Jennifer M. Yeh
    Best Practice & Research Clinical Gastroenterology.2021; 50-51: 101735.     CrossRef
  • Impact of Posttraumatic Growth and Health Promoting Behavior on Quality of Life in Patients with Gastrointestinal Cancer
    Mi-Ae Kim, Hyun-Ju Lee
    Journal of Korean Academy of Fundamentals of Nursing.2021; 28(1): 32.     CrossRef
  • Apoptotic Effects of Anthocyanins from Vitis coignetiae Pulliat Are Enhanced by Augmented Enhancer of the Rudimentary Homolog (ERH) in Human Gastric Carcinoma MKN28 Cells
    Cheol Park, Won Sup Lee, Se-Il Go, Sang-Ho Jeong, Jiyun Yoo, Hee-Jae Cha, Young-Joon Lee, Heui-Soo Kim, Sun-Hee Leem, Hye Jung Kim, Gon Sup Kim, Soon-Chan Hong, Yung Hyun Choi
    International Journal of Molecular Sciences.2021; 22(6): 3030.     CrossRef
  • Needs and Self-Care Efficacy for Cancer Patients Suffering from Side Effects of Chemotherapy
    Sae'd Abu El-Kass, Marwa M. Ragheb, Safaa' M. Hamed, Anas M. Turkman, Azhar T. Zaki, Guido Bocci
    Journal of Oncology.2021; 2021: 1.     CrossRef
  • Usefulness of postoperative surveillance MR for women after breast-conservation therapy: Focusing on MR features of early and late recurrent breast cancer
    Jeongmin Lee, Bong Joo Kang, Sung Hun Kim, Pascal A. T. Baltzer
    PLOS ONE.2021; 16(6): e0252476.     CrossRef
  • Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018)
    Mohammad Aziz Rasouli, Ghobad Moradi, Bushra Zareie, Heshmatollah Sofimajidpour, Sima Tozandehjani, Hedyeh Zafari, Fatemeh Gholami, Sonia Shahsavari, Parisa Hassani, Mahshid Mohammadian
    BMC Cancer.2021;[Epub]     CrossRef
  • Negative Impact of Endoscopic Submucosal Dissection on Short-Term Surgical Outcomes of Subsequent Laparoscopic Distal Gastrectomy for Gastric Cancer
    Hayemin Lee, Han Hong Lee, Kyo Young Song, Cho Hyun Park, Junhyun Lee
    Annals of Surgical Oncology.2020; 27(1): 313.     CrossRef
  • Metabolic comorbidities and medical institution utilization among breast cancer survivors: a national population-based study
    Jaesung Heo, Mison Chun, Young-Taek Oh, O Kyu Noh, Logyoung Kim
    The Korean Journal of Internal Medicine.2020; 35(2): 421.     CrossRef
  • Screening for Upper Gastrointestinal Malignancies in the United States—Which Immigrant Groups Should Be Considered High-Risk?
    Monika Laszkowska, Aaron Oh, Chin Hur
    Gastroenterology.2020; 158(1): 4.     CrossRef
  • MiR‐145 inhibits the migration and invasion of papillary thyroid carcinoma cells through NF‐κB pathway regulation
    Gengyu Chen, Ying Gao, Gangpu Wang, Guofeng Dai, Li Tong
    Journal of Cellular Biochemistry.2020; 121(5-6): 3325.     CrossRef
  • Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis
    Soheil Hassanipour, Hamed Delam, Morteza Arab-Zozani, Elham Abdzadeh, Seyyed Ali Hosseini, Hossein-Ali Nikbakht, Mahdi Malakoutikhah, Mohammad Taghi Ashoobi, Mohammad Fathalipour, Hamid Salehiniya, Shirin Riahi
    Annals of Global Health.2020; 86(1): 2.     CrossRef
  • Comparison of clinical outcomes according to the history of previous gastrectomy in patients undergoing pancreatoduodenectomy: a propensity score matching analysis
    Jae Ri Kim, Wooil Kwon, Jihoon Chang, Jin-Young Jang, Sun-Whe Kim
    Annals of Surgical Treatment and Research.2020; 98(4): 177.     CrossRef
  • Surveillance Endoscopy Guidelines for Postgastrectomy Patients Based on Risk of Developing Remnant Gastric Cancer
    Eui Soo Han, Ho Seok Seo, Ji Hyun Kim, Han Hong Lee
    Annals of Surgical Oncology.2020; 27(11): 4216.     CrossRef
  • 17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice
    Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Ha-Na Lee, Young-Joon Surh
    Scientific Reports.2020;[Epub]     CrossRef
  • Does Thyroidectomy Impact Quality of Life: Retrospective Case–Control Study of Post-Thyroidectomy Patients and Matched Individuals from the General Population
    Hyeong Won Yu, Ah Reum An, Hye In Kang, Yong Joon Suh, Hyungju Kwon, Su-jin Kim, Young Jun Chai, June Young Choi, Hochun Choi, Kyu Eun Lee, Belong Cho
    Medicina.2020; 56(11): 603.     CrossRef
  • Analysis of risk factors and prevention strategies for functional delayed gastric emptying in 1243 patients with distal gastric cancer
    Tao Pang, Xiao-Yi Yin, Hang-Tian Cui, Zheng-Mao Lu, Ming-Ming Nie, Kai Yin, Guo-En Fang, Tian-Hang Luo, Xu-Chao Xue
    World Journal of Surgical Oncology.2020;[Epub]     CrossRef
  • Effect of Korean Red Ginseng extract on colorectal lung metastasis through inhibiting the epithelial–mesenchymal transition via transforming growth factor-β1/Smad-signaling-mediated Snail/E-cadherin expression
    Ji-Ye Kee, Yo-Han Han, Jeong-Geon Mun, Seong-Hwan Park, Hee Dong Jeon, Seung-Heon Hong
    Journal of Ginseng Research.2019; 43(1): 68.     CrossRef
  • INC280 inhibits Wnt/β-catenin and EMT signaling pathways and its induce apoptosis in diffuse gastric cancer positive for c-MET amplification
    Sung-Hwa Sohn, Bohyun Kim, Hee Jung Sul, Yoo Jin Kim, Hyeong Su Kim, Hongtae Kim, Jong Bok Seo, Youngho Koh, Dae Young Zang
    BMC Research Notes.2019;[Epub]     CrossRef
  • Effects of 17β-estradiol on colorectal cancer development after azoxymethane/dextran sulfate sodium treatment of ovariectomized mice
    Chin-Hee Song, Nayoung Kim, Sun Min Lee, Ryoung Hee Nam, Soo In Choi, So Ra Kang, Eun Shin, Dong Ho Lee, Ha-Na Lee, Young-Joon Surh
    Biochemical Pharmacology.2019; 164: 139.     CrossRef
  • Evaluation of Absorbed Dose According to Nanoparticle Density During the Breast Cancer Brachytherapy
    Deuk-Hee Lee, Ji-Hee Nam, Jung-Hoon Kim
    Journal of Radiological Science and Technology.2019; 42(2): 131.     CrossRef
  • Obesity, abdominal obesity and subsequent risk of kidney cancer: a cohort study of 23.3 million East Asians
    Ga Eun Nam, Kyung Hwan Cho, Kyungdo Han, Chul Min Kim, Byoungduck Han, Sung Jung Cho, Seung Jin Jung, Yeongkeun Kwon, Yang Hyun Kim, Do Hoon Kim, Seon Mee Kim, Youn Seon Choi, Yong Kyun Roh, Yong Gyu Park
    British Journal of Cancer.2019; 121(3): 271.     CrossRef
  • Sexual dimorphism in the incidence of human cancers
    Daoshan Zheng, Justyna Trynda, Cecilia Williams, Jeremy A. Vold, Justin H. Nguyen, Denise M. Harnois, Sanjay P. Bagaria, Sarah A. McLaughlin, Zhaoyu Li
    BMC Cancer.2019;[Epub]     CrossRef
  • Synergistic combination of DT‐13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC‐823 cells via NM IIA/EGFR/HK II axis
    Xiao‐Wen Yu, Dandan Wei, Ying‐Sheng Gao, Hong‐Zhi Du, Bo‐Yang Yu, Rui‐Ming Li, Chang‐Min Qian, Xue‐Jun Luo, Sheng‐Tao Yuan, Jun‐Song Wang, Li Sun
    Journal of Cellular and Molecular Medicine.2019; 23(10): 6622.     CrossRef
  • Quality of Life and Supportive Care Needs of Back-to-Work Breast Cancer Survivors
    Su Jeong Han, Hye Won Kim, Dae Sung Yoon, Mi Ran Kim
    Korean Journal of Adult Nursing.2019; 31(5): 552.     CrossRef
  • A study on Polycyclic Aromatic Hydrocarbons Analysis Presented in the Residential Environment
    Sang-Ho Ko, Tae-Sook Lim
    Journal of Environmental Analysis, Health and Toxicology.2019; 22(4): 242.     CrossRef
  • MUDENG Expression Profiling in Cohorts and Brain Tumor Biospecimens to Evaluate Its Role in Cancer
    Juhyun Shin, Jun-Ha Choi, Seunghwa Jung, Somi Jeong, Jeongheon Oh, Do-Young Yoon, Man Hee Rhee, Jaehong Ahn, Se-Hyuk Kim, Jae-Wook Oh
    Frontiers in Genetics.2019;[Epub]     CrossRef
  • A qualitative study of healthcare providers’ perceptions and suggestions for developing cancer survivorship care models in South Korea
    J.W. Lim, E.J. Shon, E.J. Yang
    European Journal of Cancer Care.2018; 27(1): e12613.     CrossRef
  • A train the trainer program for healthcare professionals tasked with providing psychosocial support to breast cancer survivors
    Eunyoung Park, Junghee Yoon, Eun-kyung Choi, Im Ryung Kim, Danbee Kang, Se-Kyung Lee, Jeong Eon Lee, Seok Jin Nam, Jin Seok Ahn, Adriaan Visser, Juhee Cho
    BMC Cancer.2018;[Epub]     CrossRef
  • Association of gastric intestinal metaplasia and East Asian ethnicity with the risk of gastric adenocarcinoma in a U.S. population
    Alyssa Y. Choi, Lisa L. Strate, Matthew C. Fix, Rodney A. Schmidt, Alexander R. Ende, Matthew M. Yeh, John M. Inadomi, Joo Ha Hwang
    Gastrointestinal Endoscopy.2018; 87(4): 1023.     CrossRef
  • Clinicopathologic risk factors for right paraesophageal lymph node metastasis in patients with papillary thyroid carcinoma
    Q. A. Yu, D. K. Ma, K. P. Liu, P. Wang, C. M. Xie, Y. H. Wu, W. J. Dai, H. C. Jiang
    Journal of Endocrinological Investigation.2018; 41(11): 1333.     CrossRef
  • In silico and in vitro analysis of coumarin derivative induced anticancer effects by undergoing intrinsic pathway mediated apoptosis in human stomach cancer
    Haribalan Perumalsamy, Karuppasamy Sankarapandian, Karpagam Veerappan, Sathishkumar Natarajan, Narendran Kandaswamy, Lakshmi Thangavelu, Sri Renukadevi Balusamy
    Phytomedicine.2018; 46: 119.     CrossRef
  • Validation of a Questionnaire to Delineate the Clinical Trial Nursing Roles in Korea
    In Jung Choi, Hye-Ja Park
    Cancer Nursing.2018; 41(3): E30.     CrossRef
  • Changes in Oral Microbiota in Patients Receiving Radical Concurrent Chemoradiotherapy for The Head and Neck Squamous Cell Carcinoma
    Jin Ho Kim, Yoon Hee Choi, Soo-Youn An, Hee Young Son, Chulwon Choi, Seyeon Kim, Jin Chung, Hee Sam Na
    International Journal of Oral Biology.2018; 43(1): 13.     CrossRef
  • Optimal Endoscopic Screening Interval for Early Detection of Gastric Cancer: a Single-Center Study
    Sun Jin, Seong Woo Jeon, Yonghwan Kwon, Su Youn Nam, Seong Jae Yeo, Sang Hoon Kwon, Sang Jik Lee
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • The Flavonoid Jaceosidin from Artemisia princeps Induces Apoptotic Cell Death and Inhibits the Akt Pathway in Oral Cancer Cells
    Hye-Yeon Han, Hyung Joon Kim, Seung-Hwa Jeong, Jiyeon Kim, Sung-Hee Jeong, Gyoo Cheon Kim, Dae-Seok Hwang, Uk-Kyu Kim, Mi Heon Ryu, Solomon Habtemariam
    Evidence-Based Complementary and Alternative Medicine.2018;[Epub]     CrossRef
  • Chronologic changes in clinical and survival features of pancreatic ductal adenocarcinoma since 2000: A single-center experience with 2,029 patients
    Sang Hyun Shin, Song Cheol Kim, Ki-Byung Song, Dae Wook Hwang, Jae Hoon Lee, Kwang-Min Park, Young-Joo Lee
    Surgery.2018; 164(3): 432.     CrossRef
  • Estimation of the medical need for carbon-ion radiotherapy in Korea
    Ilsung Cho, Young Seok Seo, WonGyun Jung, Mi-sook Kim
    Journal of Radiation Research.2018; 59(5): 588.     CrossRef
  • Thyroid cancer among female workers in Korea, 2007–2015
    Seonghoon Kang, Jinho Song, Taehwan Koh, One Park, Jong-Tae Park, Won-Jin Lee
    Annals of Occupational and Environmental Medicine.2018;[Epub]     CrossRef
  • Efficacy and Safety of Robotic Procedures Performed Using the da Vinci Robotic Surgical System at a Single Institute in Korea: Experience with 10000 Cases
    Dong Hoon Koh, Won Sik Jang, Jae Won Park, Won Sik Ham, Woong Kyu Han, Koon Ho Rha, Young Deuk Choi
    Yonsei Medical Journal.2018; 59(8): 975.     CrossRef
  • Safety of Laparoscopic Radical Gastrectomy in Gastric Cancer Patients with End-Stage Renal Disease
    Hayemin Lee, Cho Hyun Park, Seung Man Park, Wook Kim, Hyung Min Chin, Jin Jo Kim, Kyo Young Song, Sung Geun Kim, Kyong Hwa Jun, Jeong Goo Kim, Han Hong Lee, Junhyun Lee, Dong Jin Kim
    Journal of Gastric Cancer.2018; 18(3): 287.     CrossRef
  • Germline Variants in MLH1, MSH2, and MSH6 in Korean Patients with Lynch Syndrome
    Kyoung-Jin Park, Dong Kyung Chang, Hee Cheol Kim, Jong-Won Kim
    Laboratory Medicine Online.2018; 8(4): 156.     CrossRef
  • Change in the Prevalences and Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in Korea: Multicenter Clinical Trials
    Young-Jae Hwang, Nayoung Kim, Sung Eun Kim, Gwang Ho Baik, Ju Yup Lee, Kyung Sik Park, Young-Eun Joo, Dae-Seong Myung, Hyeon Ju Kim, Hyun Joo Song, Heung Up Kim, Kwangwoo Nam, Jeong Eun Shin, Hyun Jin Kim, Gwang Ha Kim, Jongchan Lee, Seon Hee Lim, Geom Se
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2018; 18(4): 247.     CrossRef
  • Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer
    Young Ju Jung, In-Jae Oh, Youndong Kim, Jong Ha Jung, Minkyoung Seok, Woochang Lee, Cheol Kyu Park, Jung-Hwan Lim, Young-Chul Kim, Woo-Sung Kim, Chang-Min Choi
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • Microbiome of Hepatobiliary Diseases
    Yeseul Kim, Dongho Choi
    Hanyang Medical Reviews.2018; 38(2): 80.     CrossRef
  • Trace Element Contents in Thyroid Cancer Investigated by Instrumental Neutron Activation Analysis

    Journal of Oncology Research.2018; 1(1): 1.     CrossRef
  • Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer
    Feng Li, Janice M Yoshizawa, Kyoung-Mee Kim, Julie Kanjanapangka, Tristan R Grogan, Xiaoyan Wang, David E Elashoff, Shigeo Ishikawa, David Chia, Wei Liao, David Akin, Xinmin Yan, Min-Sun Lee, Rayun Choi, Su-Mi Kim, So-Young Kang, Jae-Moon Bae, Tae-Sung So
    Clinical Chemistry.2018; 64(10): 1513.     CrossRef
  • Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer
    Shinkyo Yoon, Changhoon Yoo, Min-Hee Ryu, Myoung Joo Kang, Baek-Yeol Ryoo, Sook Ryun Park, Jeong Hwan Yook, Sung Tae Oh, Moon-Won Yoo, Byung Sik Kim, Yoon-Koo Kang
    Gastric Cancer.2017; 20(1): 182.     CrossRef
  • Efficacy of metronomic oral cyclophosphamide with low dose dexamethasone and celecoxib in metastatic castration-resistant prostate cancer
    Yumun Jeong, Jae Lyun Lee
    Asia-Pacific Journal of Clinical Oncology.2017; 13(3): 204.     CrossRef
  • Breast, prostate, and thyroid cancer screening tests and overdiagnosis
    Minsoo Jung
    Current Problems in Cancer.2017; 41(1): 71.     CrossRef
  • Helicobacter pylori infection is an independent risk factor for colonic adenomatous neoplasms
    Ji Hyung Nam, Chang Won Hong, Byung Chang Kim, Aesun Shin, Kum Hei Ryu, Bum Joon Park, Bun Kim, Dae Kyung Sohn, Kyung Su Han, Jeongseon Kim, Chan Wha Lee
    Cancer Causes & Control.2017; 28(2): 107.     CrossRef
  • Intraperitoneal Administration of Plasma-Activated Medium: Proposal of a Novel Treatment Option for Peritoneal Metastasis From Gastric Cancer
    Shigeomi Takeda, Suguru Yamada, Norifumi Hattori, Kae Nakamura, Hiromasa Tanaka, Hiroaki Kajiyama, Mitsuro Kanda, Daisuke Kobayashi, Chie Tanaka, Tsutomu Fujii, Michitaka Fujiwara, Masaaki Mizuno, Masaru Hori, Yasuhiro Kodera
    Annals of Surgical Oncology.2017; 24(5): 1188.     CrossRef
  • Risk factors associated with high thyroglobulin level following radioactive iodine ablation, measured 12 months after treatment for papillary thyroid carcinoma
    Eun Young Kim, Kee Hoon Hyun, Yong Lai Park, Chan Heun Park, Ji-Sup Yun
    Annals of Surgical Treatment and Research.2017; 92(1): 1.     CrossRef
  • Information-sharing challenges between adolescents with cancer, their parents and health care providers: a qualitative study
    Masoud Bahrami, Mahboobeh Namnabati, Fariborz Mokarian, Parastoo Oujian, Paul Arbon
    Supportive Care in Cancer.2017; 25(5): 1587.     CrossRef
  • Trends in thyroid cancer incidence and mortality in Portugal
    Luís Raposo, Samantha Morais, Maria J. Oliveira, Ana P. Marques, Maria José Bento, Nuno Lunet
    European Journal of Cancer Prevention.2017; 26(2): 135.     CrossRef
  • Quality of Life after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Prospective Multicenter Cohort Study
    Sang Gyun Kim, Seon Mi Ji, Na Rae Lee, Seung-Hee Park, Ji Hye You, Il Ju Choi, Wan Sik Lee, Seun Ja Park, Jun Haeng Lee, Sang-Yong Seol, Ji Hyun Kim, Chul-Hyun Lim, Joo Young Cho, Gwang Ha Kim, Hoon Jai Chun, Yong Chan Lee, Hwoon-Yong Jung, Jae J. Kim
    Gut and Liver.2017; 11(1): 87.     CrossRef
  • Is it beneficial to perform surgical resection in elderly patients more than 80 years old with advanced gastric cancer?
    Jin Woo Choo, Yeonmi Ju, Hyun Lim, Sung Hee Youn, Jae Seung Soh, Ji Won Park, Ho Suk Kang, Sung Eun Kim, Sung Hoon Moon, Jong Hyeok Kim, Choong Kee Park, Hong Il Ha, Min-Jeong Kim, Kab-Choong Kim, Ji Woong Cho
    Scandinavian Journal of Gastroenterology.2017; 52(10): 1057.     CrossRef
  • Safety of laparoscopic radical gastrectomy in gastric cancer patients with liver cirrhosis
    Dong Jin Kim, Cho Hyun Park, Wook Kim, Hyung Min Jin, Jin Jo Kim, Han Hong Lee, Jun Hyun Lee
    Surgical Endoscopy.2017; 31(10): 3898.     CrossRef
  • Cutaneous Implantation Metastasis of Papillary Thyroid Carcinoma Following Fine Needle Aspiration Biopsy
    Chan Ho Na, Dong Jin Kim, Min Sung Kim, Bong Seok Shin
    Annals of Dermatology.2017; 29(1): 123.     CrossRef
  • Who are happy survivors? Physical, psychosocial, and spiritual factors associated with happiness of breast cancer survivors during the transition from cancer patient to survivor
    Danbee Kang, Im‐Ryung Kim, Eun‐Kyung Choi, Jung Hee Yoon, Se‐Kyung Lee, Jeong Eon Lee, Seok Jin Nam, Wonshik Han, Dong‐Young Noh, Juhee Cho
    Psycho-Oncology.2017; 26(11): 1922.     CrossRef
  • Epidemiology and treatment patterns of epithelial ovarian cancer
    Philip Jessmon, Talia Boulanger, Wei Zhou, Pallavi Patwardhan
    Expert Review of Anticancer Therapy.2017; 17(5): 427.     CrossRef
  • Bilateral Axillo‐Breast Approach Robotic Thyroidectomy (BABA RT) Does Not Interfere with Breast Image Follow‐Up
    Hyeong Won Yu, Young Jun Chai, Hyungju Kwon, Su‐jin Kim, June Young Choi, Kyu Eun Lee
    World Journal of Surgery.2017; 41(8): 2020.     CrossRef
  • PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Th
    Hiroji Iwata, Seock-Ah Im, Norikazu Masuda, Young-Hyuck Im, Kenichi Inoue, Yoshiaki Rai, Rikiya Nakamura, Jee Hyun Kim, Justin T. Hoffman, Ke Zhang, Carla Giorgetti, Shrividya Iyer, Patrick T. Schnell, Cynthia Huang Bartlett, Jungsil Ro
    Journal of Global Oncology.2017; 3(4): 289.     CrossRef
  • Obesity Markers as Predictors for Colorectal Neoplasia
    Jin-Hyun Kwon, Hae-Jin Ko, Chang-Ho Youn, Hye-In Choi
    Journal of Obesity & Metabolic Syndrome.2017; 26(1): 28.     CrossRef
  • Clinical features of recently diagnosed papillary thyroid carcinoma in elderly patients aged 65 and older based on 10 years of sonographic experience at a single institution in Korea
    Eun Sil Kim, Younghen Lee, Hyungsuk Seo, Gil Soo Son, Soon Young Kwon, Young-Sik Kim, Ji-A Seo, Nan Hee Kim, Sang-il Suh, Inseon Ryoo, Sung-Hye You
    Ultrasonography.2017; 36(4): 355.     CrossRef
  • Transoral endoscopic thyroidectomy: our initial experience using a new endoscopic technique
    Jun-Ook Park, Dong-Il Sun
    Surgical Endoscopy.2017; 31(12): 5436.     CrossRef
  • Can Endoscopic Bleeding Control Improve the Prognosis of Advanced Gastric Cancer Patients?
    Hyungchul Park, Ji Yong Ahn, Hwoon-Yong Jung, Joo Hyun Chun, Kwangwoo Nam, Jeong Hoon Lee, Kee Wook Jung, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Jin-Ho Kim
    Journal of Clinical Gastroenterology.2017; 51(7): 599.     CrossRef
  • Incidence of Pathological Downgrading and Treatment Outcome After Radical Prostatectomy in Patients With Biopsy Confirmed High Gleason Score Prostate Cancer
    Jun Phil Na, Jae Ho Yoo, Tae Heon Kim, Min Yong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Hyun Moo Lee, Han Yong Choi, Seong Soo Jeon
    The Korean Journal of Urological Oncology.2017; 15(2): 79.     CrossRef
  • The Prevalence of Depression among Patients with the Top Ten Most Common Cancers in South Korea
    Boram Park, Soyoung Youn, Ki-Kyung Yi, Su-yeon Lee, Jung-Sun Lee, Seockhoon Chung
    Psychiatry Investigation.2017; 14(5): 618.     CrossRef
  • β-Lapachone Inhibits Lung Metastasis of Colorectal Cancer by Inducing Apoptosis of CT26 Cells
    Ji-Ye Kee, Yo-Han Han, Jinbong Park, Dae-Seung Kim, Jeong-Geon Mun, Kwang Seok Ahn, Hyun-Jung Kim, Jae-Young Um, Seung-Heon Hong
    Integrative Cancer Therapies.2017; 16(4): 585.     CrossRef
  • Clinical features of gastric emptying after distal gastrectomy
    Dae Hoon Kim, Hyo Yung Yun, Young-Jin Song, Dong Hee Ryu, Hye-Suk Han, Joung-Ho Han, Ki Bae Kim, Soon Man Yoon, Sei Jin Youn
    Annals of Surgical Treatment and Research.2017; 93(6): 310.     CrossRef
  • Cytopathologic Features in Papillary Thyroid Cancer Arising From Benign Nodular Disease
    Su Yun Choi, Jin Chul Jung, Eun Sook Nam
    International Surgery.2017; 102(3-4): 165.     CrossRef
  • Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach
    Jisook Park, Eunjung Lee, Kyoung-Jin Park, Hyung-Doo Park, Jong-Won Kim, Hye In Woo, Kwang Hyuck Lee, Kyu-Taek Lee, Jong Kyun Lee, Joon-Oh Park, Young Suk Park, Jin Seok Heo, Seong Ho Choi, Dong Wook Choi, Kee-Taek Jang, Soo-Youn Lee
    Oncotarget.2017; 8(26): 42761.     CrossRef
  • Effects of alcohol consumption, ALDH2 rs671 polymorphism, and Helicobacter pylori infection on the gastric cancer risk in a Korean population
    Sarah Yang, Jeonghee Lee, Il Ju Choi, Young Woo Kim, Keun Won Ryu, Joohon Sung, Jeongseon Kim
    Oncotarget.2017; 8(4): 6630.     CrossRef
  • Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project
    Bo Hwa Sohn, Jun-Eul Hwang, Hee-Jin Jang, Hyun-Sung Lee, Sang Cheul Oh, Jae-Jun Shim, Keun-Wook Lee, Eui Hyun Kim, Sun Young Yim, Sang Ho Lee, Jae-Ho Cheong, Woojin Jeong, Jae Yong Cho, Joohee Kim, Jungsoo Chae, Jeeyun Lee, Won Ki Kang, Sung Kim, Sung Hoo
    Clinical Cancer Research.2017; 23(15): 4441.     CrossRef
  • Increasing thyroid cancer incidence in Queensland, Australia 1982–2008 – true increase or overdiagnosis?
    N. Pandeya, D.S. McLeod, K. Balasubramaniam, P.D. Baade, P.H. Youl, C.J. Bain, R. Allison, S.J. Jordan
    Clinical Endocrinology.2016; 84(2): 257.     CrossRef
  • A Case of von Hippel–Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas
    Su Jin Heo, Choong-kun Lee, Kyu Yeon Hahn, Gyuri Kim, Hyuk Hur, Sung Hoon Choi, Kyung Seok Han, Arthur Cho, Minkyu Jung
    Cancer Research and Treatment.2016; 48(1): 409.     CrossRef
  • Cancer literacy as a mediator for cancer screening behaviour in Korean adults
    Hee Yun Lee, Taeho Greg Rhee, Nam Keol Kim
    Health & Social Care in the Community.2016; 24(5): e34.     CrossRef
  • Postoperative Lower Extremity Edema in Patients with Primary Endometrial Cancer
    Hyo Sook Bae, Myong Cheol Lim, Jeong Seon Lee, Yumi Lee, Byung Ho Nam, Sang-Soo Seo, Sokbom Kang, Seung Hyun Chung, Joo-Young Kim, Sang-Yoon Park
    Annals of Surgical Oncology.2016; 23(1): 186.     CrossRef
  • Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013
    Mina Suh, Kui Son Choi, Boyoung Park, Yoon Young Lee, Jae Kwan Jun, Duk-Hyoung Lee, Yeol Kim
    Cancer Research and Treatment.2016; 48(1): 1.     CrossRef
  • An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer
    Jung-Yun Lee, Jina Youm, Jae Weon Kim, Kidong Kim, Hak Jae Kim, Jeong Yeon Cho, Min A Kim, Noh Hyun Park, Yong-Sang Song
    Cancer Research and Treatment.2016; 48(1): 259.     CrossRef
  • Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence‐free survival of medullary thyroid cancer: a large‐scale retrospective analysis over 30 years
    Kyong Yeun Jung, Seok‐Mo Kim, Won Sang Yoo, Bup‐Woo Kim, Yong Sang Lee, Kyung Won Kim, Kyu Eun Lee, Jong Ju Jeong, Kee‐Hyun Nam, Se Hoon Lee, Jeong Hun Hah, Woong Youn Chung, Ka Hee Yi, Do Joon Park, Yeo‐Kyu Youn, Myung‐Whun Sung, Bo Youn Cho, Cheong Soo
    Clinical Endocrinology.2016; 84(4): 587.     CrossRef
  • Age-Period-Cohort Analysis of Female Breast Cancer Mortality in Korea
    Yunhee Choi, Yeonju Kim, Sue K. Park, Hai-Rim Shin, Keun-Young Yoo
    Cancer Research and Treatment.2016; 48(1): 11.     CrossRef
  • Some Elements in Thyroid Tissue are Associated with More Advanced Stage of Thyroid Cancer in Korean Women
    Hye-Kyung Chung, Ji Sun Nam, Chul Woo Ahn, Yong Sang Lee, Kyung Rae Kim
    Biological Trace Element Research.2016; 171(1): 54.     CrossRef
  • Method evaluation of pepsinogen I/II assay based on chemiluminescent immunoassays and comparison with other test methods
    Eun-Jung Cho, Hyun-Ki Kim, Tae-Dong Jeong, Dae-Hyun Ko, Suh Eun Bae, Jong-Soo Lee, Woochang Lee, Jae Won Choe, Sail Chun, Hwoon-Yong Jung, Won-Ki Min
    Clinica Chimica Acta.2016; 452: 149.     CrossRef
  • Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma
    Lei Zhang, Hongfeng Liu, Yong Xie, Yu Xia, Bo Zhang, Guangliang Shan, Xiaoyi Li
    European Journal of Surgical Oncology (EJSO).2016; 42(1): 81.     CrossRef
  • Anti-cancer Effect of Luminacin, a Marine Microbial Extract, in Head and Neck Squamous Cell Carcinoma Progression via Autophagic Cell Death
    Yoo Seob Shin, Hyun Young Cha, Bok-Soon Lee, Sung Un Kang, Hye Sook Hwang, Hak Cheol Kwon, Chul-Ho Kim, Eun Chang Choi
    Cancer Research and Treatment.2016; 48(2): 738.     CrossRef
  • Population-Based Regional Cancer Incidence in Korea: Comparison between Urban and Rural Areas
    Haa-Na Song, Se-Il Go, Won Sup Lee, Yire Kim, Hye Jung Choi, Un Seok Lee, Myoung Hee Kang, Gyeong-Won Lee, Hoon-Gu Kim, Jung Hun Kang, Yune Sik Kang, Jeong-Hee Lee, Jin-Myung Jung, Soon Chan Hong
    Cancer Research and Treatment.2016; 48(2): 789.     CrossRef
  • Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?
    Kyung-Goo Lee, Hyuk-Joon Lee, Seung-Young Oh, Jun-Young Yang, Hye-Seong Ahn, Yun-Suhk Suh, Seong-Ho Kong, Tae-Yong Kim, Do-Youn Oh, Seock-Ah Im, Kuhn Uk Lee, Woo Ho Kim, Yung-Jue Bang, Han-Kwang Yang
    Annals of Surgical Oncology.2016; 23(4): 1234.     CrossRef
  • Diagnostic group classifications of gastric neoplasms by endoscopic resection criteria before and after treatment: real-world experience
    Jun Hee Lee, Yang Won Min, Jun Haeng Lee, Eun Ran Kim, Hyuk Lee, Byung-Hoon Min, Jae J. Kim, Kee-Taek Jang, Kyoung-Mee Kim, Cheol Keun Park
    Surgical Endoscopy.2016; 30(9): 3987.     CrossRef
  • Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer
    Feng-qi Nie, Shijie Ma, Min Xie, Yan-wen Liu, Wei De, Xiang-hua Liu
    Tumor Biology.2016; 37(6): 7693.     CrossRef
  • The caspase 3-dependent apoptotic effect of pycnogenol in human oral squamous cell carcinoma HSC-3 cells
    In-Hyoung Yang, Ji-Ae Shin, Lee-Han Kim, Ki Han Kwon, Sung-Dae Cho
    Journal of Clinical Biochemistry and Nutrition.2016; 58(1): 40.     CrossRef
  • Comparison of two- and three-dimensional sonography for the prediction of the extrathyroidal extension of papillary thyroid carcinomas
    Yang Seon Yi, Sang Soo Kim, Won Jin Kim, Min Jung Bae, Ji Hyun Kang, Bo Gwang Choi, Yun Kyung Jeon, Bo Hyun Kim, Byung Joo Lee, Soo Geun Wang, In Joo Kim, Yong Ki Kim
    The Korean Journal of Internal Medicine.2016; 31(2): 313.     CrossRef
  • CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer
    Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Rock Bum Kim, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha
    Cancer Research and Treatment.2016; 48(1): 142.     CrossRef
  • Prevalence rate and clinical characteristics of esophageal ectopic sebaceous glands in asymptomatic health screen examinees
    Areum Park, Jung-Hyun Lee, Ayoung Park, Young-Hwan Jung, Hyung-Jun Chu, Sang-Su Bae, Jeong-Kwon Kim, Won-Yong Kim, Byung-Kook Kim
    Diseases of the Esophagus.2016; : n/a.     CrossRef
  • Leptomeningeal metastasis: Clinical experience of 519 cases
    Jae-Won Hyun, In Hye Jeong, AeRan Joung, Hyo Jin Cho, Su-Hyun Kim, Ho Jin Kim
    European Journal of Cancer.2016; 56: 107.     CrossRef
  • Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer
    Dong Soo Lee, Yeon S. Kim, Chul S. Kay, Sung H. Kim, Chang D. Yeo, Jin W. Kim, Seung Joon Kim, Young K. Kim, Yoon H. Ko, Jin H. Kang, Kyo Y. Lee
    Medicine.2016; 95(6): e2795.     CrossRef
  • Survival Benefit of Early Cancer Detection Through Regular Endoscopic Screening for De Novo Gastric and Colorectal Cancers in Korean Liver Transplant Recipients
    D.H. Jung, S. Hwang, G.W. Song, C.S. Ahn, D.B. Moon, T.Y. Ha, K.H. Kim, G.C. Park, B.S. Kim, I.J. Park, S.B. Lim, J.C. Kim, M.W. Yoo, J.S. Byeon, H.Y. Jung, G.H. Lee, S.J. Myung, J. Choe, J.Y. Choi, H.W. Park, S.G. Lee
    Transplantation Proceedings.2016; 48(1): 145.     CrossRef
  • Incidence and Survival of Childhood Cancer in Korea
    Hyeon Jin Park, Eun-Kyeong Moon, Ju Young Yoon, Chang-Mo Oh, Kyu-Won Jung, Byung Kiu Park, Hee Young Shin, Young-Joo Won
    Cancer Research and Treatment.2016; 48(3): 869.     CrossRef
  • Mammographic Breast Density Evaluation in Korean Women Using Fully Automated Volumetric Assessment
    Inyoung Youn, SeonHyeong Choi, Shin Ho Kook, Yoon Jung Choi
    Journal of Korean Medical Science.2016; 31(3): 457.     CrossRef
  • The potential of deferasirox as a novel therapeutic modality in gastric cancer
    Jung Hye Choi, Jung Soon Kim, Young Woong Won, Jieun Uhm, Byeong Bae Park, Young Yiul Lee
    World Journal of Surgical Oncology.2016;[Epub]     CrossRef
  • A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population
    Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
    The Spine Journal.2016; 16(8): 937.     CrossRef
  • Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary
    Jeong-Yeol Park, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
    International Journal of Gynecology & Obstetrics.2016; 134(1): 49.     CrossRef
  • Improvement of clinical outcomes in the patients with gallbladder cancer: lessons from periodic comparison in a tertiary referral center
    Jihoon Chang, Jin‐Young Jang, Kyoung Bun Lee, Mee Joo Kang, Woohyun Jung, Yong Chan Shin, Sun‐Whe Kim
    Journal of Hepato-Biliary-Pancreatic Sciences.2016; 23(4): 234.     CrossRef
  • Management of long-term colorectal cancer survivors in Korea
    Hee-Taik Kang, Hyun Jung Bahk, Jae-Yong Shim, Nam Kyu Kim
    Journal of the Korean Medical Association.2016; 59(4): 276.     CrossRef
  • Significance of the Complete Surgical Staging of Stage I Malignant Ovarian Germ Cell Tumors
    Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
    Annals of Surgical Oncology.2016; 23(9): 2982.     CrossRef
  • Lung Cancer in Homeless People: Clinical Outcomes and Cost Analysis in a Single Institute
    Koung Jin Suh, Ki Hwan Kim, Jin Lim, Jin Hyun Park, Jin-Soo Kim, In Sil Choi
    Canadian Respiratory Journal.2016; 2016: 1.     CrossRef
  • One-Year Experience Managing a Cancer Survivorship Clinic Using a Shared-Care Model for Gastric Cancer Survivors in Korea
    Ji Eun Lee, Dong Wook Shin, Hyejin Lee, Ki Young Son, Warrick Junsuk Kim, Yun-Suhk Suh, Seong-Ho Kong, Hyuk Joon Lee, Belong Cho, Han-Kwang Yang
    Journal of Korean Medical Science.2016; 31(6): 859.     CrossRef
  • Prognostic significance of CEA expression by RT-PCR in peritoneal wash from patients with gastric cancer: result of a 5-year follow-up after curative resection
    Hyun-Dong Chae, In-Hwan Kim
    Scandinavian Journal of Gastroenterology.2016; 51(8): 956.     CrossRef
  • Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis
    Changhoon Yoo, Min-Hee Ryu, Young-Soon Na, Baek-Yeol Ryoo, Chae-Won Lee, Yoon-Koo Kang
    British Journal of Cancer.2016; 114(11): 1185.     CrossRef
  • Association between reduction in copayment and gastric cancer patient concentration to the capital area in South Korea: NHI cohort 2003–2013
    Kyu-Tae Han, Jeeyun Kim, Chung Mo Nam, Ki Tae Moon, Sang Gyu Lee, Seung Ju Kim, Yeong Jun Ju, Jeoung A Kwon, Sun Jung Kim, Woorim Kim, Eun-Cheol Park
    Health Policy.2016; 120(6): 580.     CrossRef
  • Changes in the types of liver diseases requiring hepatic resection: a single-institution experience of 9016 cases over a 10-year period
    Hwui-Dong Cho, Shin Hwang, Young-Joo Lee, Kwang-Min Park, Ki-Hun Kim, Jin Cheon Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Sung-Gyu Lee
    Korean Journal of Hepato-Biliary-Pancreatic Surgery.2016; 20(2): 49.     CrossRef
  • NKX6.3 Is a Transcription Factor for Wnt/β-catenin and Rho-GTPase Signaling-Related Genes to Suppress Gastric Cancer Progression
    Jung Hwan Yoon, Jung Woo Eun, Won Suk Choi, Olga Kim, Suk Woo Nam, Jung Young Lee, Won Sang Park
    EBioMedicine.2016; 9: 97.     CrossRef
  • Nuclear Medicine in Pediatric and Adolescent Tumors
    Pınar Özgen Kiratli, Murat Tuncel, Zvi Bar-Sever
    Seminars in Nuclear Medicine.2016; 46(4): 308.     CrossRef
  • Evaluation of Machine Learning Algorithm Utilization for Lung Cancer Classification Based on Gene Expression Levels
    Maxim D Podolsky, Anton A Barchuk, Vladimir I Kuznetcov, Natalia F Gusarova, Vadim S Gaidukov, Segrey A Tarakanov
    Asian Pacific Journal of Cancer Prevention.2016; 17(2): 835.     CrossRef
  • Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer
    Shinkyo Yoon, Byung Woog Kang, Su Yeon Park, Hye Jin Kim, Jun Seok Park, Gyu Seog Choi, Jong Gwang Kim
    Journal of Cancer Research and Clinical Oncology.2016; 142(8): 1775.     CrossRef
  • The clinical utilization of radiation therapy in Korea between 2009 and 2013
    Jin-Kyu Kang, Mi-Sook Kim, Won-Il Jang, Young Seok Seo, Hee Jin Kim, Chul Koo Cho, Hyung Jun Yoo, Eun Kyung Paik, Yu Jin Cha, Hyun Jin Song
    Radiation Oncology Journal.2016; 34(2): 88.     CrossRef
  • Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data
    Michael Carlberg, Lena Hedendahl, Mikko Ahonen, Tarmo Koppel, Lennart Hardell
    BMC Cancer.2016;[Epub]     CrossRef
  • Knowledge of HPV and Surgery among Women Who Underwent Cervical Conization: A Korean Multi-Center Study
    So Yeun Jun, Se Ik Kim, Myong Cheol Lim, Jung-Yun Lee, San Hui Lee, Yong Jung Song, Kyoung-Chul Chun, Jae Weon Kim, Sang-Yoon Park
    Yonsei Medical Journal.2016; 57(5): 1222.     CrossRef
  • High levels of carcinoembryonic antigen and smoking might be markers of colorectal adenoma in Korean males aged 40-49 years
    In Cheol Yoon, Jeong Hyeon Cho, Heejin Choi, Young Hoon Choi, Kyu Min Lim, Sung Hwa Choi, Jae Ho Han, Hyeon Ju Jeong, Hong Sub Lee
    Yeungnam University Journal of Medicine.2016; 33(1): 13.     CrossRef
  • Changing Patterns of Primary Treatment in Korean Men with Prostate Cancer Over 10 Years: A Nationwide Population Based Study
    Jinsung Park, Beomseok Suh, Dong Wook Shin, Jun Hyuk Hong, Hanjong Ahn
    Cancer Research and Treatment.2016; 48(3): 899.     CrossRef
  • Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX
    Mi-Jung Kim, Sae-Won Han, Dae-Won Lee, Yongjun Cha, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Se Hyung Kim, Seock-Ah Im, Yung-Jue Bang, Tae-You Kim
    Cancer Research and Treatment.2016; 48(3): 990.     CrossRef
  • Risk factors for lymph node metastasis in papillary thyroid microcarcinoma: Older patients with fewer lymph node metastases
    L. Zhang, J. Yang, Q. Sun, Y. Liu, F. Liang, Z. Liu, G. Chen, S. Chen, Z. Shang, Y. Li, X. Li
    European Journal of Surgical Oncology (EJSO).2016; 42(10): 1478.     CrossRef
  • Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of β-catenin
    Yoo Seob Shin, Sung Un Kang, Ju Kyeong Park, Yang Eun Kim, Yeon Soo Kim, Seung Joon Baek, Seong-Ho Lee, Chul-Ho Kim
    Phytomedicine.2016; 23(12): 1344.     CrossRef
  • Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
    Yaewon Yang, Seock-Ah Im, Bhumsuk Keam, Kyung‑Hun Lee, Tae‑Yong Kim, Koung Jin Suh, Han Suk Ryu, Hyeong-Gon Moon, Sae‑Won Han, Do‑Youn Oh, Wonshik Han, Tae‑You Kim, In Ae Park, Dong-Young Noh
    BMC Cancer.2016;[Epub]     CrossRef
  • High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
    Ji Soo Park, Hong Jae Chon, Hei-Cheul Jeung, Sang Joon Shin, Sun Young Rha, Joong Bae Ahn, Kang Young Lee, Nam Kyu Kim, Hyun Cheol Chung
    Journal of Cancer Research and Clinical Oncology.2016; 142(9): 2051.     CrossRef
  • Is a Preoperative Gastrointestinal Endoscopy for Second Primary Cancer Detection in Head and Neck Cancer Necessary? Ten-year Registry Data
    Gyeong Mi Heo, Mi Hee Kim, Jin Hwan Kim, Young Soo Rho, Woon Geon Shin
    The Korean Journal of Gastroenterology.2016; 68(1): 23.     CrossRef
  • Risk of Cardiovascular Disease Using Framingham Risk Score in Korean Cancer Survivors
    Ji-Hyun So, Jung-Kwon Lee, Jin-Young Shin, Wan Park
    Korean Journal of Family Medicine.2016; 37(4): 235.     CrossRef
  • Factors Associated with Depression Assessed by the Patient Health Questionnaire-2 in Long-Term Cancer Survivors
    Ae-Jin Goo, Yun-Mi Song, Jinyoung Shin, Hyeonyoung Ko
    Korean Journal of Family Medicine.2016; 37(4): 228.     CrossRef
  • How to Improve the Quality of Screening Endoscopy in Korea: National Endoscopy Quality Improvement Program
    Yu Kyung Cho
    Clinical Endoscopy.2016; 49(4): 312.     CrossRef
  • Gastric cancer from operating theatre to bench in Korea
    H-K Yang
    British Journal of Surgery.2016; 103(10): 1251.     CrossRef
  • Current Perspectives on Gastric Cancer
    Juan M. Marqués-Lespier, María González-Pons, Marcia Cruz-Correa
    Gastroenterology Clinics of North America.2016; 45(3): 413.     CrossRef
  • Chronic Myeloid Leukemia Following Radioactive Iodine Treatment for Thyroid Cancer: Two Case Reports and a Literature Review
    Hae Yeul Park, Sung-eun Choi, Young Hoon Ryu, Hang Seok Change, Cheong Soo Park, Kyoung Hwa Lee, Yu Ri Kim
    The Korean Journal of Medicine.2016; 91(1): 70.     CrossRef
  • Comparisons of clinicopathologic factors and survival rates between laparoscopic and open gastrectomy in gastric cancer
    Dong Jun Kim, Sang Hyuk Seo, Kwang Hee Kim, Yo-Han Park, Min Sung An, Ki Beom Bae, Chang Soo Choi, Sang Hoon Oh
    International Journal of Surgery.2016; 34: 161.     CrossRef
  • Solitary bone and brain metastasis in a patient with papillary thyroid carcinoma mimicking cavernous angioma
    Eugene Han, Ye Yeon Lee, El Kim, Sun Young Kwon, Sang Pyo Kim, Hye Soon Kim, Mi Kyung Kim
    The Korean Journal of Internal Medicine.2016; 31(5): 991.     CrossRef
  • Cervical Cancer Screening after Perimenopause: How Is Human Papillomavirus Test Performed?
    Soo-Ho Chung
    Journal of Menopausal Medicine.2016; 22(2): 65.     CrossRef
  • SIRT7, H3K18ac, and ELK4 Immunohistochemical Expression in Hepatocellular Carcinoma
    Hye Seung Lee, Wonkyung Jung, Eunjung Lee, Hyeyoon Chang, Jin Hyuk Choi, Han Gyeom Kim, Aeree Kim, Baek-hui Kim
    Journal of Pathology and Translational Medicine.2016; 50(5): 337.     CrossRef
  • Association between Socioeconomic Status and Cancer Screening in Koreans over 40 Years in Age Based on the 2010–2012 Korean National Health and Nutrition Examination Survey
    Jin-Young Kim, Hee-Taik Kang
    Korean Journal of Family Medicine.2016; 37(5): 287.     CrossRef
  • Polycyclic aromatic hydrocarbon emissions of non-road diesel engine treated with non-thermal plasma technology
    Jianbing Gao, Chaochen Ma, Shikai Xing, Liwei Sun, Jiangquan Liu
    Korean Journal of Chemical Engineering.2016; 33(12): 3425.     CrossRef
  • Return-to-Work Experiences among Nurses after Receiving Cancer Treatment
    Mi-Hye Kim, Jeong-Seon Kim, Han-Na Kim
    Journal of the Korea Academia-Industrial cooperation Society.2016; 17(6): 215.     CrossRef
  • Systematic Review of Trends in the Incidence Rates of Thyroid Cancer
    Joseph J. Wiltshire, Thomas M. Drake, Lesley Uttley, Sabapathy P. Balasubramanian
    Thyroid.2016; 26(11): 1541.     CrossRef
  • Comparison of survival of surgical resection and conservative treatment in patients with gastric cancer aged 80 years or older: a single-center experience
    Chung-Sik Gong, Jeong-Hwan Yook, Sung-Tae Oh, Byung-Sik Kim
    Annals of Surgical Treatment and Research.2016; 91(5): 219.     CrossRef
  • Development of a FFQ for breast cancer survivors in Korea
    Woo-kyoung Shin, Sihan Song, Eunkyung Hwang, Hyeong-Gon Moon, Dong-Young Noh, Jung Eun Lee
    British Journal of Nutrition.2016; 116(10): 1781.     CrossRef
  • Adjuvant radiotherapy for the treatment of stage IV rectal cancer after curative resection
    Min Jung Kim, Sang Jin Kim, Sung-Chan Park, Dae Yong Kim, Ji Won Park, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park, Heung Kwon Oh, Duck-Woo Kim, Sung-Bum Kang, Jung Nam Joo, Jae Hwan Oh
    Medicine.2016; 95(47): e4925.     CrossRef
  • Does the interval of screening endoscopy affect survival in gastric cancer patients?
    Jieun Kim, Su Mi Kim, Man Ho Ha, Jeong Eun Seo, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Sung Kim, Sin-Ho Jung, Jae Moon Bae
    Medicine.2016; 95(49): e5490.     CrossRef
  • Prevalence of Insomnia among Patients with the Ten Most Common Cancers in South Korea: Health Insurance Review and Assessment Service-National Patient Sample
    Boram Park, Soyoung Youn, Chi-Won Christine Hann, Kikyung Yi, Suyeon Lee, Jung-Sun Lee, Seockhoon Chung
    Sleep Medicine Research.2016; 7(2): 48.     CrossRef
  • Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer
    Hye rim Ha, Do-Youn Oh, Tae-Yong Kim, KyoungBun Lee, Kyubo Kim, Kyung-Hun Lee, Sae-Won Han, Eui Kyu Chie, Jin-Young Jang, Seock-Ah Im, Tae-You Kim, Sun-Whe Kim, Yung-Jue Bang, John Souglakos
    PLOS ONE.2016; 11(3): e0151406.     CrossRef
  • Converged Study on the Nurses' Knowledge and Performance of Cancer Pain Management in one city
    Kyoung Hee Jang, In Sook Jung
    Journal of the Korea Convergence Society.2016; 7(6): 115.     CrossRef
  • Metastatic prostate cancer initially presenting as chylothorax: A case report
    YU-JIN YANG, MINJUNG SEO, HEE-JEONG JEON, JIN-HEE NOH, SEOL HOON PARK, YUNSUK CHOI, JAE-CHEOL JO, JIN HO BAEK, SU-JIN KOH, HAWK KIM, YOUNG JOO MIN
    Molecular and Clinical Oncology.2016; 4(6): 1009.     CrossRef
  • Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer
    HYE YOUN SUNG, JIHYE HAN, WOONG JU, JUNG-HYUCK AHN
    Oncology Reports.2016; 36(1): 535.     CrossRef
  • Polyphenols from Korean prostrate spurge Euphorbia supina induce apoptosis through the Fas-associated extrinsic pathway and activation of ERK in human leukemic U937 cells
    MIN-HO HAN, WON SUP LEE, ARULKUMAR NAGAPPAN, HYE JUNG KIM, CHEOL PARK, GI-YOUNG KIM, SANG HOON HONG, NAM DEUK KIM, GONSUP KIM, CHUNG HO RYU, SUNG CHUL SHIN, YUNG HYUN CHOI
    Oncology Reports.2016; 36(1): 99.     CrossRef
  • Occult gastric cancer with distant metastasis proven by random gastric biopsy
    Sang Hyuk Lee, Kyu-Hyoung Lim, Seo-Young Song, Hui-Young Lee, Sung Chul Park, Chang Don Kang, Sung Joon Lee, Dong Wook Choi, Sung Bae Park, Young-Joon Ryu
    World Journal of Gastroenterology.2016; 22(16): 4270.     CrossRef
  • Synchronous and Metachronous Colon Cancers in Patients with Gastric Cancer: Report of 2 Cases
    Byoung Jo Suh
    Case Reports in Oncology.2016; 9(3): 752.     CrossRef
  • Impact of Perceived Cancer Risk on the Cancer Screening Rate in the General Korean Population: Results from the Korean Health Panel Survey Data
    Jae-Hyun Kim, Eun-Cheol Park, Ki-Bong Yoo
    Asian Pacific Journal of Cancer Prevention.2015; 15(23): 10525.     CrossRef
  • Transenteral Bowel Preparation for Colonoscopy Is More Comfortable than the Traditional Method with No Inferiority in Efficacy
    Sung-Won Jung, Da Hye Jung, Young Chul Shin, In Ho Moh, Hana Yoo, Sung Il Jang, Su Rin Shin, Jin Bae Kim, Sang Hoon Park, Myung Seok Lee
    Digestive Diseases and Sciences.2015; 60(1): 54.     CrossRef
  • Cytochrome P450 1 family and cancers
    Ryeo-Eun Go, Kyung-A Hwang, Kyung-Chul Choi
    The Journal of Steroid Biochemistry and Molecular Biology.2015; 147: 24.     CrossRef
  • Pharmacokinetic Properties of Two Erlotinib 150 mg Formulations with a Genetic Effect Evaluation in Healthy Korean Subjects
    Hyun-Gyu Choi, Ji-Young Jeon, Yong-Jin Im, Yunjeong Kim, Eun-Kee Song, Young-Hwan Seo, Seok-Je Cho, Min-Gul Kim
    Clinical Drug Investigation.2015; 35(1): 31.     CrossRef
  • Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea
    K S Choi, J K Jun, M Suh, B Park, D K Noh, S H Song, K W Jung, H-Y Lee, I J Choi, E-C Park
    British Journal of Cancer.2015; 112(3): 608.     CrossRef
  • Incidence of cancer in children aged 0–14 years in Taiwan, 1996–2010
    Yen-Lin Liu, Wei-Cheng Lo, Chun-Ju Chiang, Ya-Wen Yang, Meng-Yao Lu, Wen-Ming Hsu, Wan-Ling Ho, Meng-Ju Li, James S. Miser, Dong-Tsamn Lin, Mei-Shu Lai
    Cancer Epidemiology.2015; 39(1): 21.     CrossRef
  • RPM peptide conjugated bioreducible polyethylenimine targeting invasive colon cancer
    Yeong Mi Lee, Duhwan Lee, Jihoon Kim, Hansoo Park, Won Jong Kim
    Journal of Controlled Release.2015; 205: 172.     CrossRef
  • Intraoperatively Assessed Macroscopic Serosal Changes in Patients with Curatively Resected Advanced Gastric Cancer: Clinical Implications for Prognosis and Peritoneal Recurrence
    Changhoon Yoo, Min-Hee Ryu, Young Soo Park, Moon-Won Yoo, Sook Ryun Park, Baek-Yeol Ryoo, Se Jin Jang, Jeong Hwan Yook, Byung Sik Kim, Yoon-Koo Kang
    Annals of Surgical Oncology.2015; 22(9): 2940.     CrossRef
  • Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer
    Min-Hee Ryu, Changhoon Yoo, Jong Gwang Kim, Baek-Yeol Ryoo, Young Soo Park, Sook Ryun Park, Hye-Suk Han, Ik Joo Chung, Eun-Kee Song, Kyung Hee Lee, Seok Yun Kang, Yoon-Koo Kang
    European Journal of Cancer.2015; 51(4): 482.     CrossRef
  • Renal cryoablation of small renal masses: A Korea University experience
    Hyung Keun Kim, Jong Hyun Pyun, Jae Yoon Kim, Seung Bin Kim, Seok Cho, Sung Gu Kang, Jeong Gu Lee, Je Jong Kim, Jun Cheon, Seok Ho Kang
    Korean Journal of Urology.2015; 56(2): 117.     CrossRef
  • Effects of oriental medicine music therapy in an ovarian cancer patient with So-Eum-type constitution: a case report
    Seung-Hyun Lee, Eunhye Song, Seul-Ki Kim
    Integrative Medicine Research.2015; 4(1): 48.     CrossRef
  • Survival outcome in endometrial cancer patients according to hereditary predisposition
    Heon Jong Yoo, Myong Cheol Lim, Yedong Son, Sang-Soo Seo, Sokbom Kang, Sun Ho Kim, Chong Woo Yoo, Sang-Yoon Park
    Taiwanese Journal of Obstetrics and Gynecology.2015; 54(1): 24.     CrossRef
  • Ultimate eradication rate of Helicobacter pylori after first, second, or third‐line therapy in Korea
    Kichul Yoon, Nayoung Kim, Ryoung H Nam, Ji H Suh, Seonmin Lee, Jung M Kim, Ju Y Lee, Yong H Kwon, Yoon J Choi, Hyuk Yoon, Cheol M Shin, Young S Park, Dong H Lee
    Journal of Gastroenterology and Hepatology.2015; 30(3): 490.     CrossRef
  • Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates
    Allen S. Ho, Louise Davies, Iain J. Nixon, Frank L. Palmer, Laura Y. Wang, Snehal G. Patel, Ian Ganly, Richard J. Wong, R. Michael Tuttle, Luc G. T. Morris
    Cancer.2015; 121(11): 1793.     CrossRef
  • Gastric Cancer Screening Uptake Trends in Korea
    Sangeun Lee, Jae Kwan Jun, Mina Suh, Boyoung Park, Dai Keun Noh, Kyu-Won Jung, Kui Son Choi
    Medicine.2015; 94(8): e533.     CrossRef
  • Activation of insulin-like growth factor receptor signaling mediates resistance to histone deacetylase inhibitors
    Jin-Soo Kim, Su-Chan Lee, Hye-Young Min, Kwan Hee Park, Seung Yeob Hyun, So Jung Kwon, Sun Phil Choi, Woo-Young Kim, Hyo-Jong Lee, Ho-Young Lee
    Cancer Letters.2015; 361(2): 197.     CrossRef
  • Imaging Surveillance of Patients with Breast Cancer after Primary Treatment: Current Recommendations
    Jung Hyun Yoon, Min Jung Kim, Eun-Kyung Kim, Hee Jung Moon
    Korean Journal of Radiology.2015; 16(2): 219.     CrossRef
  • Prevalence and Characteristics of Chemotherapy-related Cognitive Impairment in Patients with Breast Cancer
    Jin-Hee Park, Sun Hyoung Bae, Yong-Sik Jung, Young-Mi Jung
    Journal of Korean Academy of Nursing.2015; 45(1): 118.     CrossRef
  • Factors Affecting the Locoregional Recurrence of Conventional Papillary Thyroid Carcinoma After Surgery: A Retrospective Analysis of 3381 Patients
    Yong Joon Suh, Hyungju Kwon, Su-jin Kim, June Young Choi, Kyu Eun Lee, Young Joo Park, Do Joon Park, Yeo-Kyu Youn
    Annals of Surgical Oncology.2015; 22(11): 3543.     CrossRef
  • Current status of randomized controlled trials for laparoscopic gastric surgery for gastric cancer in Korea
    Cheulsu Byun, Sang‐Uk Han
    Asian Journal of Endoscopic Surgery.2015; 8(2): 130.     CrossRef
  • Treatment for unresectable gastric cancer
    Tae-Yong Kim, Do-Youn Oh, Yung-Jue Bang
    Journal of the Korean Medical Association.2015; 58(3): 209.     CrossRef
  • Management of cancer survivors in Korea
    Dong Wook Shin, Sung Sunwoo, Jungkwon Lee
    Journal of the Korean Medical Association.2015; 58(3): 216.     CrossRef
  • Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Lesions
    Hae Woon Baek, Min Jee Park, Ye-Young Rhee, Kyoung Bun Lee, Min A Kim, In Ae Park
    Journal of Pathology and Translational Medicine.2015; 49(1): 52.     CrossRef
  • Feasibility of terahertz reflectometry for discrimination of human early gastric cancers
    Young Bin Ji, Chan Hyuk Park, Hyunki Kim, Sang-Hoon Kim, Gyu Min Lee, Sam Kyu Noh, Tae-In Jeon, Joo-Hiuk Son, Yong-Min Huh, Seungjoo Haam, Seung Jae Oh, Sang Kil Lee, Jin-Suck Suh
    Biomedical Optics Express.2015; 6(4): 1398.     CrossRef
  • Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer
    Jeong Il Yu, Doo Ho Choi, Seung Jae Huh, Won Park, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Won Ho Kil, Young-Hyuck Im, Jin Seok Ahn, Yeon Hee Park
    Journal of Breast Cancer.2015; 18(1): 50.     CrossRef
  • Pain Control, Nutritional and Emotional Support
    Dong Hee Koh
    Korean Journal of Pancreas and Biliary Tract.2015; 20(1): 22.     CrossRef
  • A Comparison of Outcomes of Three Reconstruction Methods after Laparoscopic Distal Gastrectomy
    Chang Hyun Kim, Kyo Young Song, Cho Hyun Park, Young Joo Seo, Seung-Man Park, Jin-Jo Kim
    Journal of Gastric Cancer.2015; 15(1): 46.     CrossRef
  • A Rare Case of Primary Thymic Adenocarcinoma Mimicking Small Cell Lung Cancer
    Eun Na Cho, Hye Sung Park, Tae Hoon Kim, Min Kwang Byun, Hyung Jung Kim, Chul Min Ahn, Yoon Soo Chang
    Tuberculosis and Respiratory Diseases.2015; 78(2): 112.     CrossRef
  • Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
    Yong-Hyub Kim, Sang-Yun Song, Hyun-Jeong Shim, Woong-Ki Chung, Sung-Ja Ahn, Mee Sun Yoon, Jae-Uk Jeong, Ju-Young Song, Taek-Keun Nam
    Radiation Oncology Journal.2015; 33(1): 12.     CrossRef
  • Sex Differences Associated With Hepatitis B Virus Surface Antigen Seropositivity Unwareness in Hepatitis B Virus Surface Antigen-positive Adults: 2007‐2012 Korea National Health and Nutrition Examination Survey
    Suk-Yong Jang, Sung-In Jang, Hong-Chul Bae, Jaeyong Shin, Eun-Cheol Park
    Journal of Preventive Medicine and Public Health.2015; 48(2): 74.     CrossRef
  • A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer
    Jin Won Kim, In Sil Choi, Yu Jung Kim, Kyung-Hun Lee, Keun-Wook Lee, Tae-Yong Kim, Sae-Won Han, Jee Hyun Kim, Tae-You Kim, Jong Seok Lee, Yung-Jue Bang, Seock-Ah Im, Do-Youn Oh
    Cancer Chemotherapy and Pharmacology.2015; 75(6): 1175.     CrossRef
  • The cytotoxic nature of Acanthopanax sessiliflorus stem bark extracts in human breast cancer cells
    Venkatesan Thamizhiniyan, Choi Young-Woong, Kim Young-Kyoon
    Saudi Journal of Biological Sciences.2015; 22(6): 752.     CrossRef
  • Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors
    Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
    Gynecologic Oncology.2015; 137(3): 418.     CrossRef
  • Overdiagnosis: epidemiologic concepts and estimation
    Jong-Myon Bae
    Epidemiology and Health.2015; 37: e2015004.     CrossRef
  • Association of Depression and Survival in Patients with Cancer over 10 Years
    Joohyung Kim, Suk Jeong Lee, Jae-Kyung Roh, Sang Jun Shin
    Asian Oncology Nursing.2015; 15(1): 37.     CrossRef
  • The Influence of Stress, Spousal Support, and Resilience on the Ways of Coping among Women with Breast Cancer
    Jiyoung Kang, Eunyoung E. Suh
    Asian Oncology Nursing.2015; 15(1): 1.     CrossRef
  • Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean
    Jong-Myon Bae
    Epidemiology and Health.2015; 37: e2015015.     CrossRef
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Hyunsoon Cho, Duk Hyoung Lee, Kang Hyun Lee
    Cancer Research and Treatment.2015; 47(2): 127.     CrossRef
  • Prediction of Cancer Incidence and Mortality in Korea, 2015
    Kyu-Won Jung, Young-Joo Won, Chang-Mo Oh, Hyun-Joo Kong, Hyunsoon Cho, Duk Hyoung Lee, Kang Hyun Lee
    Cancer Research and Treatment.2015; 47(2): 142.     CrossRef
  • The Korean guideline for thyroid cancer screening
    Ka Hee Yi, Soo Young Kim, Do Hoon Kim, Sun Wook Kim, Dong Gyu Na, You Jin Lee, Ki Wook Chung, Kui Son Choi, Yoon Woo Koh, Won Bae Kim, Kee-Hyun Nam, Seung-Kuk Baek, Jung Hwan Baek, Soon Young Lee, Yuh Seok Jung, Jung Jin Cho, Young-Su Ju, Ji Yeon Dang, Ye
    Journal of the Korean Medical Association.2015; 58(4): 302.     CrossRef
  • Flavonoids from Orostachys Japonicus A. Berger Induces Caspase-dependent Apoptosis at Least Partly through Activation of p38 MAPK Pathway in U937 Human Leukemic Cells
    Won Sup Lee, Jeong Won Yun, Arulkumar Nagappan, Ji Hyun Jung, Sang Mi Yi, Dong Hoon Kim, Hye Jung Kim, GonSup Kim, Chung Ho Ryu, Sung Chul Shin, Soon Chan Hong, Yung Hyun Choi, Jin-Myung Jung
    Asian Pacific Journal of Cancer Prevention.2015; 16(2): 465.     CrossRef
  • The impact of job status on quality of life: general population versus long-term cancer survivors
    Seo Yoon Lee, Sun Jung Kim, Jaeyong Shin, Kyu-Tae Han, Eun-Cheol Park
    Psycho-Oncology.2015; 24(11): 1552.     CrossRef
  • Nationwide epidemiology and healthcare utilization of spine tumor patients in the adult Korean population, 2009–2012
    Seil Sohn, Jinhee Kim, Chun Kee Chung, Na-Rye Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
    Neuro-Oncology Practice.2015; 2(2): 93.     CrossRef
  • Distribution of the Colonoscopic Adenoma Detection Rate According to Age: Is Recommending Colonoscopy Screening for Koreans Over the Age of 50 Safe?
    Taeseok Bae, Yunhyung Ha, Changkyun Kim, Jihyun Lee, Kwangil Ha, Sanghyun Shin, Youngcheol Lee, Yoonsik Kang
    Annals of Coloproctology.2015; 31(2): 46.     CrossRef
  • Laughter and Stress Relief in Cancer Patients: A Pilot Study
    S. H. Kim, Y. H. Kim, H. J. Kim
    Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1.     CrossRef
  • Development and application of patient decision aids
    Jong-Myon Bae
    Epidemiology and Health.2015; 37: e2015018.     CrossRef
  • The Association between the Adherence to Dietary Guidelines for Breast Cancer Survivors and Health-related Quality of Life among Korean Breast Cancer Survivors
    Sihan Song, Jiyoung Youn, Myungsook Park, Eunkyung Hwang, Hyeong-Gon Moon, Dong-Young Noh, Jung Eun Lee
    Korean Journal of Community Nutrition.2015; 20(2): 129.     CrossRef
  • Multivalent Aptamer/Gold Nanoparticle–Modified Graphene Oxide for Mass Spectrometry–Based Tumor Tissue Imaging
    Rong-Cing Huang, Wei-Jane Chiu, Irving Po-Jung Lai, Chih-Ching Huang
    Scientific Reports.2015;[Epub]     CrossRef
  • The Korean guideline for gastric cancer screening
    Hyun Ah Park, Su Youn Nam, Sang Kil Lee, Sang Gyun Kim, Ki-Nam Shim, Sang Min Park, Sun-Young Lee, Hye Seung Han, Yong Moon Shin, Kyoung-Mee Kim, Kyung-Jae Lee, Tae-Yong Lee, Il Ju Choi, Seong Sook Hong, Jae Woo Kim, Yoon Jae Lee, Soo Young Kim, Yeol Kim,
    Journal of the Korean Medical Association.2015; 58(5): 373.     CrossRef
  • Awareness of cervical cancer prevention among mothers of adolescent daughters in Korea: qualitative research
    Hae Won Kim, Duck Hee Kim
    BMJ Open.2015; 5(5): e006915.     CrossRef
  • Incidence of kidney, bladder, and prostate cancers in Korea: An update
    Wan Song, Hwang Gyun Jeon
    Korean Journal of Urology.2015; 56(6): 422.     CrossRef
  • Trends of liver cancer and its major risk factors in Korea
    Eun-Young Lee, Tran Thi Xuan Mai, Yoonjung Chang, Moran Ki
    Epidemiology and Health.2015; 37: e2015016.     CrossRef
  • The Effect of Gamisoyo-san Intravenous Pharmacopuncture on Restoration of Liver Function after Partial Hepatectomy in SD Rat
    Chan Lee, Jung-Hun Yun, Yun-kyoung Yim
    Journal of Korean Medicine.2015; 36(1): 22.     CrossRef
  • Laparoscopic Surgery for Colorectal Cancer in Korea: Nationwide Data from 2008~2013
    Sun Jin Park, Kil Yeon Lee, Suk-Hwan Lee
    The Journal of Minimally Invasive Surgery.2015; 18(2): 39.     CrossRef
  • The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database
    Zisun Kim, Sun Young Min, Chan Seok Yoon, Kyu-Won Jung, Beom Seok Ko, Eunyoung Kang, Seok Jin Nam, Seokwon Lee, Min Hee Hur
    Journal of Breast Cancer.2015; 18(2): 103.     CrossRef
  • Development of Job Standards of Clinical Dietitian for the Clinical Nutrition Therapy to Cancer Patients in Hospitals
    Soo-Kyong Choi, Gyung-Ah Wie, Song-Mi Lee, Eun Mi Kim, Mi-Sun Park, Cheongmin Sohn, Mi-Hye Woo, Dal Lae Ju, Jin-A Cha, Jung-Sook Seo
    Journal of the Korean Dietetic Association.2015; 21(2): 91.     CrossRef
  • Factors Influencing Quality of Life in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
    Hyoung-Sook Park, Hyun-Ju Lee, Jae-Hyun Ha
    Journal of Korean Academy of Fundamentals of Nursing.2015; 22(1): 69.     CrossRef
  • Alcohol Drinking, Cigarette Smoking and Risk of Colorectal Cancer in the Korean Multi-center Cancer Cohort
    Sooyoung Cho, Aesun Shin, Sue K. Park, Hai-Rim Shin, Soung-Hoon Chang, Keun-Young Yoo
    Journal of Cancer Prevention.2015; 20(2): 147.     CrossRef
  • Pachymic Acid Induces Apoptosis of EJ Bladder Cancer Cells by DR5 Up-Regulation, ROS Generation, Modulation of Bcl-2 and IAP Family Members
    Jin-Woo Jeong, Won Sup Lee, Se-il Go, Arulkumar Nagappan, Jun Young Baek, Jae-Dong Lee, Su-Jae Lee, Cheol Park, Gi Young Kim, Hye Jung Kim, Gon-Sup Kim, Taeg Kyu Kwon, Chung Ho Ryu, Sung Chul Shin, Yung Hyun Choi
    Phytotherapy Research.2015; 29(10): 1516.     CrossRef
  • Tumour volume changes assessed with high-quality KVCT in lung cancer patients undergoing concurrent chemoradiotherapy
    Y H Lee, Y S Kim, H C Lee, S W Lee, Y N Kang, J H Kang, S H Hong, Y K Kim, S J Kim, M I Ahn, D H Han, I R Yoo, J G Park, S W Sung, K Y Lee
    The British Journal of Radiology.2015; 88(1052): 20150156.     CrossRef
  • Cancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival Rates
    Kyong Yeun Jung, Sun Wook Cho, Young A Kim, Daein Kim, Byung-Chul Oh, Do Joon Park, Young Joo Park
    Journal of Pathology and Translational Medicine.2015; 49(4): 318.     CrossRef
  • Public perception of risk-reducing salpingectomy for preventing ovarian cancer
    Jun Hyeok Kang, Se Hyun Nam, Taejong Song, Woo Young Kim, Kyo Won Lee, Kye Hyun Kim
    Obstetrics & Gynecology Science.2015; 58(4): 284.     CrossRef
  • Association between information provision and decisional conflict in cancer patients
    J.A. Sim, J.S. Shin, S.M. Park, Y.J. Chang, A. Shin, D.Y. Noh, W. Han, H.K. Yang, H.J. Lee, Y.W. Kim, Y.T. Kim, S.Y. Jeong, J.H. Yoon, Y.J. Kim, D.S. Heo, T.Y. Kim, D.Y. Oh, H.G. Wu, H.J. Kim, E.K. Chie, K.W. Kang, Y.H. Yun
    Annals of Oncology.2015; 26(9): 1974.     CrossRef
  • The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
    Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
    Journal of Preventive Medicine and Public Health.2015; 48(4): 180.     CrossRef
  • The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer
    Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jeanny Kwon, Jin-Young Jang, Sun Whe Kim, Sae-Won Han, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang, Sung W. Ha
    Journal of Gastrointestinal Surgery.2015; 19(10): 1833.     CrossRef
  • Race and ethnicity considerations in GI endoscopy
    Amy Wang, Aasma Shaukat, Ruben D. Acosta, David H. Bruining, Vinay Chandrasekhara, Krishnavel V. Chathadi, Mohamad A. Eloubeidi, Robert D. Fanelli, Ashley L. Faulx, Lisa Fonkalsrud, Suryakanth R. Gurudu, Loralee R. Kelsey, Mouen A. Khashab, Shivangi Kotha
    Gastrointestinal Endoscopy.2015; 82(4): 593.     CrossRef
  • Impact of alcohol drinking on gastric cancer development according to Helicobacter pylori infection status
    Seung-Hyun Ma, Woohyun Jung, Elisabete Weiderpass, Jieun Jang, Yunji Hwang, Chunghyun Ahn, Kwang-Pil Ko, Soung-Hoon Chang, Hai-Rim Shin, Keun-Young Yoo, Sue K Park
    British Journal of Cancer.2015; 113(9): 1381.     CrossRef
  • Variable Endoscopic Findings and Clinicopathological Characteristics of Borrmann Type 4 Advanced Gastric Cancer
    Ji Young Chang, Ki-Nam Shim, Chung Hyun Tae, A Reum Choe, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Sung-Ae Jung
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2015; 15(3): 166.     CrossRef
  • Qualitative study on experience of health behavior among Korean low-income breast cancer survivors
    Young-Sun Rhee
    Journal of the Korea Academia-Industrial cooperation Society.2015; 16(5): 3188.     CrossRef
  • A Case of Sparganosis that Mimicked Recurrence of Contralateral Breast Cancer
    Seo Ae Han, Byung Woog Kang, Yee Soo Chae, Jun Seok Yoon, Sang Kyung Seo, Ho Young Park, Ji Yeong Park
    The Korean Journal of Medicine.2015; 89(4): 470.     CrossRef
  • Prevalence of Sarcopenia and Its Association with Metabolic Syndrome in Korean Cancer Survivors
    Ji Hyun Moon, Mi Hee Kong, Hyeon Ju Kim
    The Korean Journal of Obesity.2015; 24(3): 140.     CrossRef
  • Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients
    Dae-Won Lee, Sae-Won Han, Yongjun Cha, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Seock-Ah Im, Yung-Jue Bang, Ji Won Park, Seung-Bum Ryoo, Seung-Yong Jeong, Gyeong Hoon Kang, Kyu Joo Park, Tae-You Kim
    BMC Cancer.2015;[Epub]     CrossRef
  • Ablation of osteopontin suppressesN-methyl-N-nitrosourea andHelicobacter pylori-induced gastric cancer development in mice
    Su-Hyung Lee, Jun-Won Park, Du-Min Go, Hark Kyun Kim, Hyo-Jung Kwon, Sang-Uk Han, Dae-Yong Kim
    Carcinogenesis.2015; : bgv144.     CrossRef
  • Anti-oxidative and Anti-cancer Activities of Treculia africana Extract in Human Colon Adenocarcinoma HT29 Cells
    You Na Oh, Soojung Jin, Hyun-jin Park, Byung Woo Kim, Hyun Ju Kwon
    Journal of Life Science.2015; 25(5): 515.     CrossRef
  • The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in Korea
    Hee Joung Kim, Seung Hun Jang, Jeong-Seon Ryu, Jeong Eun Lee, Young Chul Kim, Min Ki Lee, Tae Won Jang, Shin-Yup Lee, Hidehiro Nakamura, Natsumi Nishikata, Maiko Mori, Yasushi Noguchi, Hiroshi Miyano, Kye Young Lee
    Lung Cancer.2015; 90(3): 522.     CrossRef
  • A qualitative study of women’s views on overdiagnosis and screening for thyroid cancer in Korea
    Sang Hee Park, Bomyee Lee, Sangeun Lee, Eunji Choi, Eun-Bi Choi, Jisu Yoo, Jae Kwan Jun, Kui Son Choi
    BMC Cancer.2015;[Epub]     CrossRef
  • Is screening and surveillance for early detection of gastric cancer needed in Korean Americans?
    Gwang Ha Kim, Sung Jo Bang, Alexander R. Ende, Joo Ha Hwang
    The Korean Journal of Internal Medicine.2015; 30(6): 747.     CrossRef
  • The necessity of an observational study on the interactions between allergic history and citrus fruit intake for the prevention of pancreatic cancer
    Jong-Myon Bae
    Epidemiology and Health.2015; 37: e2015028.     CrossRef
  • Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis
    Jong-Myon Bae
    Epidemiology and Health.2015; 37: e2015005.     CrossRef
  • Changing trends in the incidence (1999-2011) and mortality (1983-2013) of cervical cancer in the Republic of Korea
    Yoon Park, Champadeng Vongdala, Jeongseon Kim, Moran Ki
    Epidemiology and Health.2015; 37: e2015024.     CrossRef
  • Assessing Activity Limitation Among Cancer Survivors in Korea Using Data from a Nationwide Survey
    Myueng Guen Oh, Mi Ah Han, Yu Mi Byeon, Kyung Min Bae, Seong-Hyung Choi
    Asian Pacific Journal of Cancer Prevention.2015; 16(7): 2739.     CrossRef
  • Cost-effectiveness Analysis of Cervical Cancer Screening Strategies Based on the Papanicolaou Smear Test in Korea
    Min Jung Ko, Jimin Kim, Younhee Kim, Yoon Jae Lee, Sung Ran Hong, Jae Kwan Lee
    Asian Pacific Journal of Cancer Prevention.2015; 16(6): 2317.     CrossRef
  • Safety Management Status among Nurses Handling Anticancer Drugs: Nurse Awareness and Performance Following Safety Regulations
    Kyeong Weon Jeong, Bo-Young Lee, Myung Soon Kwon, Ji-Hye Jang
    Asian Pacific Journal of Cancer Prevention.2015; 16(8): 3203.     CrossRef
  • Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012
    Eun-Hye Park, Hyewon Lee, Young-Joo Won, Hee Young Ju, Chang-Mo Oh, Cecile Ingabire, Hyun-Joo Kong, Byung-Kiu Park, Ju Young Yoon, Hyeon-Seok Eom, Eunyoung Lee, Hyeon Jin Park
    Blood Research.2015; 50(4): 204.     CrossRef
  • Lung cancer risk in professional drivers in Korea: A population‐based proportionate cancer incidence ratio study
    Dong‐Hee Koh, Hyun‐Joo Kong, Chang‐Mo Oh, Kyu‐Won Jung, Donguk Park, Young‐Joo Won
    Journal of Occupational Health.2015; 57(4): 324.     CrossRef
  • Factors Affecting Prostate Cancer Screening Behavior
    Eun Nam Lee, Jin Hee Park, Sung Gum Kang, Seonyoung Yun, Kyung Mi Sin, Kyoung Mi Kim
    Asian Oncology Nursing.2015; 15(4): 256.     CrossRef
  • MHY218-induced apoptotic cell death is enhanced by the inhibition of autophagy in AGS human gastric cancer cells
    PYOUNG RAK CHOI, YONG JUNG KANG, BOKYUNG SUNG, JAE HYUN KIM, HYUNG RYONG MOON, HAE YOUNG CHUNG, SUNG EUN KIM, MOO IN PARK, SEUN JA PARK, NAM DEUK KIM
    International Journal of Oncology.2015; 47(2): 563.     CrossRef
  • The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells
    HWANG-BO HYUN, WON SUP LEE, SE-IL GO, ARULKUMAR NAGAPPAN, CHEOL PARK, MIN HO HAN, SU HYUN HONG, GONSUP KIM, GI YOUNG KIM, JAEHUN CHEONG, CHUNG HO RYU, SUNG CHUL SHIN, YUNG HYUN CHOI
    International Journal of Oncology.2015; 46(6): 2670.     CrossRef
  • Poncirin Induces Apoptosis in AGS Human Gastric Cancer Cells through Extrinsic Apoptotic Pathway by up-Regulation of Fas Ligand
    Venu Saralamma, Arulkumar Nagappan, Gyeong Hong, Ho Lee, Silvia Yumnam, Suchismita Raha, Jeong Heo, Sang Lee, Won Lee, Eun Kim, Gon Kim
    International Journal of Molecular Sciences.2015; 16(9): 22676.     CrossRef
  • The Effect of National Cancer Screening on Disparity Reduction in Cancer Stage at Diagnosis by Income Level
    Hye-Min Jung, Jin-Seok Lee, David R. Lairson, Yoon Kim, Bart O. Williams
    PLOS ONE.2015; 10(8): e0136036.     CrossRef
  • Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010)
    Yuh-S Jung, Jiwon Lim, Kyu-Won Jung, Junsun Ryu, Young-Joo Won, Jeffrey S Chang
    PLOS ONE.2015; 10(7): e0134160.     CrossRef
  • Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study
    Jae Young Joung, Jiwon Lim, Chang-Mo Oh, Kyu-Won Jung, Hyunsoon Cho, Sung Han Kim, Ho Kyung Seo, Weon Seo Park, Jinsoo Chung, Kang Hyun Lee, Young-Joo Won, Shian-Ying Sung
    PLOS ONE.2015; 10(10): e0140693.     CrossRef
  • Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
    Yung-Jue Bang, Seock-Ah Im, Keun-Wook Lee, Jae Yong Cho, Eun-Kee Song, Kyung Hee Lee, Yeul Hong Kim, Joon Oh Park, Hoo Geun Chun, Dae Young Zang, Anitra Fielding, Jacqui Rowbottom, Darren Hodgson, Mark J. O'Connor, Xiaolu Yin, Woo Ho Kim
    Journal of Clinical Oncology.2015; 33(33): 3858.     CrossRef
  • Relationship between Cancer Worry and Stages of Adoption for Breast Cancer Screening among Korean Women
    Eunji Choi, Yoon Young Lee, Hyo Joong Yoon, Sangeun Lee, Mina Suh, Boyoung Park, Jae Kwan Jun, Yeol Kim, Kui Son Choi, Ali Montazeri
    PLOS ONE.2015; 10(7): e0132351.     CrossRef
  • Diagnostic Value of Osteopontin in Ovarian Cancer: A Meta-Analysis and Systematic Review
    Zhi-De Hu, Ting-Ting Wei, Min Yang, Ning Ma, Qing-Qin Tang, Bao-Dong Qin, Hai-Tao Fu, Ren-Qian Zhong, Gianpaolo Papaccio
    PLOS ONE.2015; 10(5): e0126444.     CrossRef
  • Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients
    Anna Song
    World Journal of Gastroenterology.2015; 21(43): 12410.     CrossRef
  • Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
    Jeong Mo Bae
    World Journal of Gastroenterology.2015; 21(5): 1457.     CrossRef
  • Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea
    Suk Pyo Shin
    World Journal of Gastroenterology.2015; 21(46): 13064.     CrossRef
  • Companion diagnostics for the targeted therapy of gastric cancer
    Changhoon Yoo
    World Journal of Gastroenterology.2015; 21(39): 10948.     CrossRef
  • NKX6.3 controls gastric differentiation and tumorigenesis
    Jung Hwan Yoon, Won Suk Choi, Olga Kim, Sung Sook Choi, Eun Kyung Lee, Suk Woo Nam, Jung Young Lee, Won Sang Park
    Oncotarget.2015; 6(29): 28425.     CrossRef
  • Pediatric Patients With Multifocal Papillary Thyroid Cancer Have Higher Recurrence Rates Than Adult Patients: A Retrospective Analysis of a Large Pediatric Thyroid Cancer Cohort Over 33 Years
    Young Ah Lee, Hae Woon Jung, Hwa Young Kim, Hoonsung Choi, Hyun-Young Kim, J. Hun Hah, Do Joon Park, June-Key Chung, Sei Won Yang, Choong Ho Shin, Young Joo Park
    The Journal of Clinical Endocrinology & Metabolism.2015; 100(4): 1619.     CrossRef
  • Clinical Application of Genetics in Management of Colorectal Cancer
    Eun Ran Kim, Young-Ho Kim
    Intestinal Research.2014; 12(3): 184.     CrossRef
  • Non-surgical treatment versus radical esophagectomy for clinical T1N0M0 esophageal carcinoma: a single-center experience
    Inkeun Park, Yong-Hee Kim, Dok Hyun Yoon, Sook Ryun Park, Hyeong Ryul Kim, Jong Hoon Kim, Hwoon-Yong Jung, Gin Hyug Lee, Kyung-Ja Cho, Sung-Bae Kim
    Cancer Chemotherapy and Pharmacology.2014; 74(5): 995.     CrossRef
  • Health promotion and disease prevention in the older adults
    Chang Won Won
    Journal of the Korean Medical Association.2014; 57(9): 756.     CrossRef
  • Methodological issues for determining intervals of subsequent cancer screening
    Jong-Myon Bae
    Epidemiology and Health.2014; 36: e2014010.     CrossRef
  • Comparison of adenocarcinoma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery
    Min-Hyun Baek, Jeong-Yeol Park, Daeyeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
    Gynecologic Oncology.2014; 135(3): 462.     CrossRef
  • Two Hypotheses of Dense Breasts and Viral Infection for explaining incidence rates of breast cancer by age group in Korean women
    Jong-Myon Bae
    Epidemiology and Health.2014; : e2014020.     CrossRef
  • Serum prostate-specific antigen levels and type of work in tire manufacturing workers
    Soo-Hyeon Kim, Keun-Ho Jang, Won-Ju Park, Do-Hyeong Kwon, Won-Yang Kang, Hyeong-Min Lim, Jai-Dong Moon
    Annals of Occupational and Environmental Medicine.2014;[Epub]     CrossRef
  • Chemotherapy for Advanced Gastric Cancer in Elderly Patients
    Mi-Jung Kim, Sook Ryun Park
    Korean Journal of Medicine.2014; 87(5): 521.     CrossRef
  • Overdiagnosis and screening for thyroid cancer in Korea
    Jae-Ho Lee, Sang Won Shin
    The Lancet.2014; 384(9957): 1848.     CrossRef
  • A prospective cohort study on postoperative radiotherapy with TomoDirect using simultaneous integrated boost technique in early breast cancer
    Hyo Chun Lee, Sung Hwan Kim, Young Jin Suh, Mi Joo Chung, Dae Gyu Kang, Hyun Joo Choi, Jong Hoon Lee
    Radiation Oncology.2014;[Epub]     CrossRef
  • Difference in Adenoma Detection Rates according to Colonoscopic Withdrawal Times and the Level of Expertise
    Young Doo Kim, Won Ki Bae, Yun Ho Choi, Yoon Jung Jwa, Sang Kyung Jung, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Nam-Hoon Kim, Kyung-Ah Kim, June Sung Lee
    The Korean Journal of Gastroenterology.2014; 64(5): 278.     CrossRef
  • Prevention Strategies for Gastric Cancer: A Global Perspective
    Jin Young Park, Lawrence von Karsa, Rolando Herrero
    Clinical Endoscopy.2014; 47(6): 478.     CrossRef
  • Endoscopic Gastric Cancer Screening and Surveillance in High-Risk Groups
    Il Ju Choi
    Clinical Endoscopy.2014; 47(6): 497.     CrossRef
  • Distribution of Dense Breasts using Screening Mammography in Korean Women: a Retrospecitive Observational Study
    Jong-Myon Bae, Sang Yop Shin, Eun Hee Kim, Yoon-Nma Kim, Chung Mo Nam
    Epidemiology and Health.2014; : e2014027.     CrossRef
  • WITHDRAWN: Prostate cancer in Asia: A collaborative report
    Rui Chen, Shancheng Ren, Ming Kwong Yiu, Ng Chi Fai, Wai Sam Cheng, Lap Hong Ian, Seiji Naito, Tadashi Matsuda, Elijah Kehinde, Ali Kural, Jason Yichun Chiu, Rainy Umbas, Qiang Wei, Xiaolei Shi, Liqun Zhou, Jian Huang, Yiran Huang, Liping Xie, Lulin Ma, C
    Asian Journal of Urology.2014;[Epub]     CrossRef
  • Current Status and Future Prospect of Robotic Surgery in Korea
    Nak Song Sung, Seon-Hahn Kim
    The Journal of Minimally Invasive Surgery.2014; 17(4): 55.     CrossRef
  • Suggestions for establishing a sustainable risk communication platform for carcinogenic factors
    Keeho Park, Yong-Chan Kim, Youngho Kim, Meeyoung Cha, Woon Heui Han, Dae-Kyu Oh
    Epidemiology and Health.2014; : e2014034.     CrossRef
  • Quality Improvement of Gastrointestinal Endoscopy in Korea: Past, Present, and Future
    Jae Myung Cha
    The Korean Journal of Gastroenterology.2014; 64(6): 320.     CrossRef
  • Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010
    Yun Mi Choi, Tae Yong Kim, Eun Kyung Jang, Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Young Kee Shong, Won Bae Kim
    Endocrinology and Metabolism.2014; 29(4): 530.     CrossRef
  • Oral signs of acute leukemia for early detection
    Hyun-Chang Lim, Chang-Sung Kim
    Journal of Periodontal & Implant Science.2014; 44(6): 293.     CrossRef
  • Comparison of Compliance of Adjuvant Chemotherapy Between Laparoscopic and Open Surgery in Patients With Colon Cancer
    Kan Ho Chun, Byung Noe Bae, Hoon An, Hyeonseok Jeong, Hyunjin Cho, Geumhee Gwak, Keun Ho Yang, Ki Hwan Kim, Hong Ju Kim, Young Duk Kim
    Annals of Coloproctology.2014; 30(6): 274.     CrossRef
  • Uncut Roux-en-Y Reconstruction after Laparoscopic Distal Gastrectomy Can Be a Favorable Method in Terms of Gastritis, Bile Reflux, and Gastric Residue
    Ji Yeon Park, Yong Jin Kim
    Journal of Gastric Cancer.2014; 14(4): 229.     CrossRef
  • Nursing Needs and Burden of Family Caregivers of Middle-Aged Hepatocellular Carcinoma Patients
    Yu Jin Lee, Hyunwook Kang
    Asian Oncology Nursing.2014; 14(4): 227.     CrossRef
  • Factors Associated with Intention to receive Human Papillomavirus Vaccine in Undergraduate Women: An Application of the Theory of Planned Behavior
    Kyu Eun Lee
    Journal of Korean Academy of Fundamentals of Nursing.2014; 21(4): 457.     CrossRef
  • Knowledge, Attitude, and Preventive Health Behavior of Cancer in Middle-aged Men
    Youngrye Park, Hwee Wee
    The Korean Journal of Rehabilitation Nursing.2014; 17(2): 97.     CrossRef
  • Diet and Cancer Risk in the Korean Population: A Meta-analysis
    Hae Dong Woo, Sohee Park, Kyungwon Oh, Hyun Ja Kim, Hae Rim Shin, Hyun Kyung Moon, Jeongseon Kim
    Asian Pacific Journal of Cancer Prevention.2014; 15(19): 8509.     CrossRef
  • Cervical Cancer Trends in Mexico: Incidence, Mortality and Research Output
    Maricruz Anaya-Ruiz, Ana Karen Vincent, Martin Perez-Santos
    Asian Pacific Journal of Cancer Prevention.2014; 15(20): 8689.     CrossRef
  • Prostate cancer in Asia: A collaborative report
    Rui Chen, Shancheng Ren, Ming Kwong Yiu, Ng Chi Fai, Wai Sam Cheng, Lap Hong Ian, Seiji Naito, Tadashi Matsuda, Elijah Kehinde, Ali Kural, Jason Yichun Chiu, Rainy Umbas, Qiang Wei, Xiaolei Shi, Liqun Zhou, Jian Huang, Yiran Huang, Liping Xie, Lulin Ma, C
    Asian Journal of Urology.2014; 1(1): 15.     CrossRef
  • Creating of Standard Operating Procedures for Chronic Inhlation and Carcinogenicity Test
    Kyung-Taek Rim, Soo-Jin Kim
    Journal of Korean Society of Occupational and Environmental Hygiene.2014; 24(4): 578.     CrossRef
  • Selection of Candidate Materials and their Prioritization for Chronic Inhalation and Carcinogenicity Test
    Kyung-Taek Rim, Cheol-Hong Lim, Byung-Joon Ahn
    Journal of Korean Society of Occupational and Environmental Hygiene.2014; 24(4): 587.     CrossRef
  • Risk of Cancer Mortality according to the Metabolic Health Status and Degree of Obesity
    Chang-Mo Oh, Jae Kwan Jun, Mina Suh
    Asian Pacific Journal of Cancer Prevention.2014; 15(22): 10027.     CrossRef
  • Improving Accuracy and Completeness in the Collaborative Staging System for Stomach Cancer in South Korea
    Hyun-Sook Lim, Young-Joo Won, Yoo-Kyung Boo
    Asian Pacific Journal of Cancer Prevention.2014; 15(21): 9529.     CrossRef
  • Time Trends Analysis of Characteristics of Patients with Thyroid Cancer in a Single Medical Center
    Hyung Seo Jung, Min Ji Jeon, Dong Eun Song, Suck Joon Hong, Won Gu Kim, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Journal of Korean Thyroid Association.2014; 7(2): 159.     CrossRef
  • Oral Contraceptive Use and Breast Cancer in Korean Women
    Bo-Ram Choi, Moon-Hee Kwon, Mi-Ran Bang
    The Korean Journal of Health Service Management.2014; 8(4): 221.     CrossRef
  • Effect of Nerve-Sparing Radical Prostatectomy on Urinary Continence in Patients With Preoperative Erectile Dysfunction
    Yong Hyun Park, Oh Seong Kwon, Sung-Hoo Hong, Sae Woong Kim, Tae-Kon Hwang, Ji Youl Lee
    International Neurourology Journal.2006; 20(1): 69.     CrossRef
  • 24,753 View
  • 190 Download
  • 282 Web of Science
  • 302 Crossref
Close layer
Original Articles
Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2010
Eun-Ha Lee, Hoo-Yeon Lee, Kui Son Choi, Jae Kwan Jun, Eun-Cheol Park, Jin Soo Lee
Cancer Res Treat. 2011;43(3):141-147.   Published online September 30, 2011
DOI: https://doi.org/10.4143/crt.2011.43.3.141
AbstractAbstract PDFPubReaderePub
PURPOSE
The Korean National Cancer Screening Survey (KNCSS) is a continuous nationwide survey implemented by the National Cancer Center in Korea since 2004. The purpose of the present study was to report trends in cancer screening rates for the five major cancers (stomach, liver, colorectal, breast, and cervix uteri) in Korean men and women.
MATERIALS AND METHODS
The study used KNCSS data collected between 2004 and 2010. The survey was conducted on Korean men aged 40-74 years and Korean women aged 30-74 years with no history of cancer diagnosis. The annual percentage change and corresponding 95% confidence intervals were used to examine changes in annual screening rates.
RESULTS
Screening rates with recommendation increased by 4.4% annually for stomach cancer, 1.5% for liver cancer, 2.8% per year for colorectal cancer, 4.5% for breast cancer, and 1.2% for cervix uteri cancer. The increasing trend in cancer screening rates, with the exception of liver cancer, was significant.
CONCLUSION
Cancer screening rates have increased consistently from 2004 to 2010 among Korean men and women. Stomach and breast cancer screening rates in particular have increased markedly.

Citations

Citations to this article as recorded by  
  • A 6-year nationwide population-based study on the current status of gastric endoscopic resection in Korea using administrative data
    Jae Yong Park, Mi-Sook Kim, Beom Jin Kim, Jae Gyu Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?
    Se Kyung Lee, Seok Won Kim, Jong-Han Yu, Jeong Eon Lee, Ji Young Kim, Joohyun Woo, Seokwon Lee, Eun-Kyu Kim, Hyeong-Gon Moon, Sung Sang Ko, Seok Jin Nam
    Breast Cancer Research and Treatment.2019; 173(1): 189.     CrossRef
  • A Theory-Based and Culturally Aligned Training Program on Breast and Cervical Cancer Prevention for South Asian Community Health Workers
    Winnie K.W. So, Alice N.L. Kwong, Joanne M.T. Chen, Joanne C.Y. Chan, Bernard M.H. Law, Janet W.H. Sit, Carmen W.H. Chan
    Cancer Nursing.2019; 42(2): E20.     CrossRef
  • Effects of Screening on Gastric Cancer Management: Comparative Analysis of the Results in 2006 and in 2011
    Yun Gyoung Kim, Seong-Ho Kong, Seung-Young Oh, Kyung-Goo Lee, Yun-Suhk Suh, Jun-Young Yang, Jeongmin Choi, Sang Gyun Kim, Joo-Sung Kim, Woo Ho Kim, Hyuk-Joon Lee, Han-Kwang Yang
    Journal of Gastric Cancer.2014; 14(2): 129.     CrossRef
  • A comparison of dosimetric parameters between tomotherapy and three-dimensional conformal radiotherapy in rectal cancer
    Mina Yu, Joo Hwan Lee, Hong Seok Jang, Dong Min Jeon, Jae Suk Cheon, Hyo Chun Lee, Jong Hoon Lee
    Radiation Oncology.2013;[Epub]     CrossRef
  • Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?
    Ja Sung Choi, Jin Yi Choi, Hyeon Geun Cho, Ki Jun Han, Hee Man Kim, Jae Hee Cho, Yu Jin Kim
    Scandinavian Journal of Gastroenterology.2013; 48(6): 657.     CrossRef
  • The Status for Radiation Treatment of Cancer Patients focused on Busan Area
    Euntae Park, Sungkwang Park
    Journal of the Korean Society of Radiology.2013; 7(2): 151.     CrossRef
  • The National Cancer Screening Program for Breast Cancer in the Republic of Korea: Is it Cost-Effective?
    Moon Hae Kang, Eun-Cheol Park, Kui Son Choi, MiNa Suh, Jae Kwan Jun, Eun Cho
    Asian Pacific Journal of Cancer Prevention.2013; 14(3): 2059.     CrossRef
  • Cancer Screening in Korea, 2012: Results from the Korean National Cancer Screening Survey
    Mina Suh, Kui Son Choi, Yoon Young Lee, Boyoung Park, Jae Kwan Jun
    Asian Pacific Journal of Cancer Prevention.2013; 14(11): 6459.     CrossRef
  • Circulating Methylated Septin 9 Nucleic Acid in the Plasma of Patients with Gastrointestinal Cancer in the Stomach and Colon
    Hye Seung Lee, Sang Mee Hwang, Taek Soo Kim, Duck-Woo Kim, Do Joong Park, Sung-Bum Kang, Hyung-Ho Kim, Kyoung Un Park
    Translational Oncology.2013; 6(3): 290.     CrossRef
  • A Prospective Study on the Incidence of Postoperative Venous Thromboembolism in Korean Gastric Cancer Patients: An Inquiry into the Application of Western Guidelines to Asian Cancer Patients
    Jin Won Kim, Eun Ju Chun, Sang Il Choi, Do Joong Park, Hyung-Ho Kim, Soo-Mee Bang, Min Jeong Kim, Ju-Hee Lee, Moon-Soo Lee, Jeong-Ok Lee, Yu Jung Kim, Jee Hyun Kim, Jong Seok Lee, Keun-Wook Lee, Ju-Seog Lee
    PLoS ONE.2013; 8(4): e61968.     CrossRef
  • Obesity and Screening Compliance for Breast and Cervical Cancer in Korean Women
    Jin Kyun Park, Hyun Ah Park, Jin Joo Park, Young Gyu Cho
    Asian Pacific Journal of Cancer Prevention.2012; 13(7): 3271.     CrossRef
  • Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009
    Aesun Shin, Kyee-Zu Kim, Kyu-Won Jung, Sohee Park, Young-Joo Won, Jeongseon Kim, Dae Yong Kim, Jae Hwan Oh
    Cancer Research and Treatment.2012; 44(4): 219.     CrossRef
  • Awareness and Practice of Breast Self-examination among Korean Women: Results from a Nationwide Survey
    Bit-Na Yoo, Kui-Son Choi, Kyu-Won Jung, Jae-Kwan Jun
    Asian Pacific Journal of Cancer Prevention.2012; 13(1): 123.     CrossRef
  • Time to follow up after an abnormal finding in organized gastric cancer screening in Korea
    Hoo-Yeon Lee, Kui Son Choi, Jae Kwan Jun, Myung-Il Hahm, Eun-Cheol Park
    BMC Cancer.2012;[Epub]     CrossRef
  • Current status of the National Cancer Screening Program for cervical cancer in Korea, 2009
    Young Hwa Lee, Kui Son Choi, Hoo-Yeon Lee, Jae Kwan Jun
    Journal of Gynecologic Oncology.2012; 23(1): 16.     CrossRef
  • 13,202 View
  • 51 Download
  • 16 Crossref
Close layer
Clinical Characteristics of Malignant Pericardial Effusion Associated with Recurrence and Survival
Sung-Hwan Kim, Mi Hyang Kwak, Sohee Park, Hak Jin Kim, Hyun-Sung Lee, Moon Soo Kim, Jong Mog Lee, Jae Ill Zo, Jung Sil Ro, Jin Soo Lee
Cancer Res Treat. 2010;42(4):210-216.   Published online December 31, 2010
DOI: https://doi.org/10.4143/crt.2010.42.4.210
AbstractAbstract PDFPubReaderePub
Purpose

We evaluated clinical outcomes after drainage for malignant pericardial effusion with imminent or overt tamponade.

Materials and Methods

Between August 2001 and June 2007, 100 patients underwent pericardiocentesis for malignant pericardial effusion. Adequate follow-up information on the recurrence of pericardial effusion and survival status was available for 98 patients.

Results

Recurrence of effusion occurred in 30 patients (31%), all of whom were diagnosed with adenocarcinoma. Multivariate analysis indicated that adenocarcinoma of the lung (hazard ratio [HR], 6.6; 95% confidence interval [CI], 1.9 to 22.3; p=0.003) and progressive disease despite chemotherapy (HR, 4.3; 95% CI, 1.6 to 12.0; p=0.005) were independent predictors of recurrence. Survival rates three months after pericardiocentesis differed significantly with the type of primary cancer; the rates were 73%, 18%, 90% and 30% in patients with adenocarcinoma of the lung, squamous cell carcinoma of the lung, breast cancer and other cancers, respectively.

Conclusion

Recurrence and survival of patients with malignant pericardial effusion are dependent on the type of primary cancer and response to chemotherapy. Patients with adenocarcinoma of the lung may be good candidates for surgical drainage to avoid repeated pericardiocentesis, but pericardiocentesis is considered effective as palliative management in patients with other cancers.

Citations

Citations to this article as recorded by  
  • Pericardiocentesis versus window formation in malignant pericardial effusion: trends and outcomes
    Jaeoh Lee, Kyu Kim, Seo-Yeon Gwak, Hyun-Jung Lee, Iksung Cho, Geu-Ru Hong, Jong-Won Ha, Chi Young Shim
    Heart.2024; 110(12): 863.     CrossRef
  • Pericardial effusion in oncological patients: current knowledge and principles of management
    S. Mori, M. Bertamino, L. Guerisoli, S. Stratoti, C. Canale, P Spallarossa, I. Porto, P. Ameri
    Cardio-Oncology.2024;[Epub]     CrossRef
  • Malignant Pericardial Effusion: A Systematic Review
    Sarah E. Mudra, Danny Rayes, Ashwin K. Kumar, Jason Z. Li, Meredith Njus, Kevin McGowan, Charalampos Charalampous, Kazi A. Kalam, Alveena Syed, Muhammad Majid, Mary Schleicher, Ankit Agrawal, Abdullah Yesilyaprak, Allan L. Klein
    CJC Open.2024; 6(8): 967.     CrossRef
  • A Case Report of Video-assisted Thoracoscopic Pericardiectomy for Postpericardiotomy Recurrent Loculated Pericardial Effusion
    Hao-Wen Chang, Chen-Liang Tsai
    Journal of Medical Sciences.2024; 44(5): 231.     CrossRef
  • Recommendations of the Brazilian Society of Surgical Oncology for the Treatment of Neoplastic Pericardial Effusion
    Erlon de Avila Carvalho, Rachid Eduardo Noleto da Nobrega Oliveira, José Henrique Agner Ribeiro, Jefferson Luís Gross, Cezar Augusto Vendas Galhardo, Heládio Feitosa e Castro Neto, Giovana dos Santos, Reitan Ribeiro, Alexandre Ferreira Oliveira, Rodrigo N
    Journal of Surgical Oncology.2024;[Epub]     CrossRef
  • Prevalence, characteristics and mortality of cancer patients undergoing pericardiocentesis in the United States between 2004 and 2017
    Andrija Matetic, Bonnie Ky, Eric H. Yang, Phyo K. Myint, Muhammad Rashid, Shelley Zieroth, Timir K. Paul, Ayman Elbadawi, Mamas A. Mamas
    Cancer Medicine.2023; 12(5): 5471.     CrossRef
  • Breast Cancer Complicated by Cardiac Tamponade in a Patient With Neurofibromatosis Type 1
    Narek Hakobyan, Nosakhare Ilerhunmwuwa, Henry O Aiwuyo, Ephrem Sedeta, Ifeanyi Uche, Mustafa Wasifuddin, Jamal C Perry
    Cureus.2023;[Epub]     CrossRef
  • Cardiac tamponade
    Yehuda Adler, Arsen D. Ristić, Massimo Imazio, Antonio Brucato, Sabine Pankuweit, Ivana Burazor, Petar M. Seferović, Jae K. Oh
    Nature Reviews Disease Primers.2023;[Epub]     CrossRef
  • Peritoneal Carcinoma Unveiling a Hidden Threat: A Case of Malignant Pericardial Effusion
    Mohammed Abusuliman, Amr M Mohamed, Anas Mahmoud, Tala Beliani, Ibrahim M Ismail-Sayed
    Cureus.2023;[Epub]     CrossRef
  • Would the Addition of Immunotherapy Impact the Prognosis of Patients With Malignant Pericardial Effusion?
    Varsha Chiruvella, Asad Ullah, Islam Elhelf, Nikhil Patel, Nagla Abdel Karim
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis
    Talha Ahmed, Elie Mouhayar, Juhee Song, Efstratios Koutroumpakis, Nicolas L. Palaskas, Syed Wamique Yusuf, Juan Lopez-Mattei, Saamir A. Hassan, Peter Kim, Mehmet Cilingiroglu, Konstantinos Marmagkiolis, Ara A. Vaporciyan, Stephen Swisher, Anita Deswal, Ce
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Malignant Cardiac Tamponade: A Complication of Untreated Breast Cancer
    Mohamed Ramzi Almajed, Mark S Obri, Wasih Kamran, Abigail Entz
    Cureus.2022;[Epub]     CrossRef
  • High frequency ultrasound‐guided pericardiocentesis performed in the sitting position: A novel apical approach
    Lei Zhang, Xue‐Fei Zhang, Zhao Liu, Ying Liu, Cun‐Li Guo, Hua Shao, Bo Li, Cui Zhang, Hui Jing, Wen Cheng
    Clinical Cardiology.2021; 44(8): 1106.     CrossRef
  • How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia
    Robin Jacob, Nicolas L. Palaskas, Juan Lopez-Mattei, Saamir Hassan, Peter Kim, Teodora Donisan, Dinu Valentin Balanescu, Mehmet Cilingiroglu, Konstantinos Marmagkiolis, Cezar Iliescu
    JACC: CardioOncology.2021; 3(3): 452.     CrossRef
  • Pericardial Effusion and Cardiac Tamponade: Etiology and Evolution in the Contemporary Era
    Claudio Martins de Queiroz, Juliano Cardoso, Felix Ramires, Barbara Ianni, Viviane Tiemi Hotta, Charles Mady, Paula de Cassia Buck, Ricardo Ribeiro Dias, Luciano Nastari, Fábio Fernandes
    International Journal of Cardiovascular Sciences.2021; 34(5 Supl 1): 24.     CrossRef
  • The Effect of Lenvatinib in Patients with Thyroid Cancer with Pericardial Metastasis, Which Can Cause Cardiac Tamponade
    Keiichiro Okano, Akihito Arai, Satomi Ozawa, Hiroki Morimoto, Gaku Omura, Takahiro Tsujikawa, Shigeru Hirano
    Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo).2021; 124(11): 1525.     CrossRef
  • Clinico‐cytopathologic analysis of 574 Pericardial Effusion Specimens: Application of the international system for reporting serous fluid cytopathology (ISRSFC) and long‐term clinical follow‐up
    Min Jeong Song, Uiree Jo, Ji‐Seon Jeong, Kyung‐Ja Cho, Gyungyub Gong, Yong Mee Cho, Joon Seon Song
    Cancer Medicine.2021; 10(24): 8899.     CrossRef
  • Oncologic Emergencies—The Old, the New, and the Deadly
    Krishna Thandra, Zuhair Salah, Sanjay Chawla
    Journal of Intensive Care Medicine.2020; 35(1): 3.     CrossRef
  • Acute Myeloid Leukemia Presenting as Effusive Constrictive Pericarditis
    Andrew Lutz, Erik B. Schelbert, Konstantinos Lontos, James Rossetti, William Katz
    CASE.2020; 4(2): 97.     CrossRef
  • State-of-the-art Review: Interventional Onco-Cardiology
    Bala Pushparaji, Konstantinos Marmagkiolis, Cameron K. Miller, Moez K. Aziz, Dinu V. Balanescu, Teodora Donisan, Nicolas Palaskas, Peter Kim, Juan Lopez-Mattei, Mehmet Cilingiroglu, Saamir A. Hassan, Cezar A. Iliescu
    Current Treatment Options in Cardiovascular Medicine.2020;[Epub]     CrossRef
  • In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening
    Cheng-Guang Wu, Francesca Chiovaro, Alessandra Curioni-Fontecedro, Ruben Casanova, Alex Soltermann
    Journal of Translational Medicine.2020;[Epub]     CrossRef
  • Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes
    Massimo Imazio, Marzia Colopi, Gaetano Maria De Ferrari
    Heart.2020; 106(8): 569.     CrossRef
  • Update on diagnosis and management of neoplastic pericardial disease
    Stefano Avondo, Alessandro Andreis, Matteo Casula, Massimo Imazio
    Expert Review of Cardiovascular Therapy.2020; 18(9): 615.     CrossRef
  • Oncological Emergencies from Pathophysiology and Diagnosis to Treatment: A Narrative Review
    Ameneh Jafari, Mostafa Rezaei-Tavirani, Maryam Salimi, Reza Tavakkol, Zahra Jafari
    Social Work in Public Health.2020; 35(8): 689.     CrossRef
  • Effect of Anti-Inflammatory Drugs on Clinical Outcomes in Patients With Malignant Pericardial Effusion
    So Ree Kim, Eun Kyoung Kim, Jinhyun Cho, Sung-A Chang, Sung-Ji Park, Sang-Chol Lee, Seung Woo Park
    Journal of the American College of Cardiology.2020; 76(13): 1551.     CrossRef
  • Cancer prevalence, inpatient mortality and its predictors after pericardiocentesis
    İ̇dris Buğra ÇERİK, Ferhat DİNDAŞ, Emin KOYUN, İ̇brahim GÜL
    Cumhuriyet Medical Journal.2020;[Epub]     CrossRef
  • Neoplastic Pericardial Effusion: A Monocentric Retrospective Study
    Elisabetta Di Liso, Alice Menichetti, Maria Vittoria Dieci, Cristina Ghiotto, Alberto Banzato, Alessandra Bianchi, Giovanna Pintacuda, Marta Padovan, Floriana Nappo, Enrico Cumerlato, Federica Miglietta, Eleonora Mioranza, Giulia Zago, Luigi Corti, Valent
    Journal of Palliative Medicine.2019; 22(6): 691.     CrossRef
  • Prognostic factors and nomogram for cancer-specific death in non small cell lung cancer with malignant pericardial effusion
    Zhi Gang Hu, Ke Hu, Wen Xin Li, Fan Jun Zeng, Anna Halama
    PLOS ONE.2019; 14(5): e0217007.     CrossRef
  • Morphological characterization and molecular profiling of malignant pericardial effusion in patients with pulmonary adenocarcinoma
    Bing Zhou, Lin Li, Dayou Shi, Tao Jiang, Guohui Xue, Jianping Xiong
    Indian Journal of Pathology and Microbiology.2019; 62(4): 566.     CrossRef
  • Cardiac Interventional Procedures in Cardio-Oncology Patients
    Teodora Donisan, Dinu Valentin Balanescu, Nicolas Palaskas, Juan Lopez-Mattei, Kaveh Karimzad, Peter Kim, Konstantinos Charitakis, Mehmet Cilingiroglu, Konstantinos Marmagkiolis, Cezar Iliescu
    Cardiology Clinics.2019; 37(4): 469.     CrossRef
  • Safety and Outcome of Percutaneous Drainage of Pericardial Effusions in Patients with Cancer
    Annop Lekhakul, Chalailak Assawakawintip, Eric R. Fenstad, Sorin V. Pislaru, Jeremy J. Thaden, Larry J. Sinak, Garvan C. Kane
    The American Journal of Cardiology.2018; 122(6): 1091.     CrossRef
  • The value of the new scoring system for predicting neoplastic pericarditis in the patients with large pericardial effusion
    M. Szturmowicz, A. Pawlak-Cieślik, A. Fijałkowska, J. Gątarek, A. Skoczylas, M. Dybowska, K. Błasińska-Przerwa, R. Langfort, W. Tomkowski
    Supportive Care in Cancer.2017; 25(8): 2399.     CrossRef
  • Cardiovascular Complications of Cancer Therapy
    Hui-Ming Chang, Tochukwu M. Okwuosa, Tiziano Scarabelli, Rohit Moudgil, Edward T.H. Yeh
    Journal of the American College of Cardiology.2017; 70(20): 2552.     CrossRef
  • Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality
    Kirstine Kobberøe Søgaard, Dóra Körmendiné Farkas, Vera Ehrenstein, Krishnan Bhaskaran, Hans Erik Bøtker, Henrik Toft Sørensen
    Circulation.2017; 136(11): 996.     CrossRef
  • A Minimum Volume of More Than 60 mL Is Necessary for Adequate Cytologic Diagnosis of Malignant Pericardial Effusions
    Lisa M. Rooper, Syed Z. Ali, Matthew T. Olson
    American Journal of Clinical Pathology.2016; 145(1): 101.     CrossRef
  • Patient with Small Cell Lung Carcinoma and Suspected Right Upper Lobe Abscess Presenting with a Purulent Pericardial Effusion
    Khushboo Goel, Huthayfa Ateeli, Neil M. Ampel, Dena L’heureux
    American Journal of Case Reports.2016; 17: 523.     CrossRef
  • Surgical pericardial drainage in a series of 235 consecutive patients: an 8-year experience
    Ali Azari, Negar Manavifar, Veda Vakili, Leila Bigdelu
    Indian Journal of Thoracic and Cardiovascular Surgery.2016; 32(4): 250.     CrossRef
  • 2015 update on the diagnosis and management of neoplastic pericardial disease
    Chiara Lestuzzi, Massimiliano Berretta, Witold Tomkowski
    Expert Review of Cardiovascular Therapy.2015; 13(4): 377.     CrossRef
  • Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion
    Danielle El Haddad, Cezar Iliescu, Syed Wamique Yusuf, William Nassib William, Tarif H. Khair, Juhee Song, Elie N. Mouhayar
    Journal of the American College of Cardiology.2015; 66(10): 1119.     CrossRef
  • Haemodynamic Monitoring of Pericardial Effusion with Cardiac Tamponade in a Patient with Colorectal Cancer

    Journal of Anesthesia & Critical Care: Open Access.2015;[Epub]     CrossRef
  • Un traitement local ambitieux est-il envisageable en cas de métastases intrapéricardiques d’un cancer bronchique ?
    M. Riquet, C. Rivera, P. Mordant, É. Fabre
    Revue des Maladies Respiratoires.2014; 31(5): 439.     CrossRef
  • Les autres métastases
    A. Roche, C. Audigier-Valette
    Revue des Maladies Respiratoires Actualités.2014; 6(2): 173.     CrossRef
  • Análisis de las características clínicas, ecocardiográficas, microbiológicas y citopatológicas de derrames pericárdicos en un hospital de tercer nivel de atención
    José Martín Santa Cruz-Ruiz, Guillermo Sahagún-Sánchez, Diana González-Cabello, Nydia Sánchez-González
    Archivos de Cardiología de México.2014; 84(2): 86.     CrossRef
  • Infiltrative Cardiomyopathy and Pericardial Disease
    Syed Wamique Yusuf, Smita I. Negi, Daniel J. Lenihan
    Seminars in Oncology.2013; 40(2): 199.     CrossRef
  • Malignant Pericardial Effusion
    I. Burazor, M. Imazio, G. Markel, Y. Adler
    Cardiology.2013; 124(4): 224.     CrossRef
  • Prognostic relevance of pericardial effusion in patients with malignant diseases
    Tae-Dong Jeong, Seongsoo Jang, Chan-Jeoung Park, Hyun-Sook Chi
    The Korean Journal of Hematology.2012; 47(3): 237.     CrossRef
  • Surgical properties and survival of a pericardial window via left minithoracotomy for benign and malignant pericardial tamponade in cancer patients
    Sezai Celik, Muharrem Celik, Bulent Aydemir, Handan Tanrıkulu, Tamer Okay, Nurşen Tanrikulu
    World Journal of Surgical Oncology.2012;[Epub]     CrossRef
  • Pericardial Diseases
    David M. Dudzinski, Gary S. Mak, Judy W. Hung
    Current Problems in Cardiology.2012; 37(3): 75.     CrossRef
  • Epidemiology, diagnosis and therapy of neoplastic pericarditis
    Chiara Lestuzzi
    Journal of Cardiovascular Echography.2011; 21(2): 86.     CrossRef
  • Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment
    Mark A. Lewis, Andrea Wahner Hendrickson, Timothy J. Moynihan
    CA: A Cancer Journal for Clinicians.2011; 61(5): 287.     CrossRef
  • 12,076 View
  • 94 Download
  • 50 Crossref
Close layer
Case Report
Plasmablastic Lymphoma in the Anal Canal
Joo Han Lim, Moon Hee Lee, Man Jong Lee, Chul Soo Kim, Jin Soo Lee, Suk Jin Choi, Hyeon Gyu Yi
Cancer Res Treat. 2009;41(3):182-185.   Published online September 28, 2009
DOI: https://doi.org/10.4143/crt.2009.41.3.182
AbstractAbstract PDFPubReaderePub

Plasmablastic lymphoma (PBL) of the oral cavity is an acquired immunodeficiency syndrome-related lymphoma. The immunophenotype of this disease is associated with poor expression of B-cell markers but a positive reactivity for plasma cell markers. PBL is highly aggressive and responds poorly to treatment. Although originally described in the oral cavity, this disease can occur in other body niches. Here, we describe a very rare case of PBL in the anal canal of a 40-year-old woman with human immunodeficiency virus infection. The malignant cells were positive for Epstein-Barr virus and human herpes virus 8.

Citations

Citations to this article as recorded by  
  • Anal lymphoma: a tumor with insufficient attention
    Xibo Liu, Hongliang Chen
    Discover Oncology.2023;[Epub]     CrossRef
  • A Case of Anal Malignant Lymphoma in which Excisional Biopsy was Useful for Confirming the Diagnosis
    Shun AKIYAMA, Mitsuru YOKOTA, Akitaka MORIKAWA, Michio OKABE, Hirohisa KITAGAWA, Kazuyuki KAWAMOTO
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2023; 84(4): 620.     CrossRef
  • Anorectal pathology in the HIV population: a guide for radiologists
    Derek Vos, Margaret Wang, Sita Ramaiya, Elias G. Kikano, Sree H. Tirumani, Daniel A. Smith
    Abdominal Radiology.2022; 47(5): 1762.     CrossRef
  • Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient
    Yuka Fukuo, Tomoyoshi Shibuya, Karin Ashizawa, Kentaro Ito, Michio Saeki, Hirofumi Fukushima, Masahito Takahashi, Kei Nomura, Koki Okahara, Keiichi Haga, Yoichi Akazawa, Osamu Nomura, Kanako Ogura, Hironao Okubo, Akihito Nagahara
    Internal Medicine.2021; 60(18): 2947.     CrossRef
  • Fistulizing Epstein-Barr virus-positive plasmablastic lymphoma in an HIV-positive man
    J. Rangel, R. Novoa, C. Morrison, D. Frank, C. Kovarik
    British Journal of Dermatology.2016; 174(2): 398.     CrossRef
  • Linfoma plasmablástico anal. Reporte de dos casos
    Cristina Grijalva-Santana, David San Marcos-Romero, Billy Jiménez-Bobadilla, Saulo Mendoza-Ramírez, Milly Diorey Reyes-Hansen, Carlos Cosme-Reyes
    Cirujano General.2016; 38(2): 78.     CrossRef
  • Plasmoblastic Lymphoma as Cause of Perianal Fistula
    Firoozeh Isfahani, Surabhi Amar, Harikrishna Dave, Daniel Gridley
    Journal of the International Association of Providers of AIDS Care (JIAPAC).2015; 14(1): 17.     CrossRef
  • A Case of Oral Plasmablastic Lymphoma and Review of Current Trends in Oral Manifestations Associated With Human Immunodeficiency Virus Infection
    Nicholas Medel, Aya Hamao-Sakamoto
    Journal of Oral and Maxillofacial Surgery.2014; 72(9): 1729.     CrossRef
  • Plasmablastic Lymphoma of the Anal Canal in an HIV-Infected Patient
    Agnaldo José Lopes
    American Journal of Case Reports.2014; 15: 543.     CrossRef
  • Manifestations of gastrointestinal plasmablastic lymphoma: A case series with literature review
    Lynette Luria
    World Journal of Gastroenterology.2014; 20(33): 11894.     CrossRef
  • A Case of Anal Malignant Lymphoma Coexistent with Adult T-cell Leukemia
    Katsuhisa Ohashi, Akinori Sasaki, Yoshihiro Matsuo, Katsuhide Ohashi
    Nippon Daicho Komonbyo Gakkai Zasshi.2013; 66(4): 269.     CrossRef
  • Extraoral plasmablastic lymphoma with intravascular component and MYC translocation
    Jennifer Chapman-Fredricks, Naomi Montague, Ikechukwu Akunyili, Offiong Ikpatt
    Annals of Diagnostic Pathology.2012; 16(1): 48.     CrossRef
  • A Case of Anal Malignant Lymphoma
    Satoru Umegae, Koichi Matsumoto, Tatsushi Kitagawa, Midori Noji, Takayuki Yamamoto, Masaaki Ishii, Kiyoshi Narita, Takahiro Torii, Tomonori Himan, Manabu Yamazaki
    Nippon Daicho Komonbyo Gakkai Zasshi.2011; 64(5): 332.     CrossRef
  • Plasmablastic lymphoma associated to Crohn's disease and hepatitis C virus chronic infection
    Rocio Plaza, Angel Ponferrada, Dulce M. Benito, Noelia Arevalo, Maria Angeles Foncillas, Maria Luisa de Fuenmayor, Mercedes Aldeguer
    Journal of Crohn's and Colitis.2011; 5(6): 628.     CrossRef
  • Plasmablastic lymphoma in the ano-rectal junction presenting in an immunocompetent man: a case report
    Mayur Brahmania, Thomas Sylwesterowic, Heather Leitch
    Journal of Medical Case Reports.2011;[Epub]     CrossRef
  • Oral cavity and extra-oral plasmablastic lymphomas in AIDS patients: report of five cases and review of the literature
    M Corti, M F Villafañe, A Bistmans, A Campitelli, M Narbaitz, P Baré
    International Journal of STD & AIDS.2011; 22(12): 759.     CrossRef
  • Assessment of Plasmablastic Lymphoma by F-18 FDG PET/CT
    Thomas Cazaentre, Laurence Sanhes, Guillaume Laurent, Keltoum Costa, Xavier Vallantin, Dominique Pascal-Ortiz
    Clinical Nuclear Medicine.2010; 35(11): 882.     CrossRef
  • 10,562 View
  • 58 Download
  • 17 Crossref
Close layer
Review Article
Passive Smoking and Lung Cancer
Hwangbo Bin, Jin Soo Lee
Cancer Res Treat. 2003;35(2):90-95.   Published online April 30, 2003
DOI: https://doi.org/10.4143/crt.2003.35.2.90
AbstractAbstract PDF
Passive smoking is an important risk factor for lung cancer and its impact might be more significant than generally appreciated in Korea. We reviewed the literatures that support the biologic plausibility of Environmental Tobacco Smoke (ETS) causing lung cancer and summarized epidemiological evidences. Because ETS exposure is a preventable risk factor, more social efforts should be directed to reduce ETS exposure.
  • 3,249 View
  • 25 Download
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP